000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|ţpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1736|3354|lyfalmen|V0045|1588|1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1736||1736|3354| 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|35033|45849|lyfsjukr|||1|2|0|24,0000|Icepharma hf|Roche|Epóetín||35033||35033|45849| 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|52630|67933|lyfsjukr|||1|2|0|36,0000|Icepharma hf|Roche|Epóetín||52630||52630|67933| 000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|11138|16215|lyfalmen|V0457|4460|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||11138||11138|16215| 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|32462|43285|lyfalmen|V0475|16545|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||32462||32462|43285| 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|42217|55527|lyfalmen|V0540|32274|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||42217||42217|55527| 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|22708|31044|lyfalmen|V0456|8622|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22708||22708|31044| 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|5271|7607|lyfsjukr|||1|1|0|0,0400|Vistor hf|Ferring|Atosíban||5271||5271|7607| 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|7973|15482|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||7973||7973|15482| 000237|G02CX0101|Tractocile|irţ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|14118|19601|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||14118||14118|19601| 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|E|0|ORG|0|0|0|100|DKK|21234|29194|lyfalmen|||1|0|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||21234||21234|29194| 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|E|0|ORG|0|0|0|100|DKK|41216|54271|lyfalmen|||1|1|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||41216||41216|54271| 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|ţpakki||N02CC04|01.03.1999||R|0|0|0|0|E|0|MSD|0|0|0|100|DKK|5604|8645|lyfalmen|||1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||5604||5604|8645| 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr|||1|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657| 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr|||1|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139| 000448|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|3441|5686|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Mómetasón||||3441|5686| 000530|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|áf.spr|án nála|J07BF03|01.06.2005||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|29412|39457|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||29412||29412|39457| 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|0|0|0|0|E|0|LTH|0|0|0|100|SEK|1953|3651|lyfalmen|||1|5|0||Vistor hf|Laboratoires THEA|Ketotifen||1953||1953|3651| 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|5122|7986|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||5122||5122|7986| 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|3978|6421|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3978||3978|6421| 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|0|0|0|0|0|0|LTH|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratoires THEA|Ketotifen|||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|0|0|0|0|E|0|LTH|0|0|0|100|SEK|5801|8914|lyfalmen|V0583|8914|1|24|0||Vistor hf|Laboratoires THEA|Ketotifen||5801||5801|8914| 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|7462|10770|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Fitusambönd||7462||7462|10770| 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|3229|5396|lyfalmen|||1|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||3229||3229|5396| 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3976|6418|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3976||3976|6418| 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|183239|231847|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||183239||183239|231847| 000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|23555|31444|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||23555||23555|31444| 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|6011|8675|lyfsjukr|||1|0|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||6011||6011|8675| 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|ţpakki||M01AH01|01.03.2003||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|1534|3077|lyfalmen|V0037|2514|1|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1534||1534|3077| 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|ţpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6700|10144|lyfalmen|||1|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6700||6700|10144| 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|ţpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|22170|30368|lyfalmen|V0115|6451|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||22170||22170|30368| 001291|C07AB0206|Seloken ZOC|forđatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|2543|4458|lyfalmen|V0050|2458|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2543||2543|4458| 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|30054|39600|lyfsjukr|||1|2|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||30054||30054|39600| 001437|N05AH0308|Lazapix|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|1|0|0|0|*|0|POF|0|0|0|100|IKR|2547|1846|lyfalmen|V0278|1846|2|28|0|7,0000|Portfarma ehf|Portfarma|Olanzapín||634||634|1846| 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|6435|9782|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||6435||6435|9782| 001512|C04AD0301|Trental|forđatfl|400|mg|100|stk|1|ţpakki||C04AD03|01.05.2002||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|4649|7338|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4649||4649|7338| 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.03.2000||R|1|0|0|0|0|0|ACA|0|0|0|100|IKR|883|2187|lyfalmen|V0038|2101|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2187| 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.03.2000||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2456|4339|lyfalmen|V0039|3701|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4339| 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|23162|30951|lyfsjukr|||1|4104|0||Icepharma hf|Fresenius Kabi|Blöndur||23162||23162|30951| 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|0|0|0|0|E|0|VIF|0|0|1|100|CHF|15957|22571|lyfalmen|V0034|20007|1|25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíđ (sykurflétta)||15957||15957|22571| 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|33749|44237|lyfsjukr|||1|6160|0||Icepharma hf|Fresenius Kabi|Blöndur||33749||33749|44237| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|2554|3686|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||2554||2554|3686| 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|4327|6898|lyfalmen|V0444|6898|0|15|0|75,0000|K.Pétursson hf|Alcon|Brinzólamíđ||4327||4327|6898| 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|913|2228|lyfalmen|V0004|516|1|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||913||913|2228| 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|1946|3373|lyfalmen|V0291|3373|2|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||1750||1750|3373| 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|6936|10467|lyfalmen|V0294|10467|2|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||6936||6936|10467| 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|4678|7378|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||4678||4678|7378| 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|3353|5566|lyfalmen|V0292|5566|2|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||3353||3353|5566| 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4756|7485|lyfalmen|V0004|2066|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4756||4756|7485| 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|5263|8178|lyfalmen|V0293|8178|2|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||5263||5263|8178| 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9442|13895|lyfalmen|V0011|2864|1|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9442||9442|13895| 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|1499|3029|lyfalmen|V0005|529|1|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1499||1499|3029| 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6654|10081|lyfalmen|V0005|2114|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6654||6654|10081| 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|ţpakki||A07EC02|01.01.2000||R|1|0|0|0|B|0|TIL|0|0|0|100|SEK|5806|8921|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5806|8921| 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5827|8950|lyfalmen|V0011|2557|1|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5827||5827|8950| 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27266|36101|lyfsjukr|||1|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||27266||27266|36101| 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14471|7739|lyfalmen|V0011|5114|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4942||4942|7739| 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10613|15497|lyfalmen|V0012|2557|1|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||10613||10613|15497| 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|3296|5488|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||3296||3296|5488| 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|19243|26695|lyfalmen|V0012|5114|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||19243||19243|26695| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.08.2002||R|1|0|0|0|B|0|MSD|0|0|0|100|DKK|18080|25236|lyfalmen|V0492|16687|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||18080||18080|25236| 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|0|0|1|BAY|0|0|0|100|SEK|109471|139269|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||109471|139269| 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|0|0|1|BAY|0|0|0|100|SEK|55799|71910|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||55799|71910| 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|0|0|1|BAY|0|0|0|100|SEK|28888|38137|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||28888|38137| 002391|G03AA1201|Yasmin|töflur|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.02.2001||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3565|5856|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||||3565|5856| 002413|G03AA1204|Yasmin 28|töflur|||84|stk|1|ţpakki|3+0,03 mg|G03AA12|01.10.2007||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3565|5856|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3565||3565|5856| 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín|||||2202|31.01.2013 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|SEK|3775|6585|vetorma|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|||3775||3775|6585| 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|1331|2800|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1331||1331|2800| 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|ALL|0|0|0|100|SEK|33165|43505|lyfsjukr|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||33165||33165|43505| 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|14943|16163|lyfalmen|V0089|2088|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||11100||11100|16163| 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|11045|16088|lyfalmen|V0515|4659|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||11045||11045|16088| 003099|L01DB0104|Myocet|irţ|50|mg|2|sett|1|pakki|ördreifa|L01DB01|01.07.2006||R|0|0|0|1|0|1|ZEP|0|0|0|100|DKK|259813|327948|lyfsjukr|||1|2|0||Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||259813||259813|327948| 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|19070|26478|lyfalmen|V0253|7347|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||19070||19070|26478| 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|37054|49048|lyfalmen|V0516|14564|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||37054||37054|49048| 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|*|0|PFP|0|0|0|100|SEK|11235|16348|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||11235||11235|16348| 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|*|0|PFP|0|0|0|100|SEK|16701|23505|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||16701||16701|23505| 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|211870|267779|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||211870||211870|267779| 003310|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|10156|14872|lyfalmen|V0356|14872|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10156||10156|14872| 003325|R03AK0702|Symbicort mite Turbuhaler|innúđadu|84,5|mcg/sk|120|skammtar|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|9414|13857|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9414||9414|13857| 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|ţpakki||L04AA10|01.04.2004||R|0|0|0|1|*|0|WTE|0|0|0|100|DKK|62776|81329|lyfalmen|V0567|81329|1|100|0|33,3300|Icepharma hf|Wyeth Europe|Sirolimus||62776||62776|81329| 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|1|1|0|0|*|0|TGR|0|0|0|100|SEK|4790|7531|lyfalmen|V0578|5432|1|28|0|14,0000|Vistor hf|Takeda Europe -|Píóglítazón||4790||4790|7531| 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|ţpakki||A02BB01|01.08.2002||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|3415|5650|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3415||3415|5650| 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|1|1|0|0|*|0|TGR|0|0|0|100|SEK|16548|12266|lyfalmen|V0572|12266|1|98|0|49,0000|Vistor hf|Takeda Europe -|Píóglítazón||8251||8251|12266| 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|1|1|0|0|*|0|TGR|0|0|0|100|SEK|7244|10888|lyfalmen|||1|28|0|28,0000|Vistor hf|Takeda Europe -|Píóglítazón||7244||7244|10888| 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|1|1|0|0|*|0|TGR|0|0|0|100|SEK|24725|26501|lyfalmen|V0573|26501|1|98|0|98,0000|Vistor hf|Takeda Europe -|Píóglítazón||19088||19088|26501| 003869|R01BA5202|Clarinase|forđatfl|10|mg|10|stk|1|pakki|ţp 10+240 mg|R01BA52|01.09.1998||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|926|2246|lyfalmen|||1|10|0|10,0000|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||926||926|2246| 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.11.2000||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1017|1972|lyfalmen|V0151|1785|2|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||726||726|1972| 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|ţpakki||M01AB05|01.03.1984||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|624|1833|lyfalmen|||1|20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||624||624|1833| 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.11.2000||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2389|4247|lyfalmen|V0322|3609|2|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||2389||2389|4247| 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|5|glös|80 + 20 mg/ml|J05AE06|01.08.2003||R|0|0|0|1|0|1|ABL|0|0|0|100|DKK|77175|98737|lyfsjukr|||1|300|0|30,0000|Vistor hf|Abbott Laboratories A/S|Lopinavír||77175||77175|98737| 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.1984||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|2258|4068|lyfalmen|V0469|2532|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2258||2258|4068| 004002|L04AD0101|Sandimmun|irţ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|23152|30938|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||23152||23152|30938| 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|8404|12475|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||8404||8404|12475| 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||| 004050|R03AK0601|Seretide|innúđal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|4477|7103|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4477||4477|7103| 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|ţpakki||N06AB06|01.05.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|629|1839|lyfalmen|||1|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||629||629|1839| 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|ţpakki||N05CD01|01.12.2000||R|1|0|0|0|0|0|MAB|0|0|1|100|DKK|1125|2518|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1125||1125|2518| 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|ţpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5811|8928|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5811||5811|8928| 004282|R03AK0601|Seretide|innúđal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|8272|12295|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8272||8272|12295| 004293|R03AK0601|Seretide|innúđal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|11619|16873|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||11619||11619|16873| 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|ţpakki||R06AX27|01.05.2001||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|673|1900|lyfalmen|V0366|861|1|10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||673||673|1900| 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|6294|9589|lyfalmen|||1|66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||6294||6294|9589| 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|22368|29954|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||22368||22368|29954| 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2001||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|1757|3382|lyfalmen|V0366|2582|1|30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1757||1757|3382| 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|ţpakki||A04AA01|01.01.2009||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|7728|5306|lyfalmen|V0381|4954|1|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||3163||3163|5306| 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2001||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|4918|7706|lyfalmen|V0458|5619|1|100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||4918||4918|7706| 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|5092|9950|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||5092||5092|9950| 004455|N02AX0208|Zytram|forđatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|E|0|NOP|0|0|1|100|DKK|3448|5696|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3448||3448|5696| 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|ţpakki||C01DA08|01.06.1980||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|699|1935|lyfalmen|||1|100|0|8,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||699||699|1935| 004478|N02AX0208|Zytram|forđatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|E|0|NOP|0|0|1|100|DKK|4599|7270|lyfalmen|V0226|2895|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4599||4599|7270| 004489|N02AX0208|Zytram|forđatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|E|0|NOP|0|0|1|100|DKK|6495|9864|lyfalmen|V0227|4439|1|56|0|28,0000|Icepharma hf|Norpharma |Tramadól||6495||6495|9864| 004500|N02AX0208|Zytram|forđatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|E|0|NOP|0|0|1|100|DKK|8645|12805|lyfalmen|V0228|5724|1|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||8645||8645|12805| 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dćla|einnota dćla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2373|4225|lyfalmen|||1|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||2373||2373|4225| 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.06.2005||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|3909|3038|lyfalmen|V0494|3038|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||1505||1505|3038| 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2556|2757|lyfalmen|V0318|2620|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||1300||1300|2757| 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|39283|51183|lyfsjukr|||1|1|0|12,0000|Icepharma hf|E. Merck AB|Sómatrópín||39283||39283|51183| 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1506|3039|lyfalmen|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1506||1506|3039| 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3503|5771|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||3503||3503|5771| 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|0|0|ACA|0|0|0|100|IKR|1836|2164|lyfalmen|V0071|2164|2|28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2164| 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|5614|5356|lyfalmen|V0320|5083|2|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||3200||3200|5356| 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|776|1451|lyfalmen|V0062|1386|2|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||345||345|1451| 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2703|2620|lyfalmen|V0317|2484|2|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||1200||1200|2620| 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|926|1451|lyfalmen|V0067|1386|2|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||345||345|1451| 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíđ|||||1811| 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|0|0|1|0|1|BIA|0|0|0|100|DKK|40468|52670|lyfsjukr|||1|5|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||40468||40468|52670| 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1778|3411|lyfalmen|V0318|1467|2|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3411| 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan|||||| 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|196414|248382|lyfsjukr|||1|5|0|60,0000|Icepharma hf|E. Merck AB|Sómatrópín||196414||196414|248382| 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|0|0|0|0|*|0|SDE|0|0|0|100|NOK|11596|16842|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||11596||11596|16842| 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|7308|7846|lyfalmen|V0250|4659|1|100|0|16,6667|Icepharma hf|Pfizer ApS|Gabapentín||5020||5020|7846| 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|8893|3969|lyfalmen|||1|100|0|22,2222|Icepharma hf|Pfizer ApS|Gabapentín||2186||2186|3969|30.11.2012 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|ţpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|689|1921|lyfalmen|||2|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||689||689|1921| 004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|*|0|POF|0|0|0|100|IKR|14905|6477|lyfalmen|V0282|6215|2|56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||4019||4019|6477| 004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|5751|8300|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5751||5751|8300| 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|397|1522|lyfalmen|||2|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||397||397|1522| 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|697|1932|lyfalmen|||2|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||697||697|1932| 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|1318|2782|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1318||1318|2782| 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1922|3608|lyfalmen|||1|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||1922||1922|3608| 005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2464|4350|lyfalmen|||1|0|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||||2464|4350| 005108|G04CA0201|Omnic|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.08.1998||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|9330|7475|lyfalmen|V0148|2983|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4749||4749|7475| 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2353|4198|lyfalmen|||2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2353||2353|4198| 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2710|4686|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2710||2710|4686| 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|3705|6047|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||3705||3705|6047| 005241|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|30466|40780|lyfalmen|||1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||30466||30466|40780| 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2002||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|55974|72793|lyfalmen|V0287|44612|1|100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||55974||55974|72793| 005303|N02CC0303|Zomig Nasal|nefúđi|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|0|0|0|0|E|0|ASZ|0|0|0|100|SEK|3671|6001|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3671||3671|6001| 005330|D08AG0201|Betadine|húđlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 005336|R01AA0704|Otrivin ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|0|0|0|0|E|0|LEP|0|0|1|100|DKK|1195|2614|lyfalmen|||1|2|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1195||1195|2614| 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|*|0|AZA|0|0|0|100|SEK|67702|87511|lyfalmen|V0451|82966|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||67702||67702|87511| 005390|R03BB0101|Atrovent|innúđal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|B|0|BOI|0|0|0|100|DKK|1578|3138|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||1578||1578|3138| 005503|N05AH0301|Zyprexa|húđuđtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|1|0|0|0|*|0|ELD|0|0|0|100|XEU|31449|19431|lyfalmen|V0283|7853|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13455||13455|19431| 005526|N05AH0301|Zyprexa|húđuđtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|39998|52743|lyfalmen|V0281|22963|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||39998||39998|52743| 005538|G03AA0702|Microgyn|töflur|||63|stk|1|ţpakki||G03AA07|01.06.1977||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1383|2871|lyfalmen|V0545|2838|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||1383||1383|2871| 005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Slímlosandi lyf nema slímţynnir (mucolytica)- guaifenesin|||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|6644|10068|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||6644||6644|10068| 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|7002|10557|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||||7002|10557| 005606|J07AH0703|NeisVac-C|bóluefni|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|0|0|0|0|0|0|BAX|0|0|0|100|USD|4350|6929|lyfalmen|||1|0|0||Icepharma hf|Baxter|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||4350||4350|6929| 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|*|0|LLS|0|0|0|100|DKK|1696|3299|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||1696||1696|3299| 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|*|0|LLS|0|0|0|100|DKK|2956|5023|lyfalmen|V0020|3905|1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||2956||2956|5023| 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|*|0|LLS|0|0|0|100|DKK|7849|11716|lyfalmen|V0020|11716|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||7849||7849|11716| 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|*|0|LLS|0|0|0|100|DKK|4313|6879|lyfalmen|V0020|5858|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||4313||4313|6879| 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra|||||| 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|1897|3574|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1897||1897|3574| 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|7054|9579|lyfalmen|V0324|3272|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6287||6287|9579| 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|3345|5203|lyfalmen|V0035|3809|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||3088||3088|5203| 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|19097|33314|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||19097||19097|33314| 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6649|10074|lyfalmen|V0325|2310|1|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6649||6649|10074| 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|11217|15020|lyfalmen|V0325|4125|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||10264||10264|15020| 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5373|7880|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5045||5045|7880| 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|ţpakki||P01BC02|01.01.1993||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|3710|6054|lyfalmen|||1|8|0|2,0000|Icepharma hf|Roche|Meflókvín||3710||3710|6054| 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|939|2263|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||939||939|2263| 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|17366|21995|lyfalmen|V0326|4287|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||15498||15498|21995| 005910|C09CA0301|Diovan|filmhtfl|80|mg|28|stk|1|ţpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|3789|6162|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3789||3789|6162| 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6862|9243|lyfalmen|V0246|4738|1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6041||6041|9243| 005932|C09CA0301|Diovan|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.01.2001|30.11.2012|R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|9440|12493|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||8417||8417|12493| 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|13446|19420|lyfalmen|V0327|2233|1|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||13446||13446|19420| 005954|C09CA0301|Diovan|filmhtfl|160|mg|28|stk|1|ţpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|4979|7790|lyfalmen|||1|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||4979||4979|7790| 005963|J01CR0204|Amoxin comp|filmhtfl|875|mg|14|stk|1|ţpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|ROY|0|0|1|100|XEU|2072|2210|lyfalmen|V0169|2210|2|14|0|12,2500|Medical ehf|ratiopharm Oy|Amoxicillín og ensímblokkar||900||900|2210| 005976|C09CA0301|Diovan|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.01.2001|30.11.2012|R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|12830|17830|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||12179||12179|17830| 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|NYC|0|0|0|100|DKK|89333|113995|lyfsjukr|||1|2|0|0,7500|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||89333||89333|113995| 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|6137|9374|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||6137||6137|9374| 006079|J02AX0403|Cancidas|irţ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|110793|140928|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||110793||110793|140928| 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|5953|9122|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5953||5953|9122| 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|NYC|0|0|0|100|DKK|166354|210657|lyfsjukr|||1|3|0|1,5000|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||166354||166354|210657| 006115|J02AX0403|Cancidas|irţ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|84612|108071|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||84612||84612|108071| 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2808|4820|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2808||2808|4820| 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|8353|16212|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|||||8353|16212| 006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|spr|áfyllt sprauta|B01AX05|01.07.2012||R|0|0|0|0|E|0|GGL|0|0|0|100|GBP|7095|10685|lyfalmen|||1|5|0|10,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||7095||7095|10685| 006579|D05AX5201|Daivobet|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|0|0|0|0|B|0|LEP|0|0|0|100|DKK|7413|11120|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7413||7413|11120| 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 006732|A16AB0401|Fabrazyme|irţ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GZE|0|0|0|100|XEU|575709|724397|lyfsjukr|||1|35|0|35,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||575709||575709|724397| 006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|ţpakki||G03AD01|01.01.2005||L|0|0|0|0|0|0|LAR|0|0|0|100|IKR|||lyflausa|||0|2|0|1,0000|Vistor hf|Laboratoire HRA Pharma|Levonorgestrel|||||| 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|ţpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|15544|22053|lyfalmen|||1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||15544||15544|22053| 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4963|7768|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4963||4963|7768| 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995|30.11.2012|R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|690|1923|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||690||690|1923| 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|26972|51963|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim Danmark|||26972||26972|51963| 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15004|21375|lyfalmen|V0117|11265|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||15004||15004|21375| 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995|30.11.2012|R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|2093|3842|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2093||2093|3842| 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7484|11217|lyfalmen|||1|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||7484||7484|11217| 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|22649|30970|lyfalmen|V0118|16605|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||22649||22649|30970| 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|5847|8977|lyfalmen|||1|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5847||5847|8977| 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9406|13846|lyfalmen|||1|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||9406||9406|13846| 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|28333|38103|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||28333||28333|38103| 007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|183612|232316|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||183612||183612|232316| 007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|350391|441623|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||350391||350391|441623| 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|3282|5469|lyfalmen|V0377|4732|1|3|0|30,0000|Vistor hf|Allergan|Bimatóprost||3282||3282|5469| 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|104309|132790|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||104309||104309|132790| 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|ţpakki||A02BA02|01.09.1983||L|1|0|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|ţpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|298207|376132|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||298207||298207|376132| 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|3428|5668|lyfalmen|V0374|4529|1|2|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3428||3428|5668| 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|CPS|0|0|0|100|SEK|9432|13613|lyfsjukr|||1|50|0||Icepharma hf|Clintec parenteral SA|Vítamín||9432||9432|13613| 007449|V03AB3401|Fomepizole OPi|irţ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|125875|159856|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||125875||125875|159856| 007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABS|0|0|0|100|DKK|24814|33024|lyfsjukr|||1|250|0||Vistor hf|Abbott Scandinavia AB|Sevóflúran||24814||24814|33024| 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dćla|til inntöku|QP52AA01|01.04.2002||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2090|3646|vetorma|||0|7|0||Icepharma hf|Bayer Animal Health GmbH|||2090||2090|3646| 007505|G04BD0702|Detrusitol Retard|forđahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|6629|10047|lyfalmen|||1|30|0|10,5000|Icepharma hf|Pfizer ApS|Tólteródín||6629||6629|10047| 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.1998|30.11.2012|R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3709|6053|lyfalmen|||1|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3709||3709|6053| 007538|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|0|0|0|0|0|0|SPL|0|0|0|100|DKK|5262|8177|lyfalmen|||1|30|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||5262||5262|8177| 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|4769|6883|lyfsjukr|||1|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4769||4769|6883| 007549|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|0|0|0|0|B|0|SPL|0|0|0|100|DKK|10256|15009|lyfalmen|||1|60|0|60,0000|Vistor hf|Schering-Plough Europe|Mometasón||10256||10256|15009| 007760|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|6806|10289|lyfalmen|||1|30|0|21,0000|Icepharma hf|Pfizer ApS|Tólteródín||6806||6806|10289| 007769|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|23107|31544|lyfalmen|V0589|28037|1|100|0|70,0000|Icepharma hf|Pfizer ApS|Tólteródín||23107||23107|31544| 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|1728|3099|lyfalmen|V0290|3099|2|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1550||1550|3099| 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|međ forđaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|4247|6789|lyfalmen|||1|3|0|84,0000|Vistor hf|N.V. Organon|Skeiđarinnleg međ progestógeni og östrógeni||4247||4247|6789| 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|2500|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|0|0|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Baxter|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|ALC|0|0|0|100|USD|1382|2869|lyfalmen|||0|5|0||K.Pétursson hf|Alcon|Ólópatadín||1382||1382|2869| 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|0|1|0|1|0|1|AGA|0|0|0|100|XEU|21830|29279|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|Nituroxíđ||21830||21830|29279| 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|ţpakki||H02AB01|01.09.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|729|1976|lyfalmen|||0|30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||729||729|1976| 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|ţpakki||A10BA02|01.01.2002||R|1|0|0|0|*|0|MCK|0|0|0|100|SEK|664|1887|lyfalmen|V0502|1573|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||664||664|1887| 008058|B05BA1011|Oliclinomel N4 550E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|26013|34529|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||26013||26013|34529| 008069|B05BA1011|Oliclinomel N4 550E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|32274|42386|lyfsjukr|||1|8000|0||Icepharma hf|Baxter Medical AB|Blöndur||32274||32274|42386| 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|ţpakki||N02CC04|01.03.2003||R|0|0|0|0|E|0|MSD|0|0|0|100|DKK|5845|8975|lyfalmen|||1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5845||5845|8975| 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|58611|75439|lyfsjukr|||1|4|0|26,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||58611||58611|75439| 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|117223|148997|lyfsjukr|||1|4|0|53,3300|Vistor hf|Schering-Plough|Peginterferón alfa 2b||117223||117223|148997| 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|93413|119116|lyfsjukr|||1|4|0|42,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||93413||93413|119116| 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|138188|175308|lyfsjukr|||1|4|0|64,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||138188||138188|175308| 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|162330|205607|lyfsjukr|||1|4|0|80,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||162330||162330|205607| 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|1624|3200|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1624||1624|3200| 008219|D07AC0101|Betnovat|húđfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|311|1404|lyfalmen|||1|20|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||311||311|1404| 008223|B05BA1013|Oliclinomel N6 900E|irl|||1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|40247|52392|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||40247||40247|52392| 008234|B05BA1013|Oliclinomel N6 900E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|31515|41434|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||31515||31515|41434| 008243|D07AC0101|Betnovat|húđlausn|1|mg/g|30|ml|1|plglas|í hársvörđ|D07AC01|01.01.1985||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|609|1812|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||609||609|1812| 008245|B05BA1013|Oliclinomel N6 900E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|36824|48097|lyfsjukr|||1|8000|0||Icepharma hf|Baxter Medical AB|Blöndur||36824||36824|48097| 008301|N02AX0209|Tramol-L|forđatfl|100|mg|20|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|E|0|ACA|0|0|1|100|XEU|949|2116|lyfalmen|||2|20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||831||831|2116| 008326|D07AC0101|Betnovat|húđlausn|1|mg/g|100|ml|1|plglas|í hársvörđ|D07AC01|01.07.1988||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|1374|2858|lyfalmen|||1|100|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1374||1374|2858| 008338|N02AX0209|Tramol-L|forđatfl|100|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|E|0|ACA|0|0|1|100|XEU|3064|5170|lyfalmen|V0226|5170|2|100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||3064||3064|5170| 008360|N02AX0209|Tramol-L|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|E|0|ACA|0|0|1|100|XEU|5079|7927|lyfalmen|V0227|7927|2|100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||5079||5079|7927| 008368|N02AX0209|Tramol-L|forđatfl|200|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|E|0|ACA|0|0|1|100|XEU|6854|10229|lyfalmen|V0228|10221|2|100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||6762||6762|10229| 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|0|0|0|1|0|1|GEZ|0|0|0|100|XEU|163623|207229|lyfsjukr|||1|2|0||Vistor hf|Genzyme BV|Thýrótrópín||163623||163623|207229| 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|1|0|0|0|B|0|MKA|0|0|0|100|SEK|900|2210|lyfalmen|V0153|2210|1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||900||900|2210| 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|1|0|0|0|B|0|MKA|0|0|0|100|SEK|782|2049|lyfalmen|V0154|2049|1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||782||782|2049| 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|USD|5329|9296|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5329||5329|9296| 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|13511|26116|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||13511||13511|26116| 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|ţpakki||R06AX22|01.04.1998||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|ţpakki||R06AE07|01.09.2012||R|1|0|0|0|E|0|RGM|0|0|1|100|XEU|2447|4326|lyfalmen|V0575|3354|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Cetirizín||2447||2447|4326| 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|ţpakki||R06AX22|01.04.1998||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|3067|5174|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3067||3067|5174| 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||| 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|115847|147270|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||115847||115847|147270| 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|122206|155251|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||122206||122206|155251| 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburđur, lausn|D10AF01|01.01.1994||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|2055|3790|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2055||2055|3790| 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6428|9772|lyfalmen|V0145|9219|1|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6428|9772| 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|12664|18438|lyfalmen|V0145|18438|1|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12664|18438| 008959|R01AA0706|Naso-ratiopharm|nefúđi|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||| 009078|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|30|stk|1|ţpakki||N06AG02|01.02.2013||R|1|0|0|0|B|0|RGM|0|0|0|100|XEU|1865|3244|lyfalmen|V0064|3244|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||1656||1656|3244| 009113|B05DB0005|Balance|kviđ.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|9326|13460|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||9326||9326|13460| 009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|ţpakki||N06AG02|01.02.2013||R|1|0|0|0|B|0|RGM|0|0|0|100|XEU|4590|6711|lyfalmen|V0063|6711|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||4190||4190|6711| 009213|B05DB0005|Balance|kviđ.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|9326|13460|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||9326||9326|13460| 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|15174|21589|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||15174||15174|21589| 009216|B05DB0005|Balance|kviđ.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|9326|13460|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||9326||9326|13460| 009270|R01AA0706|Naso-ratiopharm|nefúđi|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||| 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|55355|71353|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||55355||55355|71353| 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||1863| 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|E|0|ASP|0|0|1|100|XEU|5795|8906|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5795||5795|8906| 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 009409|G03CA0316|Vivelle Dot|forđapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1211|2635|lyfalmen|||1|8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1211||1211|2635| 009443|G03CA0316|Vivelle Dot|forđapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1335|2805|lyfalmen|V0130|1785|1|8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1335||1335|2805| 009465|G03CA0316|Vivelle Dot|forđapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1545|3092|lyfalmen|V0131|2628|1|8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1545||1545|3092| 009489|G03CA0316|Vivelle Dot|forđapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1935|3626|lyfalmen|V0132|2920|1|8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1935||1935|3626| 009525|B05DB0005|Balance|kviđ.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7887|11383|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7887||7887|11383| 009560|B05DB0005|Balance|kviđ.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7887|11383|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7887||7887|11383| 009591|B05DB0005|Balance|kviđ.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7887|11383|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7887||7887|11383| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|211307|267073|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||211307||211307|267073| 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|E|0|ASP|0|0|1|100|XEU|5613|8657|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5613||5613|8657| 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|0|0|1|0|1|GIS|0|0|0|100|DKK|63232|81239|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||63232||63232|81239| 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|10147|14859|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||10147||10147|14859| 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9266|13654|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9266||9266|13654| 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8559|12687|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8559||8559|12687| 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|10656|15556|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||10656||10656|15556| 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8738|12932|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8738||8738|12932| 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9430|13879|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||9430||9430|13879| 009993|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|3|g|1|spr||QP52AF02|01.01.2013||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1315|2294|vetorma|||0|3|0||Icepharma hf|Pfizer Oy Animal Health|||1315||1315|2294| 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2306|4133|lyfalmen|V0329|2568|1|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2306||2306|4133| 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|4390|6984|lyfalmen|V0330|2965|1|30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||4390||4390|6984| 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|6273|9560|lyfalmen|||1|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||6273||6273|9560| 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|240408|303595|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||240408||240408|303595| 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|7710|11127|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||7710||7710|11127| 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|13626|19646|lyfalmen|V0331|5497|1|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||13626||13626|19646| 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|19212|26656|lyfalmen|V0332|9069|1|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||19212||19212|26656| 010290|N06DX0101|Ebixa|dropar|10|mg/g|50|g|1|fl||N06DX01|01.08.2010||R|0|0|0|0|E|0|LBK|0|0|0|100|DKK|15186|21604|lyfalmen|||1|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||15186|21604| 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|ţpakki||N06DX01|01.10.2002||R|1|0|0|0|E|0|LBK|0|0|0|100|DKK|24618|33441|lyfalmen|||1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||24618||24618|33441| 010348|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|10|áf.spr||J07BB02|01.10.1995||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|7847|11713|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||7847||7847|11713| 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|13319|19260|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||13319||13319|19260| 010437|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.09.2008||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|78591|137098|vetorma|||0|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||78591||78591|137098| 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|ţpakki||A07EC02|01.01.2003||R|1|0|0|0|B|0|TIL|0|0|0|100|SEK|7502|11241|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||7502|11241| 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7949|11472|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7949||7949|11472| 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|9780|14115|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Amínósýrur||9780||9780|14115| 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|1264|2708|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1264||1264|2708| 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6524|9416|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||6524||6524|9416| 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|10033|14474|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||10033||10033|14474| 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4438|6405|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||4438||4438|6405| 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2544|3672|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2544||2544|3672| 010705|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||| 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|9661|14195|lyfalmen|V0377|14195|1|9|0|90,0000|Vistor hf|Allergan|Bimatóprost||9661||9661|14195| 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|10020|14458|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||10020||10020|14458| 010716|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|E|0|RAT|0|0|0|100|IKR|2373|2791|lyfalmen|V0006|2149|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1325||1325|2791| 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7193|10381|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7193||7193|10381| 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4366|6301|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4366||4366|6301| 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.12.2002||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|16027|6381|lyfalmen|V0207|2340|1|12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3949||3949|6381| 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2350|3392|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2350||2350|3392| 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACT|0|0|0|100|DKK|375393|473001|lyfsjukr|||1|56|0|14,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||375393||375393|473001| 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACL|0|0|0|100|DKK|375393|473001|lyfsjukr|||1|56|0|28,0000|Actelion Registration Ltd|Actelion Registration Ltd.|Bósentan||375393||375393|473001| 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|1269|1470|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||359||359|1470| 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|4614|4385|lyfalmen|V0006|3838|2|100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||2490||2490|4385| 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|2975|2842|lyfalmen|V0006|2149|2|56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||1362||1362|2842| 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|53592|69140|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||53592||53592|69140| 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|REP|0|0|0|100|SEK|3470|5008|lyfsjukr|||1|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3470||3470|5008| 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|ţpakki||A02BC03|01.01.2004||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3153|5292|lyfalmen|||1|28|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||3153||3153|5292| 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|21498|29525|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21498||21498|29525| 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|21248|29211|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21248||21248|29211| 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|36603|48482|lyfalmen|||1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||36603||36603|48482| 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|36354|48169|lyfalmen|||1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||36354||36354|48169| 011163|A07EA0601|Entocort|forđahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|20899|28773|lyfalmen|||1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||20899||20899|28773| 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|1|0|0|0|E|0|MSD|0|0|1|100|DKK|4802|7548|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4802||4802|7548| 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|1|0|0|0|E|0|MSD|0|0|1|100|DKK|4989|7804|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4989||4989|7804| 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|21603|27984|lyfalmen|V0327|3988|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||20270||20270|27984| 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|ţpakki||M01AH05|01.01.2010||R|1|0|0|0|E|0|MSD|0|0|1|100|DKK|1273|2720|lyfalmen|||1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1273||1273|2720| 011336|N05AH0309|Kozylex|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|0|0|0|0|*|0|POF|0|0|0|100|IKR|7436|4460|lyfalmen|V0457|4460|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||2545||2545|4460| 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|0|0|0|0|*|0|LBK|0|0|0|100|DKK|12958|18807|lyfalmen|||1|5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12958||12958|18807| 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1133|2529|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1133||1133|2529| 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|3125|1883|lyfalmen|V0069|1875|2|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||661||661|1883| 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|10184|14910|lyfalmen|V0357|13629|1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10184||10184|14910| 011489|N06BA0402|Concerta|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|7862|11734|lyfalmen|||1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7862||7862|11734| 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|2588|3735|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Esketamín||2588||2588|3735| 011555|N06BA0402|Concerta|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|10319|15095|lyfalmen|||1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||10319||10319|15095| 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|2056|4090|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||2056||2056|4090| 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|5275|7613|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||5275||5275|7613| 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|fl|međ skammtadćlu|G03CA03|01.03.2000||R|0|0|0|0|E|0|OYL|0|0|0|100|SEK|1755|3380|lyfalmen|||2|64|0||Vistor hf|Oy Leiras Finland Ab|Estradíól||1755||1755|3380| 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|94017|119874|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||94017||94017|119874| 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|SEK|3093|6112|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||3093||3093|6112| 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.10.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1486|1972|lyfalmen|V0152|1972|2|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||726||726|1972| 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.10.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|4738|6307|lyfalmen|V0323|5397|2|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||3895||3895|6307| 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|4850|7000|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||4850||4850|7000| 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|2805|4048|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2805||2805|4048| 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.06.2009||R|1|0|0|0|E|0|LBK|0|0|0|100|DKK|8505|12613|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||8505|12613| 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|43233|56140|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||43233||43233|56140| 012113|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|1400|2113|lyfalmen|V0551|2075|2|7|0|1,7500|Medical ehf|ratiopharm GmbH|Flúkónazól||829||829|2113| 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|ţpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|4943|7741|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||4943||4943|7741| 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6407|9743|lyfalmen|||1|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6407||6407|9743| 012278|N07BA0106|Nicotinell|forđapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012290|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|1992|2893|lyfalmen|V0556|2828|2|4|0|3,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||1399||1399|2893| 012326|N06BA0402|Concerta|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|13147|19045|lyfalmen|||1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||13147||13147|19045| 012347|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|28|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|4199|5515|lyfalmen|V0552|5298|2|28|0|7,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||3316||3316|5515| 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012716|N07BA0106|Nicotinell|forđapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|476055|599332|lyfsjukr|||1|1|0||Icepharma hf|Wyeth Europe|Díbótermín alfa||476055||476055|599332| 012799|N07BA0106|Nicotinell|forđapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|718|1961|lyfalmen|||1|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1961| 012921|G03AA1301|Evra|forđapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|5145|8017|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||5145||5145|8017| 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|E|0|LBI|0|0|0|100|DKK|7603|11379|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||7603||7603|11379| 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|1|0|0|0|E|0|RGM|0|0|0|100|XEU|3580|4659|lyfalmen|V0250|4659|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||2690||2690|4659| 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|1|0|0|0|E|0|RGM|0|0|0|100|XEU|3898|5341|lyfalmen|V0251|5341|2|100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||3189||3189|5341| 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|6567|9962|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6567||6567|9962| 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|7418|14416|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||7418||7418|14416| 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|9915|14542|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||9915||9915|14542| 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1867|3714|vetalmen|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|||1867||1867|3714| 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|0|1|0|1|0|1|AGA|0|0|0|100|XEU|23658|31573|lyfsjukr|||1|2|0||Ísaga ehf|AGA AB|Nituroxíđ||23658||23658|31573| 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|0|0|0|0|0|1|ZLB|0|0|0|100|SEK|7712|11130|lyfsjukr|||1|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||7712||7712|11130| 013259|B02BD0901|BeneFIX|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|31470|41377|lyfsjukr|||1|1|0|0,5600|Icepharma hf|Wyeth Europe|Storkuţáttur IX||31470||31470|41377| 013270|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|53266|68731|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Wyeth Europe|Storkuţáttur IX||53266||53266|68731| 013302|C02CA0405|Cardosin Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.09.2009||R|1|0|0|0|E|0|ANO|0|0|0|100|XEU|3595|4940|lyfalmen|V0042|4940|2|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2896||2896|4940| 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|4871|9526|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||4871||4871|9526| 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|11368|22001|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||11368||11368|22001| 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1193|2373|vetalmen|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|||1193||1193|2373| 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BAL|0|0|0|100|SEK|164206|207961|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||||164206|207961| 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|ţpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|0|0|100|SEK|447644|497664|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||395045||395045|497664| 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BER|0|0|0|100|SEK|28882|38129|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||28882|38129| 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BER|0|0|0|100|SEK|109470|139267|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||109470|139267| 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BER|0|0|0|100|SEK|55799|71910|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||55799|71910| 013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5772|8875|lyfalmen|||1|28|0||Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||5772||5772|8875| 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.05.2003||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|19653|27210|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||19653||19653|27210| 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1401|2895|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1401||1401|2895| 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1510| 013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|E|0|ROY|0|0|1|100|XEU|813|2077|lyfalmen|V0562|2077|2|100|0|33,3300|Medical ehf|ratiopharm Oy|Íbúprófen||803||803|2077| 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2678|4642|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2678||2678|4642| 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|0|0|0|0|E|0|SNO|0|0|0|100|NOK|1594|3070|lyfalmen|||1|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1529||1529|3070| 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|448|1592|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||448||448|1592| 013718|M05BA0801|Zometa|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|39833|51873|lyfsjukr|||1|5|0|1,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||39833||39833|51873| 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|ţpakki||C09DA03|01.04.2005||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|5000|7819|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||5000||5000|7819| 013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|1028|2385|lyfalmen|||1|1|0|4,6700|Vistor hf|Schering-Plough Europe|Betametasón||||1028|2385| 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.01.2003||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1215|2641|lyfalmen|V0168|2641|1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2641| 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|6606|10016|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||6606||6606|10016| 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|2751|4742|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2751||2751|4742| 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|4935|7730|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4935||4935|7730| 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|189148|239263|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||189148||189148|239263| 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|402076|506488|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||402076||402076|506488| 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|2663|4622|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2663||2663|4622| 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|9920|14317|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9920||9920|14317| 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|0|0|UCB|0|0|0|100|DKK|19319|26790|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||19319||19319|26790| 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|61040|79150|lyfalmen|||1|3|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíđ||61040||61040|79150| 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|31714|41684|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||31714||31714|41684| 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|30551|40887|lyfalmen|V0357|40887|1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||30551||30551|40887| 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|1733|3350|lyfalmen|||1|30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1733||1733|3350| 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|21066|28320|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||21066||21066|28320| 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27577|36492|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||27577||27577|36492| 014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|E|0|ROY|0|0|1|100|XEU|391|1514|lyfalmen|V0563|1514|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Íbúprófen||391||391|1514| 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|NOK|2868|4902|lyfalmen|||0|100|1||Distica|Distica - óskráđ lyf|Metrónídazól||2868||2868|4902| 014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|2445|4864|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|||||2445|4864| 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|20671|28487|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||20671||20671|28487| 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GIS|0|0|0|100|DKK|88094|112440|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Adefovír||||88094|112440| 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|24|dćlur|1|pakki||QA02BX12|01.04.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|XEU|6077|11841|vetalmen|||0|24|0||Icepharma hf|Pfizer Oy Animal Health|||6077||6077|11841| 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|256702|324044|lyfsjukr|||1|60|0|36,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíđ||256702||256702|324044| 014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|E|0|ROY|0|0|1|100|XEU|986|2314|lyfalmen|V0564|2314|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Íbúprófen||976||976|2314| 014679|N02AA0501|Oxycontin|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.12.2005||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|2447|4326|lyfalmen|||1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2447||2447|4326| 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|1470|2990|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||1470||1470|2990| 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|67094|86085|lyfsjukr|||1|2|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||67094||67094|86085| 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|107347|136603|lyfsjukr|||1|2|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||107347||107347|136603| 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|1268|2713|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||||1268|2713| 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|20558|28345|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||20558||20558|28345| 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||| 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|62035|80399|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||62035||62035|80399| 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|41292|54367|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||41292||41292|54367| 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015230|R01AC0301|Lastin|nefúđi|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|0|0|0|0|E|0|MAB|0|0|1|100|SEK|844|2133|lyfalmen|||1|10|0|17,8571|Vistor hf|Meda AB|Azelastínum||844||844|2133| 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|3408|5641|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||3408||3408|5641| 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|9160|13509|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||9160||9160|13509| 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|ţpakki||N06AX11|01.07.2003||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1180|2568|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1162||1162|2568| 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|2760|4754|lyfalmen|||0|100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||2760||2760|4754| 015419|G03CA0316|Vivelle Dot|forđapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1161|2567|lyfalmen|V0129|1807|1|8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1161||1161|2567| 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.10.2005||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|2092|2285|lyfalmen|V0234|2211|1|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||955||955|2285| 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.10.2005||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|2989|2767|lyfalmen|V0233|2750|1|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1307||1307|2767| 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|10913|15907|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||10913||10913|15907| 015532|L01CX0101|Yondelis|irţ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|368125|463879|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||368125||368125|463879| 015598|L01CX0101|Yondelis|irţ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|97846|124679|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||97846||97846|124679| 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|5659|8720|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5659||5659|8720| 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|14386|20600|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14386||14386|20600| 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|5659|8720|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5659||5659|8720| 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|15552|22063|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15552||15552|22063| 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|ţpakki||J05AE08|01.04.2005|31.01.2013|R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|72570|92958|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||72570||72570|92958| 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|75056|96078|lyfsjukr|||1|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||75056||75056|96078| 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008|31.01.2013|R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|63104|81078|lyfsjukr|||1|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||63104||63104|81078| 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|5659|8720|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5659||5659|8720| 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|14235|20410|lyfalmen|||1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14235||14235|20410| 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|75056|96078|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||75056||75056|96078| 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|24067|32749|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||24067||24067|32749| 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|50131|65460|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||50131||50131|65460| 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3395|5922|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||3395||3395|5922| 015855|QP54AB5206|Advocate yfirstćrđar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4770|8321|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||4770||4770|8321| 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3028|5282|vetorma|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|||3028||3028|5282| 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3797|6624|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||3797||3797|6624| 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|ţpakki||M01CC01|01.05.1978||R|1|0|0|0|B|0|SGM|0|0|0|100|DKK|4838|7597|lyfalmen|V0200|5806|1|50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4838||4838|7597| 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4254|7421|vetorma|||0|8|0||Icepharma hf|Bayer Animal Health GmbH|||4254||4254|7421| 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||| 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|0|0|0|0|E|0|ASP|0|0|1|100|XEU|2143|3910|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||2143|3910| 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|0|0|0|0|E|0|ASP|0|0|1|100|XEU|2406|4270|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||2406||2406|4270| 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1696|3299|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1696||1696|3299| 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3395|5922|vetorma|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|||3395||3395|5922| 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||| 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|ţpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|2165|3941|lyfalmen|||1|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||2165||2165|3941| 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|16273|22968|lyfalmen|V0117|11495|1|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||16273||16273|22968| 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1260|2703|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1260||1260|2703| 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|24367|33126|lyfalmen|V0118|16944|1|100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||24367||24367|33126| 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1336|2806|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1336||1336|2806| 016038|N02CC0501|Almogran|filmhtfl|12,5|mg|3|stk|1|ţpakki||N02CC05|01.05.2001||R|1|0|0|0|E|0|ALM|0|0|0|100|SEK|2783|4786|lyfalmen|V0236|4154|1|3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2783||2783|4786| 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2914|4965|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2914||2914|4965| 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|7595|11368|lyfalmen|||1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||7595||7595|11368| 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|5613|8657|lyfalmen|||1|0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5613||5613|8657| 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11515|16731|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||11515||11515|16731| 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1924|3611|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1924||1924|3611| 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16849|23691|lyfalmen|||1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||16849||16849|23691| 016337|C08CA0302|Lomir Retard|forđahlk|5|mg|100|stk|1|ţpakki||C08CA03|01.04.1992||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|9427|13875|lyfalmen|||1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||9427||9427|13875| 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|102584|130625|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||102584||102584|130625| 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|4542|6555|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||4542||4542|6555| 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3015|5103|lyfalmen|||1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||3015||3015|5103| 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|ţpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|18738|26061|lyfalmen|||1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18738||18738|26061| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||8244| 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|36603|48482|lyfalmen|||1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||36603||36603|48482| 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1026|2367|lyfalmen|V0169|1894|2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2367| 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|197338|249542|lyfsjukr|||1|2|0|120,0000|Icepharma hf|Roche|Epóetín||197338||197338|249542| 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|8354|12407|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||8354||8354|12407| 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|E|0|LVR|0|0|0|100|DKK|3270|5452|lyfalmen|V0240|5452|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3270||3270|5452| 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|E|0|LVR|0|0|0|100|DKK|6036|9236|lyfalmen|V0433|9236|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||6036||6036|9236| 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEU|0|0|0|100|DKK|65297|84493|lyfalmen|||1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||65297||65297|84493| 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEU|0|0|0|100|DKK|96215|123295|lyfalmen|||1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||96215||96215|123295| 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEU|0|0|0|100|DKK|31093|41567|lyfalmen|||1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||31093||31093|41567| 016930|A16AB0401|Fabrazyme|irţ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GZE|0|0|0|100|XEU|84179|107527|lyfsjukr|||1|5|0|5,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||84179||84179|107527| 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|ţpakki||A02BC03|01.02.2007|30.11.2012|R|0|0|0|0|0|0|PER|0|0|0|100|DKK|2021|3744|lyfalmen|||1|14|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2021||2021|3744| 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|ţpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3795|6170|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3795|6170| 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|ţpakki||A02BC03|01.01.2004|30.11.2012|R|0|0|0|0|0|0|PER|0|0|0|100|DKK|7881|11760|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Lansóprazól||7881||7881|11760| 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GIS|0|0|0|100|XEU|42539|55269|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||42539||42539|55269| 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|ţpakki||A02BC03|01.02.2007|30.11.2012|R|0|0|0|0|0|0|PER|0|0|0|100|DKK|14023|20144|lyfalmen|||1|98|0|98,0000|Icepharma hf|Pfizer ApS|Lansóprazól||14023||14023|20144| 016979|N02AE0103|Norspan|forđapl|5|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|E|0|NOP|0|0|0|100|DKK|3361|5577|lyfalmen|||1|4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3361||3361|5577| 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.12.2006||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|20082|38733|vetalmen|||0|60|0||Icepharma hf|Pfizer Oy Animal Health|||20082||20082|38733| 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27266|36101|lyfsjukr|||1|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||27266||27266|36101| 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|1635|3215|lyfalmen|||1|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1635||1635|3215| 017111|A09AA0201|Combizym|töflur|||100|stk|1|ţpakki||A09AA02|01.07.1988||R|1|0|0|0|E|0|DSG|0|0|0|100|XEU|1536|3080|lyfalmen|||1|100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1536||1536|3080| 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|1|0|1|SKY|0|0|0|100|DKK|282318|356192|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||282318||282318|356192| 017145|C08DB0102|Cardizem Retard|forđatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|1|0|0|0|B|0|FRO|0|0|0|100|DKK|8452|12541|lyfalmen|||1|60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||8452||8452|12541| 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|AGT|0|0|0|100|XEU|6466|9824|lyfalmen|||2|500|0|333,0000|Actavis Group hf|Actavis Group hf|Zópíklón||6466||6466|9824| 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|196972|249082|lyfsjukr|||1|1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||196972||196972|249082| 017203|M05BA0601|Bondronat|irţ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|43090|55960|lyfsjukr|||1|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||43090||43090|55960| 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|1458|2973|lyfalmen|V0046|2333|2|100|0|33,3333|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||1458||1458|2973| 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|137138|173991|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||137138||137138|173991| 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|ţpakki||M05BA06|01.08.2004||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|51210|66814|lyfalmen|||1|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||51210||51210|66814| 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|ţpakki||M05BA06|01.08.2004||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|159029|202127|lyfalmen|||1|84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||159029||159029|202127| 017266|N02AE0103|Norspan|forđapl|10|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|E|0|NOP|0|0|0|100|DKK|5836|8962|lyfalmen|||1|4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5836||5836|8962| 017326|N02AE0103|Norspan|forđapl|20|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|E|0|NOP|0|0|0|100|DKK|11112|16180|lyfalmen|||1|4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||11112||11112|16180| 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|2884|4924|lyfalmen|||2|100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||2884||2884|4924| 017331|A04AD1201|Emend|hylki|||3|stk|1|ţpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|9656|13936|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||9656||9656|13936| 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|951|2280|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||951||951|2280| 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|E|0|REP|0|0|1|100|SEK|3296|5488|lyfalmen|||1|30|0|150,0000|Vistor hf|Recip AB|Prednisón||3296||3296|5488| 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1459|2641|lyfalmen|V0168|2641|2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1215||1215|2641| 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|7167|13934|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||7167||7167|13934| 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11156|16240|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||11156||11156|16240| 017809|N06DA0401|Reminyl|forđahlk|24|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|47768|62494|lyfalmen|||1|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||47768||47768|62494| 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10188|14916|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||10188||10188|14916| 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|1|0|0|0|0|0|DSH|0|0|0|100|DKK|2427|4299|lyfalmen|||1|28|0|14,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2427||2427|4299| 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|1|0|0|0|0|0|DSH|0|0|0|100|DKK|3564|5854|lyfalmen|||1|28|0|56,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3564||3564|5854| 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|1|0|0|0|0|0|DSH|0|0|0|100|DKK|11503|16714|lyfalmen|||1|98|0|196,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||11503||11503|16714| 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|1|0|0|0|0|0|DSH|0|0|0|100|DKK|8006|11931|lyfalmen|||1|98|0|49,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||8006||8006|11931| 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|BAA|0|0|0|100|SEK|4253|6797|lyfalmen|||1|0|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4253||4253|6797| 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|BAA|0|0|0|100|SEK|4644|7332|lyfalmen|||1|0|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4644||4644|7332| 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|1|0|0|0|0|0|DSH|0|0|0|100|DKK|9514|13994|lyfalmen|||1|98|0|98,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||9514||9514|13994| 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.11.2004||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|1499|1800|lyfalmen|V0243|1683|1|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||600||600|1800| 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|1|0|0|0|0|0|DSH|0|0|0|100|DKK|2981|5057|lyfalmen|||1|28|0|28,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2981||2981|5057| 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|8857|13095|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8857||8857|13095| 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|14637|20252|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||14637||14637|20252| 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|21716|29799|lyfalmen|V0441|29797|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||21716||21716|29799| 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA03|01.07.2005||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|3125|5254|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3125||3125|5254| 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|ţpakki||H02AB06|11.06.2004||R|1|0|0|0|B|0|MKA|0|0|1|100|SEK|1064|2434|lyfalmen|||1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||1064||1064|2434| 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|6272|9559|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6272||6272|9559| 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|17681|24735|lyfalmen|V0440|24735|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||17681||17681|24735| 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|36824|48759|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||36824||36824|48759| 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|135905|172443|lyfsjukr|||1|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||135905||135905|172443| 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|64942|83385|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||64942||64942|83385| 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|637|1850|lyfalmen|||2|100|0|50,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||637||637|1850| 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|1453|2890|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||1453||1453|2890| 018995|N02AB0301|Durogesic|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|11241|16356|lyfalmen|V0221|8561|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||11241||11241|16356| 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|23652|31566|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||23652||23652|31566| 019094|N02AB0301|Durogesic|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|8035|11970|lyfalmen|V0220|6719|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||8035||8035|11970| 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|26693|35382|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||26693||26693|35382| 019108|N02AB0301|Durogesic|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|4455|7073|lyfalmen|V0219|4096|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||4455||4455|7073| 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|37059|48392|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||37059||37059|48392| 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|37998|49570|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||37998||37998|49570| 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|46429|60151|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||46429||46429|60151| 019167|N02AB0301|Durogesic|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|10457|15284|lyfalmen|V0223|9767|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||10457||10457|15284| 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15493|21989|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||15493||15493|21989| 019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5313|8247|lyfalmen|||1|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||5313||5313|8247| 019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|0|0|0|1|0|1|NYC|0|0|0|100|DKK|55519|71559|lyfsjukr|||2|1|0||Vistor hf|Nycomed Danmark A/S|Fíbrínógen og Mannatromnín manna||55519||55519|71559| 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|ţykkni, lausn|B01AE06|01.05.2005||R|0|0|0|1|0|1|THE|0|0|0|100|XEU|795370|1000072|lyfsjukr|||1|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||795370||795370|1000072| 019308|QG03X0001|Alizin, vet.|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03X|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|IKR|4877|9537|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristóne||4877||4877|9537| 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dćlur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|VET|0|0|0|100|DKK|22603|43574|vetalmen|||0|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||22603|43574| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|7316|10987|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||7316||7316|10987| 019445|L01XC0701|Avastin|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|55956|72107|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||55956||55956|72107| 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|7316|10987|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||7316||7316|10987| 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|640|1854|lyfalmen|||2|100|0|100,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||640||640|1854| 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.01.2005|31.12.2012|L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|4006|5782|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||4006||4006|5782| 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.01.2005|31.12.2012|L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|669|1894|lyfalmen|||2|250|0|250,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||669||669|1894| 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|17596|23965|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||17596||17596|23965| 019781|L01XC0701|Avastin|irţ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|207792|262661|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||207792||207792|262661| 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1224|2653|lyfalmen|V0159|2652|2|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1224||1224|2653| 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019797|L01BA0401|Alimta|irţ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|1|0|1|ELD|0|0|0|100|XEU|212119|268092|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||212119||212119|268092| 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|13793|19855|lyfalmen|||1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13793||13793|19855| 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|13793|19855|lyfalmen|||1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13793||13793|19855| 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|0|0|0|1|E|0|ORG|0|0|0|100|DKK|59464|77172|lyfalmen|||1|1|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||59464||59464|77172| 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|13793|19855|lyfalmen|||1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13793||13793|19855| 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|13793|19855|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13793||13793|19855| 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|13793|19855|lyfalmen|||1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13793||13793|19855| 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|0|0|0|1|0|1|BIA|0|0|0|100|DKK|839416|1055350|lyfsjukr|||1|6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||839416||839416|1055350| 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|ţpakki||N04BC04|01.12.2006||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|429|1566|lyfalmen|||1|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||||429|1566| 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|ţpakki|600+300 mg|J05AR02|01.05.2004||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|73591|94239|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||73591||73591|94239| 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1834|3428|lyfalmen|V0160|3428|2|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1790||1790|3428| 020016|B03AA0704|Duroferon|forđatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.01.2005|31.12.2012|L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 020238|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|30|stk|1|ţpakki||G04CA02|01.04.2006||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|3119|5246|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3119||3119|5246| 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|28693|38555|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mćnusótt, stífkrampi||28693||28693|38555| 020276|A06AB0203|Dulcolax (Lyfjaver)|eţ-stíll|10|mg|50|stk|1|ţpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|3091|5207|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||3091||3091|5207| 020277|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.02.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|617|1823|lyfalmen|V0333|1638|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||617||617|1823| 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020338|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|90|stk|1|ţpakki||G04CA02|01.04.2006||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|7283|10942|lyfalmen|||1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||7283||7283|10942| 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|56845|73886|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||56845||56845|73886| 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.06.2006||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|6813|4624|lyfalmen|V0530|4624|1|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||2665||2665|4624| 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2006||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|15181|5400|lyfalmen|V0531|5400|1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||3232||3232|5400| 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|25653|34740|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||25653||25653|34740| 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|646|1863|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||646||646|1863| 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|0|0|0|0|0|0|SEV|0|0|0|100|DKK|6079|9295|lyfalmen|||1|28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||6079||6079|9295| 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|1967|3670|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1967||1967|3670| 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|0|0|0|0|0|0|SEV|0|0|0|100|DKK|17705|24765|lyfalmen|||1|84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||17705||17705|24765| 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|ţpakki||R06AX22|01.10.2005||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.01.2007||L|0|0|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||| 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dćl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|2377|4147|vetorma|||0|8|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||2377||2377|4147| 020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|166736|211136|lyfsjukr|||1|4|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||166736||166736|211136| 020861|QP52AF0202|Twinhip Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2780|4850|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2780||2780|4850| 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|2156|3928|lyfalmen|V0174|3296|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2156||2156|3928| 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|3214|5375|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||3214||3214|5375| 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|2733|4718|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2733||2733|4718| 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|ţpakki|500+125 mg|J01CR02|01.05.2005||R|0|0|0|0|0|0|DAC|0|0|1|100|IKR|827|1956|lyfalmen|||3|12|0|6,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1956| 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|ţpakki|875+125 mg|J01CR02|01.05.2005||R|0|0|0|0|0|0|DAC|0|0|1|100|IKR|1025|2381|lyfalmen|V0169|1894|3|12|0|10,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1025||1025|2381| 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.03.2005||R|1|0|0|0|E|0|ACA|0|0|1|100|IKR|453|1491|lyfalmen|V0188|1491|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||374||374|1491| 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|E|0|GEM|0|0|0|100|XEU|1088|2467|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1088||1088|2467| 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.2005||R|1|0|0|0|E|0|ACA|0|0|1|100|IKR|1187|2322|lyfalmen|V0189|2322|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||982||982|2322| 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innúđadu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|0|0|LVR|0|0|0|100|GBP|10379|14944|lyfalmen|V0437|14944|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10209||10209|14944| 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|1|0|0|0|B|0|MSD|0|0|0|100|DKK|18291|25500|lyfalmen|V0490|7981|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||18291||18291|25500| 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innúđadu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|0|0|LVR|0|0|0|100|GBP|7395|11095|lyfalmen|V0436|11095|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7395||7395|11095| 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|ţpakki||M01AB05|01.10.2004||L|1|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 021417|R01AD0504|Rhinocort (D.A.C.)|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.11.2004||R|0|0|0|0|E|0|DAC|0|0|1|100|SEK|1839|3438|lyfalmen|V0443|3438|3|120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||1798||1798|3438| 021428|A06AB0201|Dulcolax|eţ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||| 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|1|0|0|0|B|0|MSD|0|0|0|100|DKK|18581|25864|lyfalmen|V0491|15296|1|98|0|49,0000|Vistor hf|M.S.D.|Montelúkast||18581||18581|25864| 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1687|2435|lyfsjukr|||2|100|0||Icepharma hf|Fresenius Kabi|Própófól||1687||1687|2435| 021593|H01BA0201|Minirin|frţ.tfl|60|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|4689|7393|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||4689||4689|7393| 021604|H01BA0201|Minirin|frţ.tfl|60|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|14351|20556|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||14351||14351|20556| 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|ţpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15909|22511|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||15909||15909|22511| 021614|H01BA0201|Minirin|frţ.tfl|120|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|7584|11353|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||7584||7584|11353| 021625|A07EC0203|Pentasa Sachets|forđakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|B|0|FER|0|0|0|100|DKK|16115|22769|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16115||16115|22769| 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|16871|23056|lyfsjukr|||2|1000|0||Icepharma hf|Fresenius Kabi|Própófól||16871||16871|23056| 021641|H01BA0201|Minirin|frţ.tfl|120|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|24158|32863|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||24158||24158|32863| 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|16871|23056|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||16871||16871|23056| 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|25968|35135|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||25968||25968|35135| 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|ţpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4959|7763|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4959||4959|7763| 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|9701|14001|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||9701||9701|14001| 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4896|7066|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4896||4896|7066| 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|20790|28637|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||20790||20790|28637| 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|4096|6582|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4096||4096|6582| 021950|B05AA0705|HyperHAES|irl|||250|ml|10|pokar||B05AA07|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|23029|30784|lyfsjukr|||1|2500|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||23029||23029|30784| 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|5661|8723|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5661||5661|8723| 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|19509|27029|lyfalmen|||1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||19509||19509|27029| 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|87213|111335|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||87213||87213|111335| 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|20790|28637|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||20790||20790|28637| 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|89523|114234|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||89523||89523|114234| 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|136036|172608|lyfsjukr|||1|1200|0||Icepharma hf|Baxter Medical AB|Albúmín||136036||136036|172608| 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríđ|||||| 022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|7683|11489|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||7683||7683|11489| 022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|9004|13296|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||9004||9004|13296| 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|27611|37197|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||27611||27611|37197| 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|0|0|0|0|*|0|SAA|0|0|0|100|NOK|6031|9229|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||6031||6031|9229| 022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|9602|14114|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||9602||9602|14114| 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|313296|395069|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||313296||313296|395069| 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|345747|435795|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||345747||345747|435795| 022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|ţpakki||QP52AA51|01.01.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|12050|21021|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||12050||12050|21021| 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|ALL|0|0|0|100|SEK|27108|36566|lyfalmen|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||27108||27108|36566| 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2423|4227|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||2423||2423|4227| 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|1385|2874|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1385||1385|2874| 022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|ţpakki||QP52AA51|01.10.1991||L|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1475|2573|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||||1475|2573| 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|4092|2831|lyfalmen|V0056|1724|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1354||1354|2831| 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|7193|3917|lyfalmen|V0057|2114|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||2148||2148|3917| 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2294|4002|vetorma|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|||2294||2294|4002| 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|673|1900|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||673||673|1900| 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|2018|3739|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2018||2018|3739| 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1485|2591|vetorma|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|||1485||1485|2591| 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|ţpakki||C09DA03|01.11.2003||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|4998|7816|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4998||4998|7816| 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2129|2993|lyfalmen|V0321|2993|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|2993| 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1554|2046|lyfalmen|V0321|1796|2|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|2046| 022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||5038| 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|0|0|0|0|E|0|GGL|0|0|0|100|GBP|28230|37974|lyfalmen|||1|8|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||28230||28230|37974| 022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|0|0|0|0|E|0|GGL|0|0|0|100|GBP|14115|20259|lyfalmen|||1|4|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||14115||14115|20259| 022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|spr|áfyllt sprauta|B01AX05|01.04.2012||R|0|0|0|0|E|0|GGL|0|0|0|100|GBP|21195|29145|lyfalmen|||1|6|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||21195||21195|29145| 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||3008| 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|0|1|0|1|C|0|ACA|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827|2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2827| 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|0|1|0|1|C|0|ACA|0|0|0|30|IKR|2450|4196|lyfalmen|V0125|4196|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4196| 022962|V01AA1104|Alutard SQ, hrossavćrur|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|25968|35135|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||25968||25968|35135| 022970|V01AA1104|Alutard SQ, hrossavćrur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|20790|28637|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||20790||20790|28637| 023047|G04BD1001|Emselex|forđatfl|7,5|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|E|0|NOE|0|0|0|100|DKK|6044|9247|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||6044||6044|9247| 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|0|0|1|0|1|GIS|0|0|0|100|DKK|89516|114225|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||89516||89516|114225| 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|27483|37036|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||27483||27483|37036| 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|42908|56395|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||42908||42908|56395| 023124|G04BD1001|Emselex|forđatfl|7,5|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|E|0|NOE|0|0|0|100|DKK|21729|29815|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||21729||21729|29815| 023146|G04BD1001|Emselex|forđatfl|15|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|E|0|NOE|0|0|0|100|DKK|6104|9329|lyfalmen|||1|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||6104||6104|9329| 023193|G04BD1001|Emselex|forđatfl|15|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|E|0|NOE|0|0|0|100|DKK|21949|30091|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||21949||21949|30091| 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|5350|4689|lyfalmen|V0250|4659|2|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||2712||2712|4689| 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|4005|6458|lyfalmen|V0251|5341|2|100|0|22,2200|Actavis Group PTC ehf|Mylan AB|Gabapentín||4005||4005|6458| 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|0|0|0|0|0|0|DED|0|0|1|100|XEU|21023|28929|lyfalmen|||1|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||21023||21023|28929| 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|7907|11412|lyfsjukr|||1|0|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||7907||7907|11412| 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|30405|40041|lyfsjukr|||1|0|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||30405||30405|40041| 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|23024|30778|lyfsjukr|||1|0|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||23024||23024|30778| 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|54833|70698|lyfsjukr|||1|0|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||54833||54833|70698| 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|37052|48383|lyfsjukr|||1|0|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||37052||37052|48383| 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|9345|13487|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||9345||9345|13487| 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|110438|140482|lyfsjukr|||1|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||110438||110438|140482| 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|23363|31203|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||23363||23363|31203| 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|15893|21828|lyfsjukr|||1|0|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||15893||15893|21828| 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|43399|56348|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||43399||43399|56348| 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|86797|110813|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||86797||86797|110813| 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|192461|243421|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||192461||192461|243421| 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|173595|219744|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||173595||173595|219744| 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|0|0|0|1|0|1|BII|0|0|0|100|DKK|144375|183073|lyfsjukr|||1|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||144375||144375|183073| 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2007||R|1|0|0|0|E|0|SBM|0|0|0|100|NOK|29695|34288|lyfalmen|V0029|8455|1|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||25293||25293|34288| 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|3860|6259|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||3860||3860|6259| 023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|171308|216874|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||171308||171308|216874| 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|1|0|0|1|0|1|ROC|0|0|0|100|DKK|60539|77859|lyfsjukr|||1|120|0|33,3300|Icepharma hf|Roche|Saquínavír||60539||60539|77859| 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|ţpakki||G04BE03|01.08.2006||R|0|1|0|1|0|1|IPI|0|0|0|100|DKK|81961|104744|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||81961||81961|104744| 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|E|0|MSD|0|0|0|100|DKK|3133|5265|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||3133||3133|5265| 024056|N02AB0301|Durogesic|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.02.2006||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|2836|4858|lyfalmen|V0222|4006|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2836||2836|4858| 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|1|0|0|0|E|0|TPG|0|0|0|100|DKK|20708|28534|lyfalmen|||1|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||20708||20708|28534| 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2002|2889|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2002||2002|2889| 024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|24226|32286|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||24226||24226|32286| 024185|N05AH0309|Kozylex|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|0|0|0|0|*|0|POF|0|0|0|100|IKR|14561|8622|lyfalmen|V0456|8622|2|28|0|28,0000|Portfarma ehf|Portfarma|Olanzapín||5587||5587|8622| 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|ţpakki||N04BD02|01.10.2005||R|1|0|0|0|E|0|TPG|0|0|0|100|DKK|68300|88262|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||68300||68300|88262| 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|25968|35135|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||25968||25968|35135| 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|8175|12162|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||8175||8175|12162| 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|479|1634|lyfalmen|||1|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||479||479|1634| 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|8175|12162|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||8175||8175|12162| 024504|V04CL0003|Soluprick SQ ALK106 - Rauđölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|13774|19832|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13774||13774|19832| 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviđur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|13797|19860|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13797||13797|19860| 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|13939|20039|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13939||13939|20039| 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5894|9042|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5894||5894|9042| 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|NOE|0|0|0|100|DKK|74890|96532|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||74890||74890|96532| 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|13939|20039|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13939||13939|20039| 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1679|3276|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1679||1679|3276| 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5894|9042|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5894||5894|9042| 024644|V04CL0015|Soluprick SQ ALK552 - Hrossavćrur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|8175|12162|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||8175||8175|12162| 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|8175|12162|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||8175||8175|12162| 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1679|3276|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1679||1679|3276| 024991|M01AE0111|Burana|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.06.2012||R|1|0|0|0|E|0|OPF|0|0|1|100|XEU|404|1514|lyfalmen|V0563|1514|2|30|0|15,0000|Portfarma ehf|Orion Corporation|Íbúprófen||391||391|1514| 025009|M01AE0111|Burana|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.07.2012||L|1|0|0|0|0|0|OPF|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Portfarma ehf|Orion Corporation|Íbúprófen|||||| 025020|M01AE0111|Burana|filmhtfl|400|mg|100|stk|1|glas||M01AE01|01.06.2012||R|1|0|0|0|E|0|OPF|0|0|1|100|XEU|811|2088|lyfalmen|V0562|2077|2|100|0|33,3300|Portfarma ehf|Orion Corporation|Íbúprófen||811||811|2088| 025053|M01AE0111|Burana|filmhtfl|600|mg|100|stk|1|glas||M01AE01|01.06.2012||R|1|0|0|0|E|0|OPF|0|0|1|100|XEU|985|2326|lyfalmen|V0564|2314|2|100|0|50,0000|Portfarma ehf|Orion Corporation|Íbúprófen||985||985|2326| 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húđ|D07AB02|01.04.1994||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|682|1912|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||682||682|1912| 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|20790|28637|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||20790||20790|28637| 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húđ|D07AB02|01.04.1994||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|2076|3819|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2076||2076|3819| 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|20790|28637|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||20790||20790|28637| 025306|M05BB0301|Fosavance|töflur|||12|stk|1|ţpakki|70mg+70mcg|M05BB03|01.10.2006||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|14762|21071|lyfalmen|||1|12|0|84,0000|Vistor hf|M.S.D.|Alendrónsýra og kólekalsíferól||14762||14762|21071| 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|89885|114688|lyfsjukr|||1|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||89885||89885|114688| 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|83956|107247|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||83956||83956|107247| 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|10302|19954|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|||10302||10302|19954| 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|17833|24926|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||17833||17833|24926| 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|ţpakki||C09CA03|01.04.2007||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|21166|29108|lyfalmen|||1|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||21166||21166|29108| 025455|C09CA0301|Diovan|filmhtfl|320|mg|28|stk|1|ţpakki||C09CA03|01.04.2007|30.11.2012|R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|6376|9701|lyfalmen|||1|28|0|112,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||6376||6376|9701| 025458|A10BX0203|Repaglinide Portfarma|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|*|0|POF|0|0|0|100|DKK|2477|2972|lyfalmen|V0462|2906|2|90|0|11,2500|Portfarma ehf|Portfarma|Repaglíníđ||1457||1457|2972| 025469|A10BX0203|Repaglinide Portfarma|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|*|0|POF|0|0|0|100|DKK|2696|3120|lyfalmen|V0471|3049|2|90|0|22,5000|Portfarma ehf|Portfarma|Repaglíníđ||1565||1565|3120| 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|ţpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|5641|8696|lyfalmen|V0205|1219|1|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5641||5641|8696| 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|15118|21518|lyfalmen|V0205|3656|1|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||15118||15118|21518| 025632|A10BX0203|Repaglinide Portfarma|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|*|0|POF|0|0|0|100|DKK|2898|3376|lyfalmen|V0472|3296|2|90|0|45,0000|Portfarma ehf|Portfarma|Repaglíníđ||1752||1752|3376| 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|57283|74435|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||57283||57283|74435| 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|8159|11775|lyfsjukr|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||8159||8159|11775| 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|25968|35135|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||25968||25968|35135| 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|ţpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|62006|79700|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||62006|79700| 025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|14377|20588|lyfalmen|V0492|16687|2|98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||14377||14377|20588| 025963|R03DC0302|Montelukast Portfarma|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|17437|16710|lyfalmen|V0491|15296|2|98|0|49,0000|Portfarma ehf|Portfarma|Montelúkast||11500||11500|16710| 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|5068|8841|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||5068||5068|8841| 025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.11.2011||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|14706|8689|lyfalmen|V0490|7981|2|98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||5636||5636|8689| 025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|ţpakki||A07DA03|01.05.2011||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíđ|||||| 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|SEK|2935|5808|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2935||2935|5808| 026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.07.2011||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|820|2101|lyfalmen|||2|100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2101|31.01.2013 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|9984|17417|vetorma|||0|2|0||Vistor hf|Merial (MSD)|Ivermectinum||9984||9984|17417| 026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.11.2011||R|0|0|0|0|*|0|POF|0|0|0|100|IKR|23430|17285|lyfalmen|V0475|16545|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||11920||11920|17285| 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|20790|28637|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||20790||20790|28637| 026101|L01CA0501|Javlor|irţ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|45855|59431|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||45855||45855|59431| 026114|L01CA0501|Javlor|irţ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|229303|289658|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||229303||229303|289658| 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|1954|3652|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíđ||||1954|3652| 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|7403|11106|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíđ||||7403|11106| 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|3859|6258|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíđ||||3859|6258| 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|15287|21730|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíđ||||15287|21730| 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|22907|31293|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíđ||||22907|31293| 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|30528|40858|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíđ||||30528|40858| 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1604|3173|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1604||1604|3173| 026698|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||| 026702|C10AA0505|Atorvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|4560|3715|lyfalmen|V0114|3715|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||2000||2000|3715| 026946|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|1790|3428|lyfalmen|V0160|3428|3|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1790||1790|3428| 026957|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|1272|2652|lyfalmen|V0159|2652|3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1223||1223|2652| 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|477|1631|lyfalmen|||2|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||477||477|1631| 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|ţpakki||M01CC01|01.06.1982||R|1|0|0|0|B|0|SGM|0|0|0|100|DKK|2903|4950|lyfalmen|V0199|3724|1|50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2903||2903|4950| 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|*|0|ALA|0|0|0|100|USD|2597|4531|lyfalmen|||1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2597||2597|4531| 027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|1|0|0|0|*|0|MYL|0|0|0|100|SEK|7841|11705|lyfalmen|||2|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Cýpróterón||7841||7841|11705| 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|31825|13561|lyfalmen|V0341|12840|2|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||9198||9198|13561| 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|35716|15006|lyfalmen|V0342|14284|2|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||10254||10254|15006| 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|E|0|EIS|0|0|0|100|SEK|8100|12059|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíđ||8100||8100|12059| 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|E|0|EIS|0|0|0|100|SEK|10673|15579|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||10673||10673|15579| 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|B|0|NYC|0|0|0|100|DKK|903|2214|lyfalmen|V0153|2210|2|100|0|33,3300|Vistor hf|Nycomed Danmark A/S|Levótýroxínnatríum||903||903|2214| 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|B|0|NYC|0|0|0|100|DKK|903|2214|lyfalmen|V0154|2049|2|100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Levótýroxínnatríum||903||903|2214| 027733|N05AH0409|Quetiapin Orion|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|*|0|OPF|0|0|0|100|IKR|2109|2853|lyfalmen|V0284|2853|2|100|0|6,2500|Portfarma ehf|Orion Corporation|Quetíapín||1370||1370|2853| 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|0|0|0|1|0|1|SPE|0|0|0|100|DKK|108052|137488|lyfsjukr|||1|105|0|5,2500|Vistor hf|SP Europe|Posacónazól||108052||108052|137488| 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|22047|30214|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||22047||22047|30214| 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|34397|45051|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||34397|45051| 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|25481|34524|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||25481||25481|34524| 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|50684|65491|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||50684||50684|65491| 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|63847|82010|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||63847|82010| 028045|G03AB0801|Qlaira|töflur|||84|stk|1|ţpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|5711|8791|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||5711||5711|8791| 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín|||||| 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|ţpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|26096|35296|lyfalmen|V0386|35296|1|196|0|98,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||26096||26096|35296| 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|3998|5133|lyfalmen|V0364|5133|2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3037||3037|5133| 028177|C10AD5201|Tredaptive|töflur|1020|mg|98|stk|2|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|0|0|0|0|0|0|MSD|0|0|0|100|DKK|20191|27885|lyfalmen|V0120|27885|1|196|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||20191|27885| 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|60951|78376|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||60951||60951|78376| 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ ađsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2723|4704|lyfalmen|||1|0|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2723||2723|4704| 028333|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|+ 10 áf. spr.|J07CA06|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|SEK|48365|63243|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||48365||48365|63243| 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. međ leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|22862|31237|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||22862||22862|31237| 028360|J07BG0101|Rabies - Imovax|bóluefni|||1|ml|1|hgl||J07BG01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|SEK|11479|16682|lyfalmen|||1|1|0||Icepharma hf|Sanofi Pasteur MSD|Hundaćđi, dauđ veira||11479||11479|16682| 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|2092|3841|lyfalmen|V0202|3841|2|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||2092||2092|3841| 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|2345|4187|lyfalmen|V0428|3669|2|50|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2345||2345|4187| 028498|C08DB0102|Cardizem Retard|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|1|0|0|0|B|0|FRO|0|0|0|100|DKK|5654|8713|lyfalmen|||1|60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||5654||5654|8713| 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|1278|2727|lyfalmen|||1|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2727| 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|5812|4467|lyfalmen|V0245|4403|1|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||2550||2550|4467| 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|10358|9187|lyfalmen|V0232|9187|1|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||6000||6000|9187| 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|858|1430|lyfalmen|V0266|1324|2|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||330||330|1430| 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|8550|16590|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||8550||8550|16590| 028609|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|28|stk|1|ţpakki||R03DC03|01.10.2011||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|4942|7739|lyfalmen|||2|28|0|28,0000|Portfarma ehf|Portfarma|Montelúkast||4942||4942|7739| 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|5584|2674|lyfalmen|V0267|2674|2|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||1239||1239|2674| 028622|N04BC0503|Pramipexole Portfarma|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|20134|21211|lyfalmen|V0269|21080|2|100|0|28,0000|Portfarma ehf|Portfarma|Pramipexól||14873||14873|21211| 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1362|2075|lyfalmen|V0551|2075|2|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||801||801|2075| 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4998|5676|lyfalmen|V0552|5676|2|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||3434||3434|5676| 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|577|1768|lyfalmen|V0554|1768|2|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól||577||577|1768| 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|563|1749|lyfalmen|V0555|1749|2|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1749| 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|2828|lyfalmen|V0556|2828|2|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||1352||1352|2828| 029066|R01AD0801|Flixonase|nefúđi|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|0|0|0|0|E|0|GSK|0|0|1|100|GBP|1194|2612|lyfalmen|||1|16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1194|2612| 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|ţpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|SEV|0|0|0|100|DKK|8161|12143|lyfalmen|||1|28|0|28,0000|Icepharma hf|Servier|Agómelatín||8161||8161|12143| 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|ţpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|SEV|0|0|0|100|DKK|23280|31762|lyfalmen|||1|84|0|84,0000|Icepharma hf|Servier|Agómelatín||23280||23280|31762| 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|E|0|APS|0|0|1|100|DKK|3114|5239|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3114||3114|5239| 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|ţpakki||C03DB01|01.04.2009||R|0|0|0|0|E|0|AUK|0|0|0|100|GBP|279|1361|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríđ||||279|1361| 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|ţpakki||C10AA01|01.09.2005|31.12.2012|R|1|0|0|0|0|0|LVR|0|0|0|100|XEU|7674|9367|lyfalmen|||3|98|0|65,3400|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6288||6132|9367| 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|71908|92127|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||71908||71908|92127| 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|24292|32369|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||24292||24292|32369| 029528|L01CA0402 |Vinorelbin Actavis|irţ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|6281|9065|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||6281||6281|9065| 029574|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|4825|6964|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group hf|Írinótekan||4825||4825|6964| 029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5681|8750|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5681|8750| 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|17842|24937|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||17842|24937| 029717|C09DA0601|Atacand Plus|töflur|57|mg|28|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5681|8750|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5681|8750| 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|17842|24937|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||17842|24937| 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|ţpakki|međ br.losunarhrađa|J01AA02|01.12.2011||R|1|0|0|0|0|0|GAN|0|0|1|100|SEK|7228|10866|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||7228||7228|10866| 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|0|0|100|DKK|107956|137367|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||107956||107956|137367| 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|0|0|100|DKK|215911|272851|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||215911||215911|272851| 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 030108|R06AX2701|Aerius|filmhtfl|5|mg|10|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|E|0|MLD|0|0|1|100|DKK|673|1900|lyfalmen|V0366|861|1|10|0|10,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||673||673|1900| 030313|G04CA0206|Tamsulosin Portfarma|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.05.2011||R|1|0|0|0|E|0|POF|0|0|0|100|SEK|5377|3566|lyfalmen|V0148|2983|2|90|0|90,0000|Portfarma ehf|Portfarma|Tamsúlósín||1891||1891|3566| 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|E|0|EIS|0|0|0|100|SEK|25366|34379|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||25366||25366|34379| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|*|0|NOH|0|0|0|100|DKK|9937|14572|lyfalmen|V0277|14571|1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||9937||9937|14572| 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|*|0|NOH|0|0|0|100|IKR|2884|4924|lyfalmen|||1|100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||2884||2884|4924| 030754|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|770|l|1|hylki|kćlt|V03AN01|01.03.2009|30.11.2012|L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030765|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|11000|l|1|hylki|kćlt|V03AN01|01.03.2009|30.11.2012|L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|17387|30331|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||17387|30331| 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1550|3099|lyfalmen|V0051|3099|2|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Metóprólól||1550||1550|3099| 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|2449|4329|lyfalmen|||2|100|0|66,6667|Actavis Group PTC ehf|Mylan AB|Metóprólól||2449||2449|4329| 031070|A04AD0101|Scopoderm|forđapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2793| 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|3400|5630|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3400||3400|5630| 031201|L01BA0109|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|3330|5534|lyfalmen|||1|0|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3330||3330|5534| 031314|L01AX0301|Temodal|hylki|20|mg|20|sk-pokar|1|pakki||L01AX03|01.01.2010||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|70572|90450|lyfsjukr|||1|20|0||Vistor hf|Schering-Plough|Temozolomid||70572||70572|90450| 031325|L01AX0301|Temodal|hylki|100|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|85980|109787|lyfsjukr|||1|5|0||Vistor hf|Schering-Plough|Temozolomid||85980||85980|109787| 031394|L01AX0301|Temodal|hylki|250|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|189561|239782|lyfsjukr|||1|5|0||Vistor hf|Schering-Plough|Temozolomid||189561||189561|239782| 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|2352|4196|lyfalmen|||1|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2352||2352|4196| 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|6395|9727|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||6395||6395|9727| 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|25044|33313|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||25044||25044|33313| 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|2244|4049|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||2244||2244|4049| 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009|30.11.2012|R|0|0|0|0|0|1|STM|0|0|0|100|DKK|9769|14099|lyfsjukr|||2|4|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||9769|14099| 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009|30.11.2012|R|0|0|0|0|0|1|STM|0|0|0|100|DKK|14279|19803|lyfsjukr|||2|10|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||14279|19803| 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009|30.11.2012|R|0|0|0|0|0|1|STM|0|0|0|100|DKK|49407|63888|lyfsjukr|||2|50|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||49407|63888| 032190|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009|30.11.2012|L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032202|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009|30.11.2012|L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032236|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009|30.11.2012|L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032247|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009|30.11.2012|L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032258|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009|30.11.2012|L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032270|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009|30.11.2012|L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032281|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009|30.11.2012|L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032304|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.01.2009|30.11.2012|L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|0|*|0|OTS|0|0|0|100|DKK|22732|31074|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||22732||22732|31074| 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|4101|7154|vetorma|||0|50|0||Vistor hf|Merial (MSD)|Ivermectinum||4101||4101|7154| 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|16003|27916|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||16003||16003|27916| 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|*|0|FER|0|0|0|100|DKK|23040|31460|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||23040|31460| 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|*|0|FER|0|0|0|100|DKK|45952|60215|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||45952|60215| 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|1322|2306|vetorma|||0|7|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||1322||1322|2306| 033195|N02AA5501|Targin|forđatfl|15|mg|28|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|3320|5520|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||3320||3320|5520| 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|9895|19172|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríđ||||9895|19172| 033206|N02AA5501|Targin|forđatfl|15|mg|98|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|11315|16457|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||11315||11315|16457| 033218|N02AA5501|Targin|forđatfl|30|mg|28|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|6645|10069|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||6645||6645|10069| 033229|N02AA5501|Targin|forđatfl|30|mg|98|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|19613|27159|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||19613||19613|27159| 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|E|0|ALC|0|0|1|100|USD|1336|2806|lyfalmen|||0|5|0||K.Pétursson hf|Alcon|Dexametasón||1336||1336|2806| 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.04.2011||R|0|0|0|0|*|0|WIH|0|0|0|100|XEU|50343|23379|lyfalmen|V0185|23354|2|100|0|100,0000|Portfarma ehf|Williams & Halls|Letrózól||16601||16601|23379| 033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|90258|115156|lyfsjukr|||1|60|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||90258||90258|115156| 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|117728|149631|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||117728||117728|149631| 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2673|5305|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2673|5305| 034157|J07AM5104|Diftavax|bóluefni|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|0|0|0|0|0|0|SPM|0|0|1|100|XEU|806|2081|lyfalmen|||1|0|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíđ í blöndum međ barnaveikistoxóíđum||806||806|2081| 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|25969|34474|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||25969||25969|34474| 034423|J07BA0201|Ixiaro|stl|6|mcg|0,5|ml|1|spr|dreifa|J07BA02|01.01.2012||R|0|0|0|0|0|0|IAG|0|0|0|100|SEK|16807|23638|lyfalmen|||1|0|0||Intercell AG|Intercell AG|Japönsk heilabólguveira óvirk||16807||16807|23638| 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|0|1|0|0|E|0|ELD|0|0|0|100|XEU|8783|12994|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8783|12994| 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|0|1|0|0|E|0|ELD|0|0|0|100|XEU|8783|12994|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8783|12994| 034494|N05CM1801|Dexdor|irţ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|82740|105721|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||82740||82740|105721| 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|E|0|NOH|0|0|1|100|DKK|1976|3682|lyfalmen|V0367|3682|1|6|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||1976||1976|3682| 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|E|0|NOH|0|0|1|100|DKK|3305|5500|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||3305||3305|5500| 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|194254|245671|lyfsjukr|||1|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||194254||194254|245671| 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|8048|11615|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||8048||8048|11615| 035113|B05XA0501|Addex-Magnesium|irţ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2444|3527|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Magnesíum súlfat||2444||2444|3527| 035212|A07EC0202|Pentasa|forđatfl|500|mg|300|stk|1|ţpakki||A07EC02|01.04.1992||R|1|0|0|0|B|0|FER|0|0|0|100|DKK|17250|24194|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||17250||17250|24194| 035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3991|6438|lyfalmen|||1|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3991|6438| 035494|C07AB0211|Metoprolol ratiopharm|forđatfl|23,75|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|XEU|1081|2458|lyfalmen|V0050|2458|2|100|0|15,8300|Medical ehf|ratiopharm GmbH|Metóprólól||1081||1081|2458| 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.11.2005||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|1844|2575|lyfalmen|V0244|2575|2|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||1167||1167|2575| 035528|C07AB0211|Metoprolol ratiopharm|forđatfl|47,5|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|XEU|1441|2950|lyfalmen|V0048|2950|2|100|0|31,6600|Medical ehf|ratiopharm GmbH|Metóprólól||1441||1441|2950| 035563|C07AB0211|Metoprolol ratiopharm|forđatfl|95|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|XEU|2573|4499|lyfalmen|V0049|4499|2|100|0|63,3300|Medical ehf|ratiopharm GmbH|Metóprólól||2573||2573|4499| 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11446|16636|lyfalmen|V0080|13359|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||11446||11446|16636| 035597|C07AB0211|Metoprolol ratiopharm|forđatfl|190|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|XEU|5623|8245|lyfalmen|V0054|8245|2|100|0|126,6600|Medical ehf|ratiopharm GmbH|Metóprólól||5312||5312|8245| 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|1|1|0|0|0|0|GZE|0|0|0|100|XEU|33032|40009|lyfalmen|||1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||29852||29852|40009| 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|159277|201775|lyfsjukr|||1|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||159277||159277|201775| 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|1|0|0|0|E|0|MAS|0|0|1|100|SEK|6655|10083|lyfalmen|||1|60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||6655||6655|10083| 036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3266|5447|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3266||3266|5447| 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9512|13991|lyfalmen|V0081|11266|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||9512||9512|13991| 036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010||R|1|0|0|1|0|1|ABV|0|0|0|100|DKK|6549|9452|lyfsjukr|||1|30|0|2,5000|Vistor hf|AbbVie Ltd.|Ritonavír||6549||6549|9452| 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|0|0|100|DKK|212417|268466|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||212417||212417|268466| 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|0|0|100|DKK|423685|533607|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||423685||423685|533607| 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|0|0|100|DKK|845589|1063097|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||845589||845589|1063097| 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|ţpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|910|2224|lyfalmen|||1|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||910||910|2224| 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1601|3169|lyfalmen|||1|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1601||1601|3169| 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|3159|5300|lyfalmen|||1|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||3159||3159|5300| 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|ţpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|958|2289|lyfalmen|||1|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||958||958|2289| 037287|N04BC0404|Requip Depot|forđatfl|2|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|13291|11314|lyfalmen|V0532|11314|1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||7555||7555|11314| 037305|N04BC0404|Requip Depot|forđatfl|4|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|24400|19100|lyfalmen|V0533|19100|1|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||13191||13191|19100| 037323|N04BC0404|Requip Depot|forđatfl|8|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|47718|35180|lyfalmen|V0534|35180|1|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||26004||26004|35180| 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|2713|4690|lyfalmen|V0434|4690|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2713||2713|4690| 037531|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|1241|2677|lyfalmen|||1|30|0||Vistor hf|Schering-Plough Europe|Mómetasón||1241||1241|2677| 037584|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|30|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|B|0|BLP|0|0|0|100|XEU|1062|1913|lyfalmen|V0151|1913|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||683||683|1913| 037595|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|B|0|BLP|0|0|0|100|XEU|2538|3683|lyfalmen|V0322|3683|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||1977||1977|3683| 037607|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|B|0|BLP|0|0|0|100|XEU|4781|5507|lyfalmen|V0323|5507|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||3310||3310|5507| 037846|A12BA0101|Kaleorid|forđatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||2352| 037853|A12BA0101|Kaleorid|forđatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||3860| 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9373|13801|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||9373|13801| 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|ţpakki||N06AB05|01.04.1993||R|1|0|0|0|0|0|GSK|0|0|0|100|IKR|664|1499|lyfalmen|||1|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1499| 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|ţpakki||N06AB05|01.04.1993||R|1|0|0|0|B|0|GSK|0|0|0|100|IKR|2667|3155|lyfalmen|V0321|2993|1|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3155| 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|1123|2515|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1123||1123|2515| 038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|2878|4916|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2878||2878|4916| 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|188443|238378|lyfsjukr|||1|1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||188443||188443|238378| 038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|81449|104101|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||81449||81449|104101| 039005|L01XA0301|Eloxatin|irţ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|0|0|0|1|0|1|SNO|0|0|0|100|NOK|46131|59777|lyfsjukr|||1|10|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||46131||46131|59777| 039014|L01XA0301|Eloxatin|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|0|0|0|1|0|1|SNO|0|0|0|100|NOK|77115|98662|lyfsjukr|||1|20|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||77115||77115|98662| 039141|B01AX0601 |Xarelto|filmhtfl|15|mg|42|stk|1|ţpakki||B01AX06|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|17772|24849|lyfalmen|V0031|23288|1|42|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||17772|24849| 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|7751|11467|lyfalmen|||1|0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7667||7667|11467| 039575|D01AE1503|Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009|30.11.2012|L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|15|0||D.A.C. ehf|D.A.C. ehf|Terbínafín|||||| 039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|ţpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SAA|0|0|0|100|NOK|5132|7999|lyfalmen|||1|20|0|10,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||5132|7999| 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|ţpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SAA|0|0|0|100|NOK|25144|34101|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||25144|34101| 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|ţpakki||N06AX03|01.06.2010||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|4002|6453|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||4002||4002|6453| 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|ţpakki||C07AB03|01.04.1992||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|639|1716|lyfalmen|V0541|1612|2|98|0|32,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||539||539|1716| 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|719|1775|lyfalmen|V0542|1660|2|98|0|65,3333|Actavis Group PTC ehf|Mylan AB|Atenólól||582||582|1775| 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1392|2883|lyfalmen|||1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1392||1392|2883| 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|2007|3724|lyfalmen|||1|22|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||2007||2007|3724| 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1483|2140|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1483||1483|2140| 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|IKR|1630|2252|lyfalmen|V0110|1965|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||931||931|2252| 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.01.2010||R|1|0|0|0|E|0|AGP|0|0|1|100|GBP|9300|9470|lyfalmen|V0182|9470|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||6207||6207|9470| 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3717|5365|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3717||3717|5365| 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.01.2010||R|1|0|0|0|E|0|AGP|0|0|1|100|GBP|2014|2164|lyfalmen|V0033|2164|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||866||866|2164| 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|7415|10702|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||7415||7415|10702| 040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2012||R|1|0|0|0|E|0|APC|0|0|1|100|XEU|1409|2582|lyfalmen|V0366|2582|2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||1172||1172|2582| 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|E|0|SAL|0|0|0|100|IKR|||lyfalmen|||0|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Gervitár og ađrar óvirkar samsetningar|||||1723| 040735|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|3|stk|1|ţpakki||J01FA10|01.12.2012||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|1694|3296|lyfalmen|V0174|3296|2|3|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||1694||1694|3296| 040822|C10AA0504|Atorvastatin Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|4539|2449|lyfalmen|V0112|2449|2|100|0|50,0000|Portfarma ehf|Portfarma|Atorvastatín||1075||1075|2449| 041423|G03AA1203|Yasminelle|töflur|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.12.2006||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3773|6140|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3773||3773|6140| 041490|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|2521|2620|lyfalmen|V0318|2620|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1200||1200|2620| 041704|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.08.2010||R|0|0|0|0|0|0|IPF|1|0|0|100|DKK|30156|52606|vetorma|||0|240|0||Icepharma hf|Pfizer Limited|gonadotropin releasing factor analogue, conjugated||||30156|52606| 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4723|8239|vetorma|||0|100|0||Vistor hf|Intervet International BV|||4723||4723|8239| 041795|M02AA1503|Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009|31.12.2012|L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|100|0||D.A.C. ehf|D.A.C. ehf|Díklófenak|||||| 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|ţpakki||N06AX03|01.06.2008||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1322|2787|lyfalmen|||2|90|0|15,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||||1322|2787| 041938|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|4333|2155|lyfalmen|V0005|2114|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||860||860|2155| 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|1700|3304|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1700||1700|3304| 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|14304|19834|lyfsjukr|||1|500|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||14304||14304|19834| 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2727|3936|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2727||2727|3936| 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3296|4757|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||3296||3296|4757| 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4666|6734|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4666||4666|6734| 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4782|6902|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||4782||4782|6902| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6093|8794|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||6093||6093|8794| 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BA03|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|7519|10852|lyfsjukr|||2|4000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7519||7519|10852| 042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BA03|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4075|5881|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4075||4075|5881| 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3119|4501|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||3119||3119|4501| 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2383|3439|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2383||2383|3439| 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2984|4307|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2984||2984|4307| 042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BB01|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3915|5650|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3915||3915|5650| 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2674|3859|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2674||2674|3859| 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1926|2780|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1926||1926|2780| 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BB01|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6538|9436|lyfsjukr|||2|4000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6538||6538|9436| 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2182|3149|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2182||2182|3149| 042549|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|1|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|832|2117|lyfalmen|||1|0|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||832||832|2117| 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3089|4458|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||3089||3089|4458| 042556|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|15904|22505|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||15904||15904|22505| 042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|1441|2866|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1441||1441|2866| 042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|2148|4273|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2148||2148|4273| 042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|2880|5703|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2880||2880|5703| 042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|5762|11236|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||5762||5762|11236| 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|6625|12894|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||6625||6625|12894| 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2601|3754|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2601||2601|3754| 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|4000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|ICE|0|0|0|100|GBP|2477|4367|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||2477||2477|4367| 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|639|1853|lyfalmen|||2|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||639||639|1853| 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|3543|5113|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||3543||3543|5113| 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|25710|14702|lyfalmen|V0516|14564|2|100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||10032||10032|14702| 043379|R03AC1201|Serevent|innúđal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|5363|6429|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3984||3984|6429| 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|6551|9455|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||6551||6551|9455| 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|ţpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|606|1808|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||606||606|1808| 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.07.1989||R|0|0|0|0|E|0|ORG|0|0|0|100|DKK|1317|2780|lyfalmen|||1|30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1317||1317|2780| 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúđađar|B03AA07|01.09.2009||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|0|0|0|0|E|0|LVR|0|0|1|100|CHF|13914|20007|lyfalmen|V0034|20007|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíđ (sykurflétta)||13914||13914|20007| 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|409316|515574|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||409316|515574| 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|577617|726792|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||577617|726792| 044739|N04BC0502|Sifrol|forđatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|24857|33741|lyfalmen|||1|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||24857||24857|33741| 044752|N04BC0502|Sifrol|forđatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|94945|121701|lyfalmen|||1|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||94945||94945|121701| 044763|N04BC0502|Sifrol|forđatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|2876|4913|lyfalmen|||1|10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2876||2876|4913| 044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dćla|QN05CM90|01.01.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|2241|4458|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||2241||2241|4458| 045385|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|10|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|7951|11855|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||7951||7951|11855| 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|IKR|1050|1770|lyfalmen|V0109|1616|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||578||578|1770| 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|IKR|868|1636|lyfalmen|V0108|1482|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||480||480|1636| 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|0|0|0|0|0|1|VIL|0|0|0|100|NOK|3229|4660|lyfsjukr|||1|10|0|2,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||3229||3229|4660| 045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|0|0|0|0|0|1|VIL|0|0|0|100|NOK|6458|9321|lyfsjukr|||1|10|0|5,0000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||6458||6458|9321| 045634|N02AA5907|Pinex Comp Forte|eţ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|0|0|0|0|0|0|AGT|0|0|1|100|XEU|405|1533|lyfalmen|||2|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema međ geđlyfjum||405||405|1533| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|0|0|0|0|0|0|PFV|0|0|0|100|DKK|22717|43793|vetalmen|||0|10|0||Icepharma hf|Pfizer vet.|||22717||22717|43793| 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.03.2006||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1106|2492|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1106||1106|2492| 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|E|0|VIS|0|0|0|100|DKK|4224|6757|lyfalmen|V0382|6757|1|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||4224||4224|6757| 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|*|0|ACA|0|0|0|100|XEU|729|1886|lyfalmen|V0021|1886|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríđ||663||663|1886| 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|*|0|ACA|0|0|0|100|XEU|1197|2352|lyfalmen|V0022|2352|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1004||1004|2352| 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|*|0|ACA|0|0|0|100|XEU|1505|2733|lyfalmen|V0023|2731|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1282||1282|2733| 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|E|0|VIS|0|0|0|100|DKK|7034|10601|lyfalmen|||1|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||7034||7034|10601| 046745|N04BC0405|Ropinirol Portfarma|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|0|0|0|0|E|0|POF|0|0|0|100|GBP|5509|4624|lyfalmen|V0530|4624|2|84|0|7,0000|Portfarma ehf|Portfarma|Rópíníról||2665||2665|4624| 046767|N04BC0405|Ropinirol Portfarma|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|0|0|0|0|E|0|POF|0|0|0|100|GBP|6910|5400|lyfalmen|V0531|5400|2|84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||3232||3232|5400| 046779|N05AH0308|Lazapix|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|*|0|POF|0|0|0|100|IKR|10558|7853|lyfalmen|V0283|7853|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||5025||5025|7853| 046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.02.2012||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|10969|3656|lyfalmen|V0205|3656|2|3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||1957||1957|3656| 046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|*|0|POF|0|0|0|100|IKR|3407|2434|lyfalmen|V0279|2434|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||1064||1064|2434| 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1133|2529|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1133||1133|2529| 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||13388||13388|18684| 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||47555||47555|61564| 047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|157886|200029|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||157886||157886|200029| 047941|N03AX2101|Trobalt|filmhtfl|300|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|28029|37722|lyfalmen|||1|84|0|28,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||28029||28029|37722| 047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|13570|7244|lyfalmen|V0420|7102|2|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||4580||4580|7244| 047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|25698|18538|lyfalmen|V0421|18407|2|30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||12743||12743|18538| 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5888|8498|lyfsjukr|||1|250|0||Icepharma hf|Baxter Medical AB|Albúmín||5888||5888|8498| 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|9398|13564|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||9398||9398|13564| 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9294|13414|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Albúmín||9294||9294|13414| 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|2907|3272|lyfalmen|V0324|3272|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1676||1676|3272| 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2700|3809|lyfalmen|V0035|3809|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2069||2069|3809| 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|8380|4280|lyfalmen|V0325|4125|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2413||2413|4280| 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|8233|4415|lyfalmen|V0326|4287|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2512||2512|4415| 048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|4223|4738|lyfalmen|V0246|4738|2|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2748||2748|4738| 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|16463|4151|lyfalmen|V0327|3988|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2319||2319|4151| 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|E|0|MAB|0|0|0|100|DKK|1258|2700|lyfalmen|||1|100|0||Vistor hf|Meda AB|Klídín og geđlyf||1258||1258|2700| 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|ţpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|14943|21299|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||14943||14943|21299| 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|4592|7261|lyfalmen|||1|100|0|66,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||4592||4592|7261| 048447|G03AA0901|Marvelon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1986||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1928|3616|lyfalmen|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1928||1928|3616| 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|ţpakki||L04AA06|01.03.1999||R|0|0|0|1|*|0|ROC|0|0|0|100|DKK|66260|82058|lyfalmen|V0187|33166|1|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||63357||63357|82058| 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|1|0|1|GZE|0|0|0|100|XEU|1062718|1335594|lyfsjukr|||1|1|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||1062718||1062718|1335594| 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|518|1687|lyfalmen|V0230|1592|1|100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||518||518|1687| 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|ţpakki||A02BA02|01.10.1987||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|2633|4581|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2633||2633|4581| 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|18638|25936|lyfalmen|||1|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||18638||18638|25936| 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|1|0|0|0|E|0|BOI|0|0|0|100|DKK|2576|4503|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2576||2576|4503| 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|0|0|0|0|0|0|GAN|0|0|1|100|CHF|7103|10695|lyfalmen|||1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||7103||7103|10695| 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|1059|2060|lyfalmen|V0108|1482|2|98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||790||790|2060| 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|1154|2278|lyfalmen|V0109|1616|2|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||950||950|2278| 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|1827|2551|lyfalmen|V0110|2005|2|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||1149||1149|2551| 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.04.1993||R|1|0|0|0|0|0|NOH|0|0|0|100|IKR|8006|4999|lyfalmen|V0123|3306|1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4999| 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.04.2006||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1287|2726|lyfalmen|V0496|2724|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1277||1277|2726| 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa|||0|30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.08.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|2652|3842|lyfalmen|||2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||2093||2093|3842| 049834|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 049845|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 049856|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1417| 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|ţpakki||L04AA06|01.03.1999||R|0|0|0|1|*|0|ROC|0|0|0|100|DKK|66260|85701|lyfalmen|V0470|80724|1|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||66260||66260|85701| 050010|G04CB0104|Finasterid LYFIS|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.12.2012||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|3548|4169|lyfalmen|V0445|4169|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Fínasteríđ||2332||2332|4169| 050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.12.2012||R|1|0|0|0|E|0|RAT|0|0|0|100|XEU|4621|6857|lyfalmen|V0550|6857|2|90|0|120,0000|LYFIS ehf|ratiopharm GmbH|Alfúzósín||4297||4297|6857| 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.12.2006||R|0|0|0|1|0|1|BAP|0|0|0|100|DKK|643818|809874|lyfsjukr|||1|112|0||Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||643818||643818|809874| 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|ţpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NOE|0|0|0|100|DKK|77150|98706|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||77150|98706| 050483|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|7624|3671|lyfalmen|V0012|2864|2|56|0|74,6700|Portfarma ehf|Portfarma|Esómeprazól||1968||1968|3671| 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|ţpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3391|5618|lyfalmen|||1|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3391||3391|5618| 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14399|20616|lyfalmen|||1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||14399||14399|20616| 050660|C02CA0402|Carduran Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.01.2007||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|5917|5473|lyfalmen|V0042|4940|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3285||3285|5473| 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|E|0|AGT|0|0|0|100|IKR|4615|5247|lyfalmen|V0002|5247|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3120||3120|5247| 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|E|0|AGT|0|0|0|100|IKR|4435|3852|lyfalmen|V0006|3838|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2100||2100|3852| 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|E|0|AGT|0|0|0|100|IKR|10567|5077|lyfalmen|||2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2996||2996|5077| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|E|0|DEA|0|0|0|100|XEU|1833|3486|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1833||1833|3486| 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|E|0|DEA|0|0|0|100|XEU|1894|3570|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1894||1894|3570| 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|1587|2759|lyfalmen|V0363|2759|2|30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1301||1301|2759| 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|4314|5954|lyfalmen|V0365|5954|2|100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3637||3637|5954| 051550|N03AX1401|Keppra|irţ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|32612|42811|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||32612||32612|42811| 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|1695|2028|lyfalmen|V0056|1724|2|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||767||767|2028| 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|2870|2532|lyfalmen|V0057|2114|2|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||1135||1135|2532| 051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|B|0|AZD|0|0|1|100|SEK|1095|2477|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1095||1095|2477| 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|238|1304|lyfalmen|V0047|1304|2|20|0|5,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||238||238|1304| 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|560|1745|lyfalmen|V0305|1049|2|50|0|12,5000|Actavis Group PTC ehf|Mylan AB|Alprazólam||560||560|1745| 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|369050|465040|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||369050||369050|465040| 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|397|1522|lyfalmen|V0439|1522|2|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||397|1522| 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1274|2722|lyfalmen|||2|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||1274||1274|2722| 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|817|2097|lyfalmen|V0305|2097|2|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||817||817|2097| 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|770947|969421|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||770947||770947|969421| 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|683302|859427|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||683302||683302|859427| 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|4198|6722|lyfalmen|||1|3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||4198||4198|6722| 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.03.2007||L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|2|0||D.A.C. ehf|D.A.C. ehf|Acíklóvír|||||| 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|39913|51973|lyfsjukr|||1|8212|0||Icepharma hf|Fresenius Kabi|Blöndur||39913||39913|51973| 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|32447|42603|lyfsjukr|||1|7698|0||Icepharma hf|Fresenius Kabi|Blöndur||32447||32447|42603| 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|34253|44870|lyfsjukr|||1|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||34253||34253|44870| 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|28658|37848|lyfsjukr|||1|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||28658||28658|37848| 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|38541|50251|lyfsjukr|||1|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||38541||38541|50251| 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|35787|46795|lyfsjukr|||1|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||35787||35787|46795| 052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|16660|23453|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíđ||16660||16660|23453| 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|ţpakki||N05CF02|01.11.2006||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|2651|4185|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||2344||2344|4185| 053025|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.07.1989||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|2545|4460|lyfalmen|V0134|3808|1|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2545||2545|4460| 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|1|0|0|1|0|1|ABT|0|0|0|100|DKK|67108|86103|lyfsjukr|||1|120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopinavír||67108||67108|86103| 053055|C01BA0302|Durbis Retard|forđatfl|250|mg|100|stk|1|ţpakki||C01BA03|01.05.1983||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|6205|9467|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíđ||6205||6205|9467| 053155|N02AA5501|Targin|forđatfl|60|mg|28|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|13053|18927|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||13053||13053|18927| 053166|N02AA5501|Targin|forđatfl|60|mg|98|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|38877|51336|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||38877||38877|51336| 053200|N02AA5501|Targin|forđatfl|7,5|mg|98|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|6508|9882|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||6508||6508|9882| 053211|N02AA5501|Targin|forđatfl|7,5|mg|28|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1908|3583|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1904||1904|3583| 053231|J07BB0201|Fluarix|bóluefni|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|6714|10163|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||6714||6714|10163| 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|*|0|SDE|0|0|0|100|NOK|43786|57497|lyfalmen|V0453|46667|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||43786||43786|57497| 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|*|0|SDE|0|0|0|100|NOK|36754|48671|lyfalmen|V0454|42053|1|100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||36754||36754|48671| 053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|ţpakki||N05CF02|01.11.2006||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|706|1422|lyfalmen|V0060|1093|2|20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||324||324|1422| 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|17155|24075|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||17155||17155|24075| 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|1669|3262|lyfalmen|||1|1|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1669||1669|3262| 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburđur, lausn|D10AF01|01.07.1985||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1244|2681|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1244||1244|2681| 054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||R03DC03|01.11.2011||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|8439|8846|lyfalmen|V0490|8144|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||5751||5751|8846| 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4531|7177|lyfalmen|||1|0|0||Icepharma hf|Sanofi Pasteur MSD|Haemophilus influenzae B||4531||4531|7177| 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 054278|D01AE1502|Lamisil Once|húđlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|ţpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2942|5003|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2942||2942|5003| 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|ţpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|4057|6529|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||4057||4057|6529| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|69668|89316|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||69668||69668|89316| 054376|B05AA0113|Albunorm 20%|irl|200|g/líter|100|ml|1|fl|lausn|B05AA01|01.06.2012|30.11.2012|R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|10003|14436|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Albúmín||10003||10003|14436| 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|1|100|SEK|1218|2645|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1218||1218|2645| 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|ţpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1837|3492|lyfalmen|V0061|3492|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1837||1837|3492| 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|ALS|0|0|0|100|DKK|5176|10111|vetalmen|||0|10|0||Icepharma hf|Alstoe Limited|Buprenorphinhýdróklóríđ||||5176|10111| 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|8383|14624|vetorma|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|Medroxyprogesteronum||8383||8383|14624| 054974|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|5995|9180|lyfalmen|||1|60|0||Vistor hf|Almirall S.A.|Aclídínumbrómíđ||5995||5995|9180| 055164|S01AX2201|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AX22|01.08.2010||R|0|0|0|0|0|0|ALA|0|0|1|100|USD|1848|3507|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Moxífloxasín hýdróklóríđ||||1848|3507| 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|869|2168|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||869||869|2168| 055277|N02AA0101|Contalgin|forđatfl|60|mg|100|stk|1|ţpakki||N02AA01|01.10.1995||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|10042|14716|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||10042||10042|14716| 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|2064|2939|lyfalmen|V0467|2843|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1433||1433|2939| 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|4539|2449|lyfalmen|V0112|2449|2|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1075||1075|2449| 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|6185|2005|lyfalmen|V0113|1991|2|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||750||750|2005| 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|IKR|7867|3852|lyfalmen|V0114|3715|2|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||2100||2100|3852| 056183|B01AC2401|Brilique|filmhtfl|90|mg|100|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|E|0|AZA|0|0|0|100|SEK|20397|28143|lyfalmen|V0459|27113|1|100|0|50,0000|Vistor hf|AstraZeneca AB|Ticagrelor||20397||20397|28143| 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|29440|51357|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||29440||29440|51357| 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1414|2913|lyfalmen|||1|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1414||1414|2913| 056664|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|100|stk|1|glas|Til skömmtunar|N06AX16|01.10.2011||R|2|0|0|0|B|0|AGP|0|0|0|100|XEU|4059|6531|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||4059|6531| 056675|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|100|stk|1|glas|til skömmtunar|N06AX16|01.10.2011||R|2|0|0|0|B|0|AGP|0|0|0|100|XEU|4059|6531|lyfalmen|||2|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||4059|6531| 056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|E|0|MAB|0|0|1|100|DKK|3266|5447|lyfalmen|||1|15|0||Vistor hf|Meda AB|Pímekrólímus||3266||3266|5447| 056915|L04AA2301|Tysabri|irţ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|1|0|1|EPI|0|0|0|100|XEU|253927|320561|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||253927||253927|320561| 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008|31.01.2013|R|1|0|0|1|0|1|POF|0|0|0|100|DKK|61137|78609|lyfsjukr|||2|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||61137||61137|78609| 057026|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3991|6438|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||3991||3991|6438| 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12698|18481|lyfalmen|V0095|14718|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||12698||12698|18481| 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|12803|17950|lyfsjukr|||1|5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||12803||12803|17950| 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|7362|10625|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||7362||7362|10625| 057367|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl|lausn|J06BA02|01.10.2011||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|271145|342169|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||271145||271145|342169| 057401|N06DA0404|Galantamine Portfarma|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.12.2011||R|1|0|0|0|E|0|POF|0|0|0|100|SEK|25953|35116|lyfalmen|||2|84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||25953||25953|35116| 057422|B05XA3102|Tracel|irţ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5326|7687|lyfsjukr|||1|200|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5326||5326|7687| 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|4059|5858|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||4059||4059|5858| 057492|L01XC1001|Arzerra|irţ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|391257|492910|lyfsjukr|||1|50|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||391257||391257|492910| 057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|0|0|0|1|0|1|JAS|0|0|0|100|SEK|607924|764827|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag AB|Abírateron||607924||607924|764827| 057703|J01DD0401|Rocephalin|irţ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|26986|35750|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche|Ceftríaxón||26986||26986|35750| 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|ţpakki||N07BA03|01.03.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|21968|30115|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||21968|30115| 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|E|0|BOI|0|0|0|100|DKK|464|1614|lyfalmen|||1|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||464||464|1614| 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|141544|179520|lyfsjukr|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||141544||141544|179520| 058283|QI01AD040|Avipro Thymovac|frţlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|176876|308551|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||176876|308551| 058294|QI01AD040|Avipro Thymovac|frţlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|268691|468718|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||268691|468718| 058397|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|18993|26381|lyfalmen|||1|0|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||18993||18993|26381| 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1144|2544|lyfalmen|||1|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1144||1144|2544| 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|109244|138984|lyfsjukr|||1|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||109244||109244|138984| 058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|46441|60829|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||46441||46441|60829| 058735|C03CA0105|Lasix Retard|forđahlk|30|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|1401|2895|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||1401||1401|2895| 058768|C03CA0105|Lasix Retard|forđahlk|60|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|2613|4553|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||2613||2613|4553| 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|ţpakki||A02BC01|01.05.2011||R|1|0|0|0|E|0|AGT|0|0|0|100|IKR|2374|2805|lyfalmen|V0006|2149|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1335||1335|2805| 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|1685|3284|lyfalmen|||1|250|0|20,8300|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1685||1685|3284| 059295|S01AA0104|Kloramfenikol - Lyfjaver|augnsm|1|%|5|g|1|túpa||S01AA01|01.06.2012||R|0|0|0|0|E|0|LOL|0|0|1|100|IKR|2297|4121|lyfalmen|||0|5|1||Lyfjaver ehf|Lyfjaver- óskráđ|Klóramfeníkól||2297||2297|4121| 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|108248|138396|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||108248||108248|138396| 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|||0,5|ml|10|spr||J07CA06|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|36264|48056|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||36264||36264|48056| 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008|31.01.2013|R|0|0|0|1|0|1|POF|0|0|0|100|DKK|95389|121596|lyfsjukr|||2|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||95389||95389|121596| 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|ţpakki||N03AF04|01.03.2010||R|1|0|0|0|E|0|BPC|0|0|0|100|SEK|45355|52044|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||39441||39441|52044| 060114|N02AB0305|Fentanyl ratiopharm|forđapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|E|0|RGM|0|0|0|100|XEU|2960|4096|lyfalmen|V0219|4096|2|5|0|7,5000|Medical ehf|ratiopharm GmbH|Fentanýl||2279||2279|4096| 060123|N02AB0305|Fentanyl ratiopharm|forđapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|E|0|RGM|0|0|0|100|XEU|4700|6719|lyfalmen|V0220|6719|2|5|0|15,0000|Medical ehf|ratiopharm GmbH|Fentanýl||4196||4196|6719| 060132|N02AB0305|Fentanyl ratiopharm|forđapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|E|0|RGM|0|0|0|100|XEU|6093|8561|lyfalmen|V0221|8561|2|5|0|22,5000|Medical ehf|ratiopharm GmbH|Fentanýl||5543||5543|8561| 060141|N02AB0305|Fentanyl ratiopharm|forđapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|E|0|RGM|0|0|0|100|XEU|7105|9767|lyfalmen|V0223|9767|2|5|0|30,0000|Medical ehf|ratiopharm GmbH|Fentanýl||6424||6424|9767| 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NOE|0|0|0|100|DKK|410318|517494|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||410318||410318|517494| 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NOE|0|0|0|100|DKK|205176|260041|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||205176||205176|260041| 060848|N06AA0402|Anafranil Retard|forđatfl|75|mg|100|stk|1|ţpakki||N06AA04|01.10.1989||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|6139|9377|lyfalmen|||1|100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||6139||6139|9377| 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|PFA|0|0|0|100|DKK|2992|5918|vetalmen|||0|4|0||Icepharma hf|Pfizer Animal Health|||||2992|5918| 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|PFA|0|0|0|100|DKK|1568|3119|vetalmen|||0|4|0||Icepharma hf|Pfizer Animal Health|||||1568|3119| 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|0|0|0|0|0|0|PFA|1|0|0|100|DKK|9260|17953|vetalmen|||0|20|0||Icepharma hf|Pfizer Animal Health|||||9260|17953| 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.04.2010||R|0|0|0|0|E|0|DAC|0|0|0|100|DKK|7605|11382|lyfalmen|V0133|11382|3|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Tíbólón||7605||7605|11382| 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.07.1998||R|0|0|0|0|E|0|ORG|0|0|0|100|DKK|7607|11385|lyfalmen|V0133|11382|1|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||7607||7607|11385| 061580|QP52AF0201|Banminth, vet.|pasta|439|mg/g|26|g|1|spr||QP52AF02|01.04.1992||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1853|3232|vetorma|||0|26|0||Icepharma hf|Pfizer Oy Animal Health|||1853||1853|3232| 061715|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.05.2008||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|174101|220379|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||174101||174101|220379| 061937|L04AD0101|Sandimmun|irţ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|4833|6975|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||4833||4833|6975| 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|17259|23543|lyfsjukr|||1|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||17259||17259|23543| 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|24299|32378|lyfsjukr|||1|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||24299||24299|32378| 062117|N05BA1204|Tafil Retard|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|500|1663|lyfalmen|V0307|1511|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||500||500|1663| 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|ţpakki||L04AA06|01.08.2010||R|0|0|0|1|*|0|AGP|0|0|0|100|XEU|65020|33166|lyfalmen|V0187|33166|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||24399||24399|33166| 062387|N04BC0502|Sifrol|forđatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|1795|3434|lyfalmen|||1|10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1795||1795|3434| 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|ţpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 062729|N05BA1204|Tafil Retard|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1008|2358|lyfalmen|V0308|2057|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||1008||1008|2358| 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|1|0|0|0|E|0|AGT|0|0|1|100|XEU|2016|3737|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||2016||2016|3737| 062745|QP53AF0102|Sebacil vet.|húđlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|19599|34189|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||19599||19599|34189| 062761|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|44989|58344|lyfsjukr|||1|2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||44989||44989|58344| 062772|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|54929|70818|lyfsjukr|||1|2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||54929||54929|70818| 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|17977|17882|lyfalmen|||1|0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||12221||12221|17882| 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|ţpakki||J05AB09|01.10.1995||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|4582|7247|lyfalmen|||1|10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||4582||4582|7247| 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||3121| 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|2765|3348|lyfalmen|V0123|3306|2|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||1732||1732|3348| 063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.07.2011||R|1|0|0|0|E|0|DAC|0|0|1|100|XEU|4932|6712|lyfalmen|V0458|5619|3|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||4191||4191|6712| 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|8469|12223|lyfsjukr|||1|2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||8469||8469|12223| 063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|0|0|0|0|0|0|PAS|0|0|0|100|XEU|2764|4822|vetorma|||0|12|0||Vistor hf|Pfizer Oy Animal Health|||2764||2764|4822| 063941|N05BA1204|Tafil Retard|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1059|2428|lyfalmen|V0309|2125|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||1059||1059|2428| 063958|N05BA1204|Tafil Retard|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2218|4013|lyfalmen|V0310|3073|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2218||2218|4013| 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|1182762|1486249|lyfsjukr|||1|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1182762|1486249| 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|473104|595628|lyfsjukr|||1|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||473104|595628| 064170|N05BA1204|Tafil Retard|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2329|4165|lyfalmen|V0311|3073|1|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2329||2329|4165| 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|4731049|5939349|lyfsjukr|||1|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4731049|5939349| 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|2365525|2970616|lyfsjukr|||1|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2365525|2970616| 064732|A03BB0101|Buscopan|húđuđtfl|10|mg|100|stk|1|ţpakki||A03BB01|01.03.2012||R|1|0|0|0|E|0|BOI|0|0|0|100|DKK|2287|4107|lyfalmen|||1|100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2287||2287|4107| 064733|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|1|áfspr||J07BB02|01.10.1985||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|897|2206|lyfalmen|||1|0|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||897||897|2206| 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|63710|81839|lyfsjukr|||1|1|0|1,4300|Vistor hf|Octapharma AB|Storkuţćttir lX,ll,Vll,X||63710||63710|81839| 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|0|0|0|0|0|0|SLL|0|0|0|100|DKK|2125|3886|lyfalmen|||1|25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||2125||2125|3886| 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|17213|23485|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||17213||17213|23485| 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|2725|3967|lyfalmen|V0376|2298|1|2|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2184||2184|3967| 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|*|0|LVR|0|0|0|100|SEK|67700|82966|lyfalmen|V0451|82966|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||64080||64080|82966| 065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|8166|11661|lyfalmen|V0376|6894|1|8|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||7809||7809|11661| 065729|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065740|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1088|2168|lyfalmen|V0163|2168|2|70|0|5,6000|Medical ehf|ratiopharm GmbH|Amoxicillín og ensímblokkar||869||869|2168| 065752|N07BA0142|Nicorette Invisi|forđapl|10|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065775|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065786|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|5338|7704|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||5338||5338|7704| 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|4445|8708|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|||4445||4445|8708| 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|7272|10927|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíđ||7272||7272|10927| 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|35824|46842|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||35824||35824|46842| 066399|N07BA0106|Nicotinell|forđapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066407|N07BA0106|Nicotinell|forđapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|922|2240|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||922||922|2240| 066423|N07BA0106|Nicotinell|forđapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066593|A02BC0111|Omeprazol Pensa|sţ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|E|0|PEN|0|0|0|100|IKR|2100|3852|lyfalmen|V0006|3838|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||2100||2100|3852| 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr|||1|120|0||Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603| 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.11.2006||R|1|0|0|0|B|0|DAC|0|0|0|100|NOK|1703|3309|lyfalmen|V0036|3309|3|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1703||1703|3309| 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 066897|L01CD0104|Paclitaxel Actavis|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|16670|22803|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||16670||16670|22803| 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|9399|13565|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||9399||9399|13565| 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|ţpakki||N05BB01|01.07.1994||R|1|0|0|0|0|0|UCN|0|0|0|100|SEK|1623|3199|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1623||1623|3199| 067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|0|0|0|0|*|0|APC|0|0|0|100|DKK|2018|2696|lyfalmen|V0376|2298|2|2|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1255||1255|2696| 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1567|2075|lyfalmen|V0551|2075|2|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||801||801|2075| 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|5748|5676|lyfalmen|V0552|5676|2|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||3434||3434|5676| 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|664|1768|lyfalmen|V0554|1768|2|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||577||577|1768| 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|612|1749|lyfalmen|V0555|1749|2|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1749| 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|2031|2828|lyfalmen|V0556|2828|2|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||1352||1352|2828| 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|14199|13437|lyfalmen|V0419|13437|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||9107||9107|13437| 068043|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|2|glas|sk-úđari|R01AA07|01.02.2010|30.11.2012|L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|20|0|25,0000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|0|0|1|0|0|0|VEQ|1|0|0|100|XEU|6651|12943|vetalmen|||0|50|0||Icepharma hf|Vétoquinol AG|||6651||6651|12943| 068358|L01XC1001|Arzerra|irţ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|117377|149191|lyfsjukr|||1|15|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||117377||117377|149191| 068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|ţpakki||B02BX05|01.04.2011||R|1|1|0|1|0|1|GTS|0|0|0|100|GBP|86344|110244|lyfsjukr|||1|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||86344||86344|110244| 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|ţpakki||C01BC04|01.04.1987||R|1|0|0|1|B|0|MEB|0|0|0|100|SEK|1988|3698|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníđ||1988||1988|3698| 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|ţpakki||C01BC04|01.04.1987||R|1|0|0|1|B|0|MEB|0|0|0|100|SEK|6582|9983|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníđ||6582||6582|9983| 068698|N06DA0206|Donepezil Medical|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|1|0|0|0|E|0|MED|0|0|0|100|XEU|28863|14697|lyfalmen|V0342|13998|2|98|0|130,6600|Medical ehf|Medical ehf|Dónepezíl||10028||10028|14697| 068811|L01BA0109|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|4031|6493|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||4031||4031|6493| 068896|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2740|3955|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Natríumklóríđ||2740||2740|3955| 068905|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|3410|4921|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Kalíumklóríđ||3410||3410|4921| 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068951|V07AB09|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068960|V07AB09|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 069106|H01BA0201|Minirin|frţ.tfl|240|mcg|30|stk|1|ţpakki||H01BA02|01.08.2012||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|15399|21871|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||15399||15399|21871| 069115|H01BA0201|Minirin|frţ.tfl|240|mcg|100|stk|1|ţpakki||H01BA02|01.08.2012||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|48606|63546|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||48606||48606|63546| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 069850|C09AA0210|Enalapril LYFIS|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|468|1619|lyfalmen|V0448|1619|2|100|0|50,0000|LYFIS ehf|LYFIS ehf|Enalapríl||468||468|1619| 070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|20494|28265|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||20494|28265| 070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|29641|39745|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||29641|39745| 070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|38388|50722|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||38388|50722| 070113|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group hf|Asetýlsalicýlsýra|||||| 070142|G04BD0704|Tolterodin Actavis|forđahlk|4|mg|100|stk|1|ţpakki||G04BD07|01.01.2013||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|20400|28147|lyfalmen|V0589|28037|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||20400||20400|28147| 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|52153|67335|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||52153||52153|67335| 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006|31.12.2012|R|0|0|0|0|0|0|PAB|1|0|0|100|IKR|10511|20355|vetalmen|||0|100|0||Vistor hf|Pharmaxim AB|||10511||10511|20355| 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|međ skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|13929|20026|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||13929||13929|20026| 071076|QA12CE9902|Selevitan, vet.|kyrni|||1250|g|1|plbrús||QA12CE99|01.12.2006|31.12.2012|R|0|0|0|0|0|0|PAB|0|0|0|100|SEK|6620|12884|vetalmen|||0|1250|0||Vistor hf|Pharmaxim AB|||6620||6620|12884| 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|1|0|0|0|*|0|ACA|0|0|0|100|XEU|760|2019|lyfalmen|||2|100|0|22,1631|Actavis Group hf|Actavis hf|Litíum||760||760|2019| 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|73907|94636|lyfsjukr|||1|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíđ||73907||73907|94636| 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|369539|465654|lyfsjukr|||1|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíđ||369539||369539|465654| 071591|N05AH0405|Seroquel Prolong|forđatfl|150|mg|30|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|9607|14121|lyfalmen|||1|30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||9607|14121| 071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|11845|10148|lyfalmen|V0144|9578|3|12|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||6703||6703|10148| 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GZE|0|0|0|100|XEU|101811|129655|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||101811||101811|129655| 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|ţpakki||B01AC04|01.01.2010||R|1|0|0|0|E|0|PSA|0|0|0|100|XEU|3435|1993|lyfalmen|V0009|1993|2|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||741||741|1993| 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|7639|14841|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||7639||7639|14841| 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|ţpakki||N07BA01|01.02.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.12.2009||R|1|0|0|0|E|0|PSA|0|0|0|100|XEU|10800|8470|lyfalmen|V0029|8455|2|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||5476||5476|8470| 072520|V01AA1104|Alutard SQ, hrossavćrur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|20790|28637|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||20790||20790|28637| 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946| 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946| 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|725|1046|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||725||725|1046| 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|0|1|0|1|0|1|ABV|0|0|0|100|DKK|161215|204207|lyfsjukr|||1|2|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||161215||161215|204207| 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|17997|25131|lyfalmen|||1|1|0|20,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||17997||17997|25131| 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|17997|25131|lyfalmen|||1|2|0|40,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||17997||17997|25131| 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|83048|106108|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||83048||83048|106108| 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|1146|2547|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1146||1146|2547| 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|4146|6650|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ og tamsúlósínhýdroklóríđ||4146||4146|6650| 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|1785|3421|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1785||1785|3421| 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.09.2011||R|0|0|0|0|*|0|AGP|0|0|0|100|XEU|55740|23379|lyfalmen|V0185|23354|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||16601||16601|23379| 073776|C09AA0210|Enalapril LYFIS|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|780|2046|lyfalmen|V0066|2046|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Enalapríl||780||780|2046| 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|332|1433|lyfalmen|V0047|1304|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||332||332|1433| 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|816|2095|lyfalmen|V0305|1049|1|50|0|12,5000|Icepharma hf|Pfizer ApS|Alprazólam||816||816|2095| 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1042|2404|lyfalmen|V0305|2097|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||1042||1042|2404| 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|561|1746|lyfalmen|V0439|1522|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||561||561|1746| 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1524|3064|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1524||1524|3064| 073935|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA03|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|4054|7072|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Doramectinum||4054||4054|7072| 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|ţpakki||L04AX01|01.12.2010||R|0|0|0|0|*|0|APT|0|0|0|100|GBP|1474|2995|lyfalmen|||1|50|0|8,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||1474||1474|2995| 074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|ţpakki||G04BE03|01.12.2009||R|1|0|0|0|0|0|DAC|0|0|0|100|DKK|5048|7884|lyfalmen|V0142|7884|3|4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||5048||5048|7884| 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NOE|0|0|0|100|DKK|3904|6319|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3904||3904|6319| 074083|B03BB0106|Folic Acid (D.A.C.)|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.03.2011||R|1|0|0|0|E|0|DAC|0|0|1|100|GBP|444|1581|lyfalmen|V0391|1581|3|28|0|350,0000|D.A.C. ehf|D.A.C. ehf|Fólínsýra||440||440|1581| 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|19707|26615|lyfsjukr|||1|50|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||19707||19707|26615| 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|521|1692|lyfalmen|||2|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||521||521|1692| 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|864|2161|lyfalmen|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||864||864|2161| 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|1171|2581|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||1171||1171|2581| 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|22510|39268|vetorma|||0|25|0||Icepharma hf|Pfizer Oy Animal Health|||22510||22510|39268| 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|ţpakki||N06AA09|01.03.2011||R|1|0|0|0|B|0|AUK|0|0|0|100|GBP|454|1577|lyfalmen|V0510|1577|2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||437||437|1577| 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|ţpakki||N06AA09|01.02.2011||R|1|0|0|0|B|0|AUK|0|0|0|100|GBP|829|2053|lyfalmen|V0512|2053|2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||785||785|2053| 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|B|0|AEG|0|0|0|100|GBP|1050|2415|lyfalmen|||1|60|0|12,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||1050||1050|2415| 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|B|0|APT|0|0|0|100|GBP|560|1745|lyfalmen|||1|100|0|100,0000|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Digoxín||560||560|1745| 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|ţpakki||L04AX01|01.08.2011||R|0|0|0|0|*|0|APT|0|0|0|100|GBP|2806|4771|lyfalmen|||1|100|0|33,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||2772||2772|4771| 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|0|0|NOE|0|0|1|100|DKK|5315|8250|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5315||5315|8250| 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|B|0|NOE|0|0|1|100|DKK|15945|22556|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15945||15945|22556| 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|ţpakki||J02AB02|01.01.1985||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|1971|3675|lyfalmen|||1|10|0|10,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól||1971||1971|3675| 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|B|0|NOE|0|0|1|100|DKK|5315|8250|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5315||5315|8250| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|2201|2987|lyfalmen|V0363|2759|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1468||1468|2987| 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|B|0|NOE|0|0|1|100|DKK|15945|22556|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15945||15945|22556| 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|2|0|1|0|0|0|ACA|0|0|1|100|XEU|2035|3763|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||2035||2035|3763| 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|2|0|1|0|0|0|ACA|0|0|1|100|NOK|3454|5704|lyfalmen|||2|300|0|100,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||3454||3454|5704| 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|0|0|0|0|0|0|NBV|0|0|0|100|XEU|2837|4860|lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hćgđalyf međ osmótíska verkun||||2837|4860| 075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|1|0|0|0|E|0|LVR|0|0|1|100|DKK|14437|20664|lyfalmen|V0196|20664|3|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||14437||14437|20664| 075356|G04BD0703|Detrusitol SR (Lyfjaver)|forđahlk|4|mg|84|stk|1|ţpakki||G04BD07|01.07.2011||R|1|0|0|0|E|0|LVR|0|0|0|100|XEU|19413|23551|lyfalmen|V0589|23551|3|84|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Tólteródín||16738||16738|23551| 075382|V04CL0030|Soluprick SQ, rauđölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075413|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|1|0|0|0|E|0|LVR|0|0|0|100|XEU|21715|29797|lyfalmen|V0441|29797|3|90|0|180,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||21715||21715|29797| 075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075425|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|1|0|0|0|E|0|LVR|0|0|0|100|XEU|17681|24735|lyfalmen|V0440|24735|3|90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||17681||17681|24735| 075440|V04CL0026|Soluprick SQ, hesliviđur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.05.2011||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|4468|4452|lyfalmen|V0445|4169|2|98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríđ||2539||2539|4452| 075465|V04CL0024|Soluprick SQ, haliđagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075470|L01CD0201|Taxotere|irţ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|34871|45646|lyfsjukr|||1|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||34871||34871|45646| 075482|L01CD0201|Taxotere|irţ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|130885|166143|lyfsjukr|||1|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||130885||130885|166143| 075507|V04CL0018|Soluprick SQ, axhnođapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075689|V04CL0027|Soluprick SQ, hrossavćrur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 075724|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|106377|135386|lyfsjukr|||1|1|0|2,2200|Icepharma hf|Wyeth Europe|Storkuţáttur IX||106377||106377|135386| 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|ţpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|1040|2069|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||1040||1040|2069| 075869|B05DB0005|Balance|kviđ.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6599|9524|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6599||6599|9524| 075888|B05DB0005|Balance|kviđ.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6599|9524|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6599||6599|9524| 075906|B05DB0005|Balance|kviđ.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6599|9524|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6599||6599|9524| 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|ţpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|AUK|0|0|0|100|GBP|486|1644|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||486||486|1644| 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|ţpakki|80+400 mg|J01EE01|01.12.2009||R|0|0|0|0|0|0|AEA|0|0|1|100|XEU|490|1649|lyfalmen|||2|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||490||490|1649| 075991|C09AA0210|Enalapril LYFIS|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|972|2306|lyfalmen|V0449|2306|2|100|0|200,0000|LYFIS ehf|LYFIS ehf|Enalapríl||970||970|2306| 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|ţpakki||A10BH01|01.01.2010||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|7123|10723|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||7123||7123|10723| 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|ţpakki||A10BH01|01.11.2007||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|24261|32993|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||24261||24261|32993| 076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|ţpakki||A10BH01|01.02.2013||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|24816|33689|lyfalmen|||1|98|0|24,5000|Vistor hf|M.S.D.|Sítagliptín||24816||24816|33689| 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|ţpakki||A10BH01|01.10.2012||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|24831|33708|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||24831||24831|33708| 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||| 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|445|1588|lyfalmen|V0045|1588|2|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1588| 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|*|0|POF|0|0|0|100|IKR|1986|3099|lyfalmen|V0290|3099|2|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1550||1550|3099| 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|*|0|POF|0|0|0|100|IKR|1946|3373|lyfalmen|V0291|3373|2|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||1750||1750|3373| 076533|N05AB0301|Trilafon|filmhtfl|2|mg|100|stk|1|ţpakki||N05AB03|01.04.2009|30.11.2012|R|1|0|0|0|*|0|SPL|0|0|0|100|DKK|902|2213|lyfalmen|||1|100|0|6,6667|Vistor hf|Schering-Plough Europe|Perfenazín||902||902|2213| 076542|N05AB0301|Trilafon|filmhtfl|4|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|1|0|0|0|*|0|SPL|0|0|0|100|DKK|1340|2812|lyfalmen|V0026|2812|1|100|0|13,3333|Vistor hf|Schering-Plough Europe|Perfenazín||||1340|2812| 076551|N05AB0301|Trilafon|filmhtfl|8|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|1|0|0|0|*|0|SPL|0|0|0|100|DKK|1910|3592|lyfalmen|V0027|3592|1|100|0|26,6667|Vistor hf|Schering-Plough Europe|Perfenazín||||1910|3592| 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|7763|13542|vetorma|||0|100|0||Vistor hf|Merial (MSD)|Ivermectinum||7763||7763|13542| 076871|G01AF0202|Canesten (D.A.C.)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|251|1322|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||251||251|1322| 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|738|1988|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||738||738|1988| 077821|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|10799|8483|lyfalmen|V0029|8455|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||5486||5486|8483| 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|869|2168|lyfalmen|||1|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||869||869|2168| 078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|20|0||D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|ţpakki||J02AC01|01.12.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12606|lyfalmen|V0419|12541|2|28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||8500||8500|12606| 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|590|1786|lyfalmen|||1|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||590||590|1786| 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|899|2209|lyfalmen|||1|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||899||899|2209| 078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1517|3054|lyfalmen|V0560|3054|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1517||1517|3054| 078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|2169|3946|lyfalmen|V0561|3946|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||2169||2169|3946| 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|0|0|0|1|0|1|SAG|0|0|0|100|DKK|140096|177703|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||140096||140096|177703| 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|ţpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|9659|6522|lyfalmen|V0069|1875|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||4052||4052|6522| 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3411|4923|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||3411||3411|4923| 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|6821|9844|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||6821||6821|9844| 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|13685|19057|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||13685||13685|19057| 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|ţpakki||J05AH02|01.11.2002||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3958|6393|lyfalmen|||1|10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3958||3958|6393| 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|0|0|0|0|*|0|SPL|0|0|0|100|DKK|19997|27641|lyfalmen|||1|10|0|154,5714|Vistor hf|Schering-Plough Europe|Perfenazín||19997||19997|27641| 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2010||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|3667|5995|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3667||3667|5995|31.01.2013 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|2245|3240|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2245||2245|3240| 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|ţpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517|2|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1517| 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|ţpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852|2|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1852| 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|ţpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864|2|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1864| 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|ţpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577|2|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2577| 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9745|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9745| 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|4354|8533|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||4354|8533| 080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|0|0|0|0|*|0|LYF|0|0|0|100|XEU|19125|18407|lyfalmen|V0421|18407|2|30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíđ||12639||12639|18407| 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|ţpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|11063|19299|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||11063||11063|19299| 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.2012||R|0|0|0|0|*|0|RAT|0|0|0|100|XEU|17995|10669|lyfalmen|V0170|10669|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||7084||7084|10669| 080482|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.2012||R|0|0|0|0|*|0|RAT|0|0|0|100|XEU|39765|23354|lyfalmen|V0185|23354|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||16581||16581|23354| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|2436|4311|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2436||2436|4311| 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhrađa|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|6518|9895|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||6518||6518|9895| 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|2879|3785|lyfalmen|V0143|2634|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2051||2051|3785| 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhrađa|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|3385|5609|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3385||3385|5609| 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|37050|64632|vetorma|||0|500|0||Vistor hf|Merial (MSD)|Ivermectinum||37050||37050|64632| 080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|8137|7902|lyfalmen|V0143|7902|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||5061||5061|7902| 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|3178|3887|lyfalmen|V0144|3193|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2126||2126|3887| 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|16208|22224|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||16208||16208|22224| 080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|11846|10148|lyfalmen|V0144|9578|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||6703||6703|10148| 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|31953|41984|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||31953||31953|41984| 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||| 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||| 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||| 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||| 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||| 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||| 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||| 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||| 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|8722|4730|lyfalmen|V0515|4659|2|100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||2742||2742|4730| 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|ţpakki||G03DA04|01.04.2011||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|4994|7810|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lćgemidler A/S|Prógesterón||4994||4994|7810| 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1978|2855|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1978||1978|2855| 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.04.2010||R|0|0|0|0|*|0|DAC|0|0|0|100|XEU|21238|16745|lyfalmen|V0456|8622|3|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||11525||11525|16745| 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|*|0|SAA|0|0|0|100|NOK|6557|9949|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||6557||6557|9949| 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|*|0|SDE|0|0|0|100|NOK|9850|14453|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9850||9850|14453| 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2011||R|0|0|0|0|*|0|AGP|0|0|0|100|XEU|41180|15639|lyfalmen|V0184|14564|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||10717||10717|15639| 082040|D07XC0101|Diprosalic|áburđur|||100|ml|1|glas||D07XC01|01.01.1987||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|2429|4302|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Betametasón||2429||2429|4302| 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kćlt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||| 082685|R03BA0502|Flixotide Diskus|innúđadu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|3488|5230|lyfalmen|||1|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3108||3108|5230| 082719|R03BA0502|Flixotide Diskus|innúđadu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|6181|9434|lyfalmen|||1|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||6181||6181|9434| 082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1030|2388|lyfalmen|||2|125|0|6,2500|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1030||1030|2388| 082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.02.2012||L|0|0|0|0|0|0|GGK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|GlaxoSmithKline ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól|||||| 082883|R03BA0201|Pulmicort|innúđal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|5244|8152|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5244||5244|8152| 082933|R03BA0201|Pulmicort|innúđal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|6200|9460|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||6200||6200|9460| 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|9741|13632|lyfalmen|V0080|13632|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||9250||9250|13632| 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|14197|20362|lyfalmen|||1|56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||14197||14197|20362| 083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.1998||R|0|0|0|0|*|0|AZA|0|0|0|100|SEK|20992|28890|lyfalmen|V0186|7902|1|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||20992||20992|28890| 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|14827|21153|lyfalmen|V0344|14831|1|56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||14827||14827|21153| 083154|R03BA0201|Pulmicort|innúđal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|8193|12187|lyfalmen|||1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||8193||8193|12187| 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|0|0|0|1|0|1|ABV|0|0|0|100|DKK|82856|105867|lyfsjukr|||1|450|0|30,0000|Vistor hf|AbbVie Ltd.|Ritonavír||82856||82856|105867| 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|32173|42922|lyfalmen|V0346|31868|1|112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||32173||32173|42922| 083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|1415|2915|lyfalmen|V0231|2664|1|300|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||1415||1415|2915| 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|0|0|0|1|0|1|SNO|0|0|0|100|NOK|9385|13545|lyfsjukr|||1|11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||9385||9385|13545| 084097|C09CA0105|Losartan LYFIS|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.05.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|2288|1875|lyfalmen|V0069|1875|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Lósartan||655||655|1875| 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|290|1376|lyfalmen|||2|10|0|2,5000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||290||290|1376| 084192|N05BA1206|Alprazolam Krka|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|2198|3073|lyfalmen|V0311|3073|2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1531||1531|3073| 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|560|1745|lyfalmen|||2|20|0|5,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||560||560|1745| 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|78954|100970|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||78954||78954|100970| 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|66047|84771|lyfsjukr|||1|0|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||66047||66047|84771| 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|86102|109941|lyfsjukr|||1|0|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||86102||86102|109941| 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|106520|135565|lyfsjukr|||1|0|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||106520||106520|135565| 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|22016|29513|lyfsjukr|||1|0|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||22016||22016|29513| 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|34386|45037|lyfsjukr|||1|0|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||34386||34386|45037| 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|44031|57141|lyfsjukr|||1|0|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||44031||44031|57141| 084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|13636|18996|lyfsjukr|||1|0|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||13636|18996| 084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|51980|67117|lyfsjukr|||1|0|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||51980|67117| 084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|160095|202802|lyfsjukr|||1|1|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||160095|202802| 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|E|0|EIS|0|0|0|100|SEK|1046|2410|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||1046||1046|2410| 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|E|0|EIS|0|0|0|100|SEK|12415|18126|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||12415||12415|18126| 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|E|0|EIS|0|0|0|100|SEK|40402|53250|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||40402||40402|53250| 085068|N02AA0101|Contalgin|forđatfl|100|mg|100|stk|1|ţpakki||N02AA01|01.10.1985||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|16691|23492|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||16691||16691|23492| 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|*|0|GAN|0|0|0|100|NOK|48674|63631|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||48674||48674|63631| 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2834|4856|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2834||2834|4856| 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|32173|42922|lyfalmen|V0345|31868|1|112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||32173||32173|42922| 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|821|2102|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||821||821|2102| 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|21895|30023|lyfalmen|V0412|25092|1|375|0|12,5000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||21895||21895|30023| 085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|37960|50185|lyfalmen|V0412|50185|1|750|0|25,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||37960||37960|50185| 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|ţpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|ELD|0|0|0|100|XEU|101654|129458|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||101654||101654|129458| 085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|ţpakki||N07XX02|01.11.2012||R|1|0|0|0|E|0|AGP|0|0|0|100|SEK|46536|60948|lyfalmen|V0579|60948|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||46536||46536|60948| 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|0|0|0|0|0|AEU|0|0|0|100|DKK|42982|56488|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||42982||42982|56488| 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|*|0|API|0|0|0|100|SEK|3274|5458|lyfalmen|V0465|4738|1|3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||3274||3274|5458| 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|*|0|API|0|0|0|100|SEK|9676|14215|lyfalmen|V0465|14215|1|9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||9676||9676|14215| 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|4573|5665|lyfalmen|V0364|5133|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3426||3426|5665| 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|6192|6589|lyfalmen|V0365|5954|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||4101||4101|6589| 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|9039|13046|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||9039||9039|13046| 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|15714|21604|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||15714||15714|21604| 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|32536|43378|lyfalmen|||1|600|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||32536||32536|43378| 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|65071|84209|lyfalmen|||1|1200|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||65071||65071|84209| 086434|L04AA2401|Orencia|stl/irţ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|57736|74341|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||57736||57736|74341| 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|20671|28487|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||20671||20671|28487| 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|54147|69837|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||54147||54147|69837| 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|ţpakki||G03CX01|01.07.1998||R|0|0|0|0|E|0|ORG|0|0|0|100|DKK|3212|5373|lyfalmen|||1|28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||3212||3212|5373| 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|ţpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||| 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|ţpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|483|1640|lyfalmen|V0060|1640|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||483||483|1640| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|173348|219434|lyfsjukr|||1|60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||173348||173348|219434| 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|327|1426|lyfalmen|V0312|458|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||327||327|1426| 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|288|1373|lyfalmen|V0312|1373|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||288||288|1373| 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|2424|4295|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2424||2424|4295| 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3586| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|ţpakki||G03GB02|01.07.1986||R|0|0|0|0|E|0|MEC|0|0|0|100|SEK|974|2311|lyfalmen|||1|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||974||974|2311| 087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.11.2010||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|3776|1924|lyfalmen|V0009|1860|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||691||691|1924| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.09.2007||R|0|0|0|0|*|0|AGP|0|0|0|100|XEU|11575|7244|lyfalmen|V0420|7102|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||4580||4580|7244| 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|ţpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|33938|59203|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||33938||33938|59203| 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|ţpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||| 087969|QD07AC0001|Cortavance|húđúđi|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|DKK|4787|9364|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||4787||4787|9364| 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|31133|54310|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||31133||31133|54310| 088261|R01AD1201|Avamys|nefúđi|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|E|0|GGL|0|0|1|100|GBP|1468|2987|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1468||1468|2987| 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|ţpakki||M01AX01|01.04.1995||R|0|0|0|0|E|0|MAB|0|0|1|100|SEK|1698|3302|lyfalmen|||1|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1698||1698|3302| 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|ţpakki||M01AX01|01.04.1995||R|0|0|0|0|E|0|MAB|0|0|1|100|SEK|6551|9940|lyfalmen|||1|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||6551||6551|9940| 088393|A03FA0101|Primperan|eţ-stíll|20|mg|6|stk|1|pakki||A03FA01|01.10.1995|30.11.2012|R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|416|1548|lyfalmen|||1|6|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||416||416|1548| 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|B|0|LEP|0|0|0|100|DKK|5456|8442|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||5456||5456|8442| 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|B|0|LEP|0|0|0|100|DKK|10540|15397|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||10540||10540|15397| 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|B|0|LEP|0|0|0|100|DKK|16171|22840|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||16171||16171|22840| 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.12.2008||R|0|0|0|0|*|0|AGP|0|0|0|100|XEU|24559|18538|lyfalmen|V0421|18407|2|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||12743||12743|18538| 088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|0|0|0|0|*|0|POF|0|0|0|100|DKK|6861|6894|lyfalmen|V0376|6894|2|8|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||4324||4324|6894| 088975|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1884|3556|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1884||1884|3556| 089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|SEK|25141|34097|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||25141||25141|34097| 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|ţpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5674| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|173348|219434|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||173348||173348|219434| 089156|A03AA0406|Mebeverin Dura|filmhtfl|135|mg|100|stk|1|ţpakki||A03AA04|01.07.2010||R|1|0|0|0|E|0|MYD|0|0|0|100|SEK|4451|7068|lyfalmen|||2|100|0|45,0000|Actavis Group PTC ehf|Mylan dura GmbH|Mebeverín||4451||4451|7068| 089281|R06AX1305|Loratadin LYFIS|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||| 089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||| 089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|E|0|LYF|0|0|1|100|XEU|||lyfalmen|V0362|2328|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||2328| 089533|V03AE0401|OsvaRen|filmhtfl|||180|stk|1|glas|435 mg / 235 mg|V03AE04|01.10.2012||R|1|0|0|0|0|0|FMC|0|0|0|100|XEU|7199|10827|lyfalmen|||1|180|0|30,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|Kalsíum asetat og ţungt magnesíum karbón||7199||7199|10827| 089801|B03AC0601|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC06|01.10.2012||R|0|0|0|0|E|0|PAC|0|0|1|100|DKK|26659|36002|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||26659||26659|36002| 089913|B03AC0601|Monofer|irl|100|mg/ml|5|ml|5|hgl||B03AC06|01.10.2012||R|0|0|0|0|E|0|PAC|0|0|1|100|DKK|143893|169830|lyfalmen|||1|25|0|25,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||133295||133295|169830| 089936|B03AC0601|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC06|01.10.2012||R|0|0|0|0|E|0|PAC|0|0|1|100|DKK|106636|136373|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||106636||106636|136373| 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995|30.11.2012|R|1|0|0|0|B|0|FRO|0|0|0|100|DKK|2355|4200|lyfalmen|||1|100|0|25,0000|Vistor hf|Ferrosan A/S|Diltíazem||2355||2355|4200| 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|ţpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|1710|3318|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1710||1710|3318| 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|ţpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|3397|5626|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3397||3397|5626| 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|1020|2374|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1020||1020|2374| 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|NOM|0|0|0|100|DKK|6252|9023|lyfsjukr|||1|10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||6252||6252|9023| 090662|R01AD1101|Nasacort|nefúđi|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|1995|3708|lyfalmen|||1|16|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1995||1995|3708| 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|1|0|1|ACK|0|0|0|100|USD|17396|23714|lyfsjukr|||1|60|0||Vistor hf|Alcon Denmark A/S|Flúorescein||||17396|23714| 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|3068|4428|lyfsjukr|||1|2|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||3068||3068|4428| 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|5303|7654|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||5303||5303|7654| 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|15560|21410|lyfsjukr|||1|18|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||15560||15560|21410| 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|3612|5920|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||3612||3612|5920| 091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|ţpakki||A10BH05|01.12.2012||R|1|0|0|0|*|0|BII|0|0|0|100|DKK|7052|10626|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||7052||7052|10626| 091649|L01DB0105|Doxorubicin Actavis|sts|10|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|1933|2790|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||1933|2790| 091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|7908|11413|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||7908|11413| 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|0|0|0|0|E|0|CHA|0|0|1|100|DKK|4262|6809|lyfalmen|||1|30|0||Vistor hf|CCS Healthcare AB|Dexametasón||4262||4262|6809| 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|1413|1886|lyfalmen|V0021|1886|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||663||663|1886| 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|2442|2352|lyfalmen|V0022|2352|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||1004||1004|2352| 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|B|0|AGT|0|0|0|100|XEU|672|1898|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||672||672|1898| 092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|0|0|0|0|0|0|LBK|0|0|0|100|DKK|4152|6659|lyfalmen|||1|15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||4152|6659| 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|9841|19069|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||9841||9841|19069| 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|ţpakki||B01AC04|01.12.1999||R|1|0|0|0|E|0|SBM|0|0|0|100|NOK|8881|11966|lyfalmen|V0009|1860|1|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||8032||8032|11966| 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092586|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|2438|4314|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2438||2438|4314| 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|1|0|0|0|*|0|DAC|0|0|0|100|DKK|9936|14571|lyfalmen|V0277|14571|3|100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||9936||9936|14571| 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|ţpakki|320/25 mg|C09DA03|01.11.2008||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|25723|34828|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||25723||25723|34828| 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|1|0|0|0|E|0|AUK|0|0|1|100|GBP|473|1626|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||473||473|1626| 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|1|0|0|0|E|0|AUK|0|0|1|100|GBP|615|1820|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||615||615|1820| 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.05.2010||R|1|0|0|0|E|0|WIH|0|0|0|100|XEU|3603|3886|lyfalmen|V0203|3843|2|12|0|84,0000|Portfarma ehf|Williams & Halls|Alendrónsýra||2125||2125|3886| 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOR|0|0|0|100|DKK|1231|2663|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma a/s|Oxýcódon||||1231|2663| 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOR|0|0|0|100|DKK|2824|4842|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma a/s|Oxýcódon||||2824|4842| 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOR|0|0|0|100|DKK|5489|8488|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma a/s|Oxýcódon||||5489|8488| 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|7486|11219|lyfalmen|||1|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7486||7486|11219| 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|B|0|NOH|0|0|0|100|DKK|1574|3132|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1574||1574|3132| 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|28362|49476|vetorma|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|Medroxyprogesteronum||28362||28362|49476| 093736|L02AE0305|Zoladex LA (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|0|0|0|1|*|0|DAC|0|0|0|100|SEK|67700|84922|lyfalmen|V0451|82966|3|1|0|83,7209|D.A.C. ehf|D.A.C. ehf|Góserelín||65639||65639|84922| 093747|C09AA0503|Ramipril Actavis (DAC)|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.11.2011||R|1|0|0|0|B|0|DAC|0|0|0|100|XEU|1276|2724|lyfalmen|V0496|2724|3|100|0|200,0000|D.A.C. ehf|D.A.C. ehf|Ramipríl||1276||1276|2724| 093757|N02AA0501|Oxycontin|forđatfl|80|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|17297|24253|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||17297||17297|24253| 093799|N02AA0501|Oxycontin|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|48812|63804|lyfalmen|V0588|50471|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||48812||48812|63804| 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|609753|767123|lyfsjukr|||1|0|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||609753||609753|767123| 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|656673|826007|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||656673||656673|826007| 094111|N02CC0501|Almogran|filmhtfl|12,5|mg|6|stk|1|ţpakki||N02CC05|01.07.2010||R|1|0|0|0|E|0|ALM|0|0|0|100|SEK|5665|8728|lyfalmen|V0236|8309|1|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||5665||5665|8728| 094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|ţpakki||N02CC05|01.07.2010||R|1|0|0|0|E|0|ALM|0|0|0|100|SEK|8395|12463|lyfalmen|V0236|12463|1|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||8395||8395|12463| 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1911|3801|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|||1911||1911|3801| 094287|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|13969|20076|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13969||13969|20076| 094757|N04BC0406|Ropinirole Portfarma|forđatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|33297|37023|lyfalmen|V0534|35180|2|84|0|112,0000|Portfarma ehf|Portfarma|Rópíníról||27472||27472|37023| 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|ţpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|88120|112473|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||88120||88120|112473| 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|APE|0|0|1|100|XEU|50880|66400|lyfalmen|||1|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||50880|66400| 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|6942|12110|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6942||6942|12110| 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|1577|3136|lyfalmen|||0|100|1|50,0000|Distica|Distica - óskráđ lyf|Magnesíum hýdroxíđ||1577||1577|3136| 095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|5424|5581|lyfalmen|V0143|5268|3|8|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||3364||3364|5581| 095588|N07BB0101|Antabus|freyđit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|E|0|AGT|0|0|0|100|DKK|6535|9918|lyfalmen|||1|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||6535||6535|9918| 095652|N05AX1301|Invega|forđatfl|3|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|19801|27395|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||19801||19801|27395| 095680|N05AX1301|Invega|forđatfl|6|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|19801|27395|lyfalmen|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||19801||19801|27395| 095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2060|2973|lyfsjukr|||2|100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||2060||2060|2973| 095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|3226|4656|lyfsjukr|||2|200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||3226||3226|4656| 095707|N05AX1301|Invega|forđatfl|9|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|19801|27395|lyfalmen|||1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||19801||19801|27395| 095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2704|3903|lyfsjukr|||2|50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2704|3903| 095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|3741|5399|lyfsjukr|||2|100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3741|5399| 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|E|0|AGP|0|0|1|100|XEU|1143|1542|lyfalmen|V0225|1542|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||412||412|1542| 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|XEU|3909|7678|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3909||3909|7678| 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|XEU|5158|10077|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5158||5158|10077| 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|XEU|9393|18209|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9393||9393|18209| 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|36045|47119|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||36045||36045|47119| 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|13707|19085|lyfsjukr|||1|10|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||13707||13707|19085| 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|107159|136367|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||107159||107159|136367| 096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.05.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|XEU|2571|1941|lyfalmen|V0088|1936|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||703||703|1941| 096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.05.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|XEU|2676|2097|lyfalmen|V0089|2088|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||817||817|2097| 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|0|0|0|0|0|0|GGL|0|0|1|100|GBP|2219|4014|lyfalmen|||1|5|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||2219||2219|4014| 096260|N06DA0301|Exelon|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|E|0|NOE|0|0|0|100|DKK|17235|24175|lyfalmen|V0347|22828|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17235||17235|24175| 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|0|0|100|XEU|736248|925874|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||736248||736248|925874| 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|0|0|100|XEU|780462|981362|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||780462||780462|981362| 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|0|0|100|XEU|820855|1032056|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||820855||820855|1032056| 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|0|0|100|XEU|900859|1132461|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||900859||900859|1132461| 096679|N06DA0301|Exelon|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|E|0|NOE|0|0|0|100|DKK|17235|24175|lyfalmen|V0349|22828|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17235||17235|24175| 096685|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|30|stk|1|ţpakki||C03BA11|01.03.1999||R|1|0|0|0|E|0|SEV|0|0|0|100|DKK|1589|3153|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíđ||1589||1589|3153| 096688|N06DA0301|Exelon|forđapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|E|0|NOE|0|0|0|100|DKK|34472|45808|lyfalmen|||1|60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||34472||34472|45808| 096768|L02AE0102|Suprecur|nefúđi|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|E|0|SNO|0|0|0|100|NOK|20757|28595|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||20757||20757|28595| 097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.04.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|29202|38531|lyfsjukr|||2|10000|0||Actavis Group hf|Braun|Hýdróxyetýl sterkja||29202||29202|38531| 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|78591|137098|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||78591||78591|137098| 097080|R06AX2701|Aerius|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|E|0|MLD|0|0|1|100|DKK|1757|3382|lyfalmen|V0366|2582|1|30|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1757||1757|3382| 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|8673|16826|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||8673|16826| 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.06.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|2347|4169|lyfalmen|V0461|4169|3|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2332||2332|4169| 097498|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.12.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|617|1823|lyfalmen|V0333|1638|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||617||617|1823| 097531|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11886|17238|lyfalmen|V0334|5904|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11886||11886|17238| 097577|N06AX1602|Efexor Depot|forđahlk|150|mg|98|stk|1|ţpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|22566|30865|lyfalmen|V0335|5904|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||22566|30865| 097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.02.2012||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|2596|4530|lyfalmen|||0|100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2596||2596|4530| 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|3506|2731|lyfalmen|V0023|2731|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||1281||1281|2731| 097896|N02CC0104|Sumacta|húđuđtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.11.2007||R|0|0|0|0|E|0|AGP|0|0|0|100|IKR|1917|2211|lyfalmen|V0234|2211|2|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||901||901|2211| 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|1178|2568|lyfalmen|V0329|2568|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1162||1162|2568| 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|7048|2109|lyfalmen|V0072|2109|2|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||826||826|2109| 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|9032|2109|lyfalmen|V0073|2109|2|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||826||826|2109| 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|B|0|BIG|0|0|1|100|SEK|665|1889|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||665||665|1889| 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|B|0|BIG|0|0|1|100|SEK|665|1889|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||665||665|1889| 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||| 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|E|0|RGM|0|0|0|100|XEU|1063|2003|lyfalmen|V0243|2003|2|50|0|4,1600|Medical ehf|ratiopharm GmbH|Lamótrigín||749||749|2003| 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|E|0|RGM|0|0|0|100|XEU|1812|2433|lyfalmen|V0244|2299|2|50|0|8,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||1063||1063|2433| 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|E|0|RGM|0|0|0|100|XEU|5116|4516|lyfalmen|V0245|4493|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||2586||2586|4516| 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|E|0|RGM|0|0|0|100|XEU|9166|9497|lyfalmen|V0232|9374|2|100|0|66,6600|Medical ehf|ratiopharm GmbH|Lamótrigín||6227||6227|9497| 098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|19999|26981|lyfsjukr|||2|25|0||Actavis Group hf|Braun|Flúmazeníl||19999||19999|26981| 098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|18799|26138|lyfalmen|||1|0|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||18799||18799|26138| 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|1|0|1|ASZ|0|0|0|100|SEK|108295|137793|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||108295||108295|137793| 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|*|0|MYL|0|0|0|100|IKR|6128|2853|lyfalmen|V0284|2853|2|100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Quetíapín||1370||1370|2853| 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|*|0|MYL|0|0|0|100|IKR|14070|9871|lyfalmen|V0285|9840|2|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||6500||6500|9871| 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|*|0|MYL|0|0|0|100|IKR|23001|20743|lyfalmen|V0286|20555|2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||14500||14500|20743| 099705|D08AG0201|Betadine|húđlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|E|0|AGP|0|0|0|100|XEU|3146|4210|lyfalmen|V0247|4210|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2362||2362|4210| 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|E|0|AGP|0|0|0|100|XEU|4351|6438|lyfalmen|V0248|6438|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||3991||3991|6438| 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|E|0|AGP|0|0|0|100|XEU|8837|10798|lyfalmen|V0249|10798|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||7178||7178|10798| 099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|ţpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|IPI|0|0|0|100|DKK|198257|250695|lyfsjukr|||1|28|0|-1,0000|Icepharma hf|Pfizer Limited|Sunitíníb||198257||198257|250695| 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|ţpakki||H02AB06|01.01.2011||R|1|0|0|0|B|0|AUK|0|0|1|100|GBP|756|2013|lyfalmen|||2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||756||756|2013|31.01.2013 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|14084|20221|lyfalmen|||1|28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||14084|20221| 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|14084|20221|lyfalmen|||1|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||14084|20221| 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|2152|3919|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||2149||2149|3919| 101034|R06AX2704|Desloratadine ratiopharm|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.10.2012||R|1|0|0|0|E|0|RGM|0|0|1|100|XEU|3769|6135|lyfalmen|V0458|5619|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||3769||3769|6135| 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|13415|14155|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||9632||9632|14155| 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|18555|25832|lyfalmen|||1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||18555||18555|25832| 101691|C08CA0502|Adalat Oros|forđatfl|20|mg|28|stk|1|ţpakki||C08CA05|01.10.1999||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|2247|4053|lyfalmen|||1|28|0|18,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||2247|4053| 101709|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.10.1999||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|7251|10898|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||7251|10898| 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|1452|2965|lyfalmen|V0330|2965|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1452||1452|2965| 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|B|0|AGP|0|0|0|100|XEU|3303|5497|lyfalmen|V0331|5497|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3303||3303|5497| 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|4143|1976|lyfalmen|V0088|1976|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||729||729|1976| 101760|N06AX1104|Miron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|5914|9069|lyfalmen|V0332|9069|2|96|0|144,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||5914||5914|9069| 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|4805|2131|lyfalmen|V0089|2131|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||842||842|2131| 101769|N02AX0211|Nobligan Retard (D.A.C.)|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.09.2007||R|1|0|1|0|E|0|DAC|0|0|1|100|DKK|5493|8493|lyfalmen|V0227|7927|3|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||5493||5493|8493| 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|SEK|19122|36890|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||||19122|36890| 101825|A09AA0206|Creon 10.000|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.09.2011||R|1|0|0|0|E|0|APR|0|0|0|100|DKK|3423|5661|lyfalmen|||1|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||||3423|5661| 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|ţpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|7595|11368|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||7595||7595|11368| 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|ţpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|22783|31138|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||22783||22783|31138| 102871|C01DA1401|Imdur|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.07.1989||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|4126|6623|lyfalmen|V0041|3946|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||4126||4126|6623| 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1994||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|2068|2985|lyfsjukr|||1|50|0||Vistor hf|AstraZeneca AB|Própófól||2068||2068|2985| 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1988||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|3361|4851|lyfsjukr|||1|50|0||Vistor hf|AstraZeneca AB|Própófól||3361||3361|4851| 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|3503|2709|lyfalmen|V0088|1936|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1265||1265|2709| 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|4280|3014|lyfalmen|V0089|2088|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1488||1488|3014| 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.02.2008||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|2992|2340|lyfalmen|V0069|1875|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||995||995|2340| 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.02.2008||R|1|0|0|0|E|0|POF|0|0|1|100|GBP|2771|2164|lyfalmen|V0033|2164|2|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||866||866|2164| 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|ţpakki||J05AB11|01.02.2008||R|1|0|0|0|E|0|POF|0|0|1|100|GBP|10961|9065|lyfalmen|V0182|9019|2|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||5911||5911|9065| 103678|N06AX1604|Venlafaxin (Portfarma)|forđahlk|75|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|4454|6024|lyfalmen|V0334|6024|2|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||3688||3688|6024| 103687|N06AX1604|Venlafaxin (Portfarma)|forđahlk|150|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|7148|6024|lyfalmen|V0335|6024|2|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||3688||3688|6024| 103806|N02AB0305|Fentanyl ratiopharm|forđapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|E|0|RGM|0|0|0|100|XEU|2241|4006|lyfalmen|V0222|4006|2|5|0|3,6000|Medical ehf|ratiopharm GmbH|Fentanýl||2213||2213|4006| 103813|B02BC0001|Tisseel|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|380813|479803|lyfsjukr|||1|40|0||Icepharma hf|Baxter AG|Lyf til ađ minnka stađbundna blćđingu||380813||380813|479803| 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|4256|8345|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníđ og amídín-Klórhexidín í blöndum||4256||4256|8345| 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1975| 103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||| 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|15199|20957|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||15199||15199|20957| 104047|C09CA0304|Valsartan LYFIS|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|3272|2250|lyfalmen|V0073|2109|2|98|0|196,0000|LYFIS ehf|LYFIS ehf|Valsartan||929||929|2250| 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|3362|5578|lyfalmen|||1|2|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||3362||3362|5578| 104498|N05CH0101|Circadin|forđatfl|2|mg|21|stk|1|ţpakki||N05CH01|01.11.2007||R|1|0|0|0|0|0|NER|0|0|1|100|DKK|2312|4142|lyfalmen|V0574|3517|1|21|0|21,0000|Vistor hf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2312||2312|4142| 104760|A07EC0202|Pentasa|eţ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|B|0|FER|0|0|0|100|DKK|8864|13104|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8864||8864|13104| 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|B|0|FER|0|0|0|100|DKK|4977|7787|lyfalmen|V0017|7787|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4977||4977|7787| 104851|A07EC0202|Pentasa|forđatfl|500|mg|100|stk|1|ţpakki||A07EC02|01.04.1992||R|1|0|0|0|B|0|FER|0|0|0|100|DKK|5633|8685|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5633||5633|8685| 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|137648|174631|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||137648|174631| 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007|30.11.2012|R|1|0|0|0|0|0|DAC|0|0|0|100|SEK|4308|5987|lyfalmen|||3|28|0|18,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||3661||3661|5987| 105315|G03AA0705|Microgynon (D.A.C.)|töflur|||63|stk|1|ţpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|DAC|0|0|0|100|DKK|29182|2838|lyfalmen|V0545|2838|3|63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og ethinylestradíól||1359||1359|2838| 105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|4227|6761|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4227||4227|6761| 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|14695|20987|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||14695||14695|20987| 105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|4872|7644|lyfalmen|||1|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4872||4872|7644| 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|16949|23816|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||16949||16949|23816| 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2683|4649|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2683||2683|4649| 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3171|5317|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||3171||3171|5317| 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|1972|3676|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1972||1972|3676| 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3945|6375|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3945||3945|6375| 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|1|0|0|0|0|0|ABS|0|0|1|100|DKK|2854|4883|lyfalmen|||1|14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2854||2854|4883| 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|20366|27442|lyfsjukr|||1|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||20366||20366|27442| 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|11263|16018|lyfsjukr|||1|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||11263||11263|16018| 106932|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.11.2012||R|1|1|0|0|*|0|TEV|0|0|0|100|XEU|9946|13026|lyfalmen|V0572|12266|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||8807||8807|13026| 107092|N05AH0311|Olanzapine Ranbaxy|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|*|0|RAN|0|0|0|100|XEU|2174|1900|lyfalmen|V0278|1846|2|28|0|7,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||673||673|1900| 107138|C07AG0203|Carvedilol Actavis|filmhtfl|6,25|mg|100|stk|1|ţpakki||C07AG02|01.05.2012||R|1|0|0|0|B|0|ADG|0|0|0|100|XEU|1674|3269|lyfalmen|||2|100|0|16,6600|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||1674||1674|3269| 107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|1683|3281|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1683||1683|3281| 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||R|0|0|0|0|0|0|CRO|0|0|0|100|XEU|1653|2884|vetorma|||0|6|0||Portfarma ehf|Cross Vetpharm Group Ltd.|Ivermectinum||1653||1653|2884| 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|ţpakki||A02BA02|01.07.1986||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|992|2336|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||992||992|2336| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.01.1991||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|3204|5362|lyfalmen|||1|100|0|33,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||3204|5362| 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|ţpakki||A10BH02|01.09.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|3530|5808|lyfalmen|||1|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3530||3530|5808| 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|ţpakki||A10BH02|01.09.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|10476|15310|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||10476||10476|15310| 108802|N05AH0310|Zalasta (LYFIS)|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.10.2011|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|13890|6504|lyfalmen|||3|56|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||4009||4039|6504| 108845|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|E|0|AZD|0|0|1|100|SEK|1297|2753|lyfalmen|||1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1297||1297|2753| 108852|R01AD0501|Rhinocort Aqua|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|E|0|AZD|0|0|1|100|SEK|1799|3440|lyfalmen|V0443|3438|1|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1799||1799|3440| 109357|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2347|2105|lyfalmen|V0004|2066|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||823||823|2105| 109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|25968|35135|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||25968||25968|35135| 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|20790|28637|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||20790||20790|28637| 109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377| 109515|N02AA0505|Oxycodone ratiopharm|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.01.2013|31.01.2013|R|1|0|1|0|E|0|RGM|0|0|0|100|XEU|36970|48942|lyfalmen|||2|98|0|104,5300|Medical ehf|ratiopharm GmbH|Oxýcódon||36970||36970|48942| 109569|N02AA0505|Oxycodone ratiopharm|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|E|0|RGM|0|0|0|100|XEU|3931|6356|lyfalmen|V0584|6356|2|28|0|7,4700|Medical ehf|ratiopharm GmbH|Oxýcódon||3931||3931|6356| 109578|N02AA0505|Oxycodone ratiopharm|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|E|0|RGM|0|0|0|100|XEU|11580|16820|lyfalmen|V0585|16820|2|98|0|26,1300|Medical ehf|ratiopharm GmbH|Oxýcódon||11580||11580|16820| 109588|N02AA0505|Oxycodone ratiopharm|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|E|0|RGM|0|0|0|100|XEU|7522|11269|lyfalmen|V0586|11269|2|28|0|14,9300|Medical ehf|ratiopharm GmbH|Oxýcódon||7522||7522|11269| 109597|N02AA0505|Oxycodone ratiopharm|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|E|0|RGM|0|0|0|100|XEU|20079|27744|lyfalmen|V0587|27744|2|98|0|52,2700|Medical ehf|ratiopharm GmbH|Oxýcódon||20079||20079|27744| 109615|N02AA0505|Oxycodone ratiopharm|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|E|0|RGM|0|0|0|100|XEU|38245|50471|lyfalmen|V0588|50471|2|98|0|104,5300|Medical ehf|ratiopharm GmbH|Oxýcódon||38188||38188|50471| 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|ţpakki||N02BE01|01.12.1983||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól|||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.07.1992||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|ţpakki||N02BE01|01.11.1981||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|448|1592|lyfalmen|V0230|1592|2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||448||448|1592| 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||| 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|555|1738|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||555||555|1738| 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||| 110395|G03AA0902|Mercilon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1990||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1647|3232|lyfalmen|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1647||1647|3232| 110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||| 110635|C08DA0104|Veraloc Retard|forđatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|B|0|ORC|0|0|0|100|DKK|4211|6739|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||4211||4211|6739| 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|120690|153348|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||120690||120690|153348| 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|6294|7778|lyfalmen|V0373|7778|2|15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||4970||4970|7778| 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|802|2076|lyfalmen|||1|100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||802||802|2076| 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|23267|31745|lyfalmen|||1|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||23267||23267|31745| 112056|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|3|innö.t||R03BB05|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|17985|25116|lyfalmen|||1|180|0||Vistor hf|Almirall S.A.|Aclídínumbrómíđ||17985||17985|25116| 112641|M05BA0407|Alendronat Ranbaxy|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.04.2009||R|1|0|0|0|E|0|RAN|0|0|0|100|IKR|2094|3843|lyfalmen|V0203|3843|2|12|0|84,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alendrónsýra||2094||2094|3843| 113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Icepharma hf|Orifarm Generics A/S|Nikótín|||||| 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|9101|13429|lyfalmen|V0024|12166|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||9101||9101|13429| 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|27053|36497|lyfalmen|V0024|36497|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||27053||27053|36497| 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|9219|13590|lyfalmen|V0025|12297|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||9219||9219|13590| 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dćla|B01AB05|01.10.1995||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|4197|6720|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4197||4197|6720| 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|27368|36892|lyfalmen|V0025|36892|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||27368||27368|36892| 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dćla|B01AB05|01.10.1995||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|7191|10816|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7191||7191|10816| 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|ţpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NOE|0|0|0|100|DKK|712877|896543|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||712877||712877|896543| 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|793|2064|lyfalmen|||1|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||793||793|2064| 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1007|2356|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1007||1007|2356| 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1537|3081|lyfalmen|||1|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1537||1537|3081| 114033|R03AC0210|Ventolin Diskus|innúđadu|200|mcg/sk|60|skammtar|1|stk|Diskus tćki|R03AC02|01.03.1999||R|0|0|0|0|B|0|GSK|0|0|1|100|IKR|999|2345|lyfalmen|||1|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||999||999|2345| 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|56277|72510|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||56277||56277|72510| 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|ţpakki||M01AH05|01.01.2010||R|1|0|0|0|E|0|MSD|0|0|1|100|DKK|4420|7025|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||4420||4420|7025| 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.03.1999||R|0|0|0|0|*|0|MSD|0|0|0|100|DKK|2522|4429|lyfalmen|V0373|2593|1|5|0|25,0000|Vistor hf|M.S.D.|Tímólól í blöndum||2522||2522|4429| 114512|D06BB0401|Condyline|áburđur|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|2372|4224|lyfalmen|||1|4|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2372||2372|4224| 114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|6875|10384|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||6875||6875|10384| 114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|*|0|KNM|0|0|0|100|XEU|2664|1871|lyfalmen|V0278|1846|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||652||652|1871| 114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|*|0|KNM|0|0|0|100|XEU|3485|2480|lyfalmen|V0279|2434|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1097||1097|2480| 114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|*|0|KNM|0|0|0|100|XEU|12092|7888|lyfalmen|V0280|7888|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5051||5051|7888| 114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|*|0|KNM|0|0|0|100|XEU|12724|6215|lyfalmen|V0282|6215|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||3828||3828|6215| 114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|*|0|KNM|0|0|0|100|XEU|7899|7347|lyfalmen|V0457|4460|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4655||4655|7347| 115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|*|0|KNM|0|0|0|100|XEU|15468|15130|lyfalmen|V0456|8622|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||10345||10345|15130| 115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|*|0|KNM|0|0|0|100|XEU|25300|16545|lyfalmen|V0475|16545|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||11379||11379|16545| 115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|*|0|KNM|0|0|0|100|XEU|39005|32274|lyfalmen|V0540|32274|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||23688||23688|32274| 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|2037|3765|lyfalmen|||1|10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||2037||2037|3765| 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|9494|13702|lyfsjukr|||2|10|0||Actavis Group hf|Braun|Naloxón||9494||9494|13702| 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|ţpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1732|3348|lyfalmen|||2|20|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1732||1732|3348| 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|12221|17882|lyfalmen|||1|60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||12221||12221|17882| 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|2037|3765|lyfalmen|||1|10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||2037||2037|3765| 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|12221|17882|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||12221||12221|17882| 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|0|0|0|0|*|0|MSD|0|0|0|100|DKK|2029|3754|lyfalmen|V0369|3122|1|5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíđ||2029||2029|3754| 115931|R03AC1202|Serevent Diskus|innúđadu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|4045|6512|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||4045||4045|6512| 115980|P03AX0301|Prioderm|húđlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|0|0|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||0|55|0||Icepharma hf|Norpharma |Malatíón|||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|4063|5864|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||4063||4063|5864| 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|2124|3065|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2124||2124|3065| 116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|1153|1724|lyfalmen|V0056|1724|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||545||545|1724| 116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|1826|2114|lyfalmen|V0057|2114|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||830||830|2114| 116244|D11AF01|Verucid|áburđur|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf viđ vörtum og líkţornum|||||| 116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|2779|4780|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Mómetasón||2779||2779|4780| 116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|3194|5348|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Mómetasón||3194||3194|5348| 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|ţpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|ţpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|ţpakki||M01AE01|01.08.2008||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|813|2091|lyfalmen|V0562|2077|2|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||813||813|2091| 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|ţpakki||M01AE01|01.07.2008||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|405|1533|lyfalmen|V0563|1514|2|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||405||405|1533| 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|ţpakki||M01AE01|01.05.2008||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|986|2328|lyfalmen|V0564|2314|2|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||986||986|2328| 116694|G04BD1101|Toviaz|forđatfl|4|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|E|0|IPI|0|0|0|100|DKK|18944|26320|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||18944||18944|26320| 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|8095|11496|lyfalmen|V0081|11496|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||7688||7688|11496| 116705|G04BD1101|Toviaz|forđatfl|4|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|E|0|IPI|0|0|0|100|DKK|6455|9809|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6455||6455|9809| 116716|G04BD1101|Toviaz|forđatfl|8|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|E|0|IPI|0|0|0|100|DKK|6932|10462|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6932||6932|10462| 116727|G04BD1101|Toviaz|forđatfl|8|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|E|0|IPI|0|0|0|100|DKK|20465|28229|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||20465||20465|28229| 116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|0|1|0|0|0|0|IPI|0|0|0|100|DKK|8829|13057|lyfalmen|||1|0|0||Icepharma hf|Pfizer Limited|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar (cojugated)||8829||8829|13057| 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX00|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|11767|22767|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|||11767||11767|22767| 117515|M01AE0303|Orudis|forđahlk|200|mg|100|stk|1|glas||M01AE03|01.10.1995||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|3610|5917|lyfalmen|||1|100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||3610||3610|5917| 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|4850|7613|lyfalmen|V0435|7501|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4850||4850|7613| 117550|N05AH0405|Seroquel Prolong|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|16347|23061|lyfalmen|||1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||16347|23061| 117561|N05AH0405|Seroquel Prolong|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|28891|38803|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||28891|38803| 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|1719|3330|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1719||1719|3330| 117573|N05AH0405|Seroquel Prolong|forđatfl|300|mg|10|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|4996|7813|lyfalmen|||1|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4996|7813| 117584|N05AH0405|Seroquel Prolong|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|49956|65240|lyfalmen|||1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||49956|65240| 117595|N05AH0405|Seroquel Prolong|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|57781|75060|lyfalmen|||1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||57781|75060| 117676|L01DB0103|Caelyx|irţ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|73517|94146|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||73517||73517|94146| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|10399|18141|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|||10399||10399|18141| 117788|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.07.1994||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|2616|4557|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||2616|4557| 117796|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|6255|9535|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||6255|9535| 117820|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|9364|13788|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||9364|13788| 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|8220|15956|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|||8220||8220|15956| 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|14416|27853|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|||14416||14416|27853| 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.05.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|4282|1878|lyfalmen|V0278|1846|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||657||657|1878| 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|6087|2488|lyfalmen|V0279|2434|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1103||1103|2488| 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|23605|6667|lyfalmen|V0282|6215|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||4158||4158|6667| 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|18033|8090|lyfalmen|V0283|7853|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||5198||5198|8090| 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|2420|4289|lyfalmen|||1|100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2420||2420|4289| 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||9512||9512|13728| 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|18557|8144|lyfalmen|V0280|7888|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||5238||5238|8144| 118570|A07EC0203|Pentasa Sachets|forđakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998|31.12.2012|R|0|0|0|0|B|0|FER|0|0|0|100|DKK|7589|11360|lyfalmen|||1|50|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7589||7589|11360| 118612|A07EC0203|Pentasa Sachets|forđakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|B|0|FER|0|0|0|100|DKK|24740|33594|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||24740||24740|33594| 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|1|0|0|0|*|0|LVR|0|0|0|100|IKR|2883|4923|lyfalmen|||3|100|0|8,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||2883||2883|4923|31.12.2012 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|1|0|0|0|*|0|LVR|0|0|0|100|DKK|9593|14102|lyfalmen|||3|100|0|33,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||9593||9593|14102|31.12.2012 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|ţpakki||C01AA05|01.12.2010||R|1|0|0|0|B|0|AEG|0|0|0|100|XEU|524|1696|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||524||524|1696| 119031|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|0|1|0|1|0|1|AEU|0|0|0|100|DKK|82767|105755|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||82767||82767|105755| 119825|N05BA1206|Alprazolam Krka|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|1033|2125|lyfalmen|V0309|2125|2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||838||838|2125| 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.03.2008||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen|||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|0|0|100|GBP|485208|610819|lyfsjukr|||1|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||485208||485208|610819| 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|0|0|100|GBP|485208|610819|lyfsjukr|||1|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||485208||485208|610819| 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|E|0|SAL|0|0|0|100|USD|1033|2392|lyfalmen|||1|10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||1033||1033|2392| 120062|L01BA0401|Alimta|irţ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|1|0|1|LIL|0|0|0|100|XEU|51603|66644|lyfsjukr|||1|1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||51603||51603|66644| 120392|M01AE0110|Ibuprofen Actavis|filmhtfl|200|mg|24|stk|1|ţpakki||M01AE01|01.01.2012||L|1|0|0|0|0|0|AHF|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Actavis Group PTC ehf|Actavis Group hf|Íbúprófen|||||| 120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|0|0|100|DKK|34009|44564|lyfsjukr|||1|2|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||34009||34009|44564| 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.05.2008|31.12.2012|R|1|0|0|0|0|0|LVR|0|0|0|100|DKK|17959|25084|lyfalmen|||3|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||17959||17959|25084| 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|6218|9485|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6218||6218|9485| 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|ORG|0|0|0|100|DKK|10147|14617|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Rókúrón, brómíđ||10147||10147|14617| 121302|N02BA5102|Treo|freyđit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||| 121327|R03AC0204|Ventolin|innúđal|0,1|mg/sk|200|skammtar|1|stauk||R03AC02|01.12.1972||R|0|0|0|0|B|0|GSK|0|0|1|100|IKR|467|1618|lyfalmen|||1|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||467||467|1618| 121550|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|8128|5155|lyfalmen|V0011|5012|2|98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||3053||3053|5155| 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.01.2008||R|1|0|0|0|E|0|AUK|0|0|1|100|GBP|444|1584|lyfalmen|V0391|1581|2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||442||442|1584| 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|ţpakki||N06AA04|01.03.1977||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|1885|3557|lyfalmen|V0314|3158|1|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||1885||1885|3557| 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|ţpakki||H02AB06|01.01.2011||R|1|0|0|0|B|0|AUK|0|0|1|100|GBP|297|1385|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||297||297|1385| 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|IKR|9600|16747|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9600||9600|16747| 122577|A04AA0105|Ondansetron BMM Pharma|filmhtfl|4|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|1|0|0|0|E|0|BMM|0|0|0|100|XEU|3346|4954|lyfalmen|V0381|4954|2|10|0|2,5000|LYFIS ehf|BMM Pharma AB|Ondansetrón||2906||2906|4954| 122588|A04AA0105|Ondansetron BMM Pharma|filmhtfl|4|mg|50|stk|1|ţpakki||A04AA01|01.11.2012||R|1|0|0|0|E|0|BMM|0|0|0|100|XEU|16505|20498|lyfalmen|||2|50|0|12,5000|LYFIS ehf|BMM Pharma AB|Ondansetrón||14305||14305|20498| 122610|A04AA0105|Ondansetron BMM Pharma|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|1|0|0|0|E|0|BMM|0|0|0|100|XEU|3821|4452|lyfalmen|V0384|4452|2|10|0|5,0000|LYFIS ehf|BMM Pharma AB|Ondansetrón||2539||2539|4452| 122643|A04AA0105|Ondansetron BMM Pharma|filmhtfl|8|mg|50|stk|1|ţpakki||A04AA01|01.11.2012||R|1|0|0|0|E|0|BMM|0|0|0|100|XEU|16505|20498|lyfalmen|||2|50|0|25,0000|LYFIS ehf|BMM Pharma AB|Ondansetrón||14305||14305|20498| 123216|N05BA0105|Stesolid|eţ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|897|2206|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||897||897|2206| 123224|N05BA0105|Stesolid|eţ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1211|2635|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1211||1211|2635| 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|28338|49434|vetorma|||0|100|0||Icepharma hf|Icepharma hf|||28338||28338|49434| 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|B|0|AGT|0|0|0|100|XEU|263|1339|lyfalmen|||2|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||263|1339| 123954|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|2324|2484|lyfalmen|V0317|2484|2|100|0|50,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1100||1100|2484| 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|ţpakki||N07XX02|01.05.1998||R|1|0|0|0|E|0|AVS|0|0|0|100|NOK|51025|66582|lyfalmen|V0579|60948|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||51025||51025|66582| 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1952|3883|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1952|3883| 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|ţpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SBM|0|0|0|100|NOK|42588|55993|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||42588|55993| 124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.04.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|XEU|2047|2254|lyfalmen|V0234|2211|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||932||932|2254| 124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|ţpakki||N02CC01|01.04.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|XEU|2924|2750|lyfalmen|V0233|2750|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1295||1295|2750| 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|ţpakki||G02AB01|01.03.1980||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|1070|2443|lyfalmen|||1|30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1070||1070|2443| 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|ţpakki||C09AA02|01.01.1994||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|548|1729|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||548||548|1729| 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|11075|16129|lyfalmen|V0464|16129|0|8|0|75,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||11075||11075|16129| 124936|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.11.1999||R|0|0|1|0|0|1|RBP|0|0|0|100|DKK|1362|1966|lyfsjukr|||1|7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1362||1362|1966| 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.1994||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|901|2046|lyfalmen|V0066|2046|2|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||780||780|2046| 125973|D01BA0205|Terbinafin BMM Pharma|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.08.2012||R|1|0|0|0|0|0|BMM|0|0|0|100|XEU|2658|3306|lyfalmen|V0123|3306|2|28|0|28,0000|LYFIS ehf|BMM Pharma AB|Terbínafín||1701||1701|3306| 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|ţpakki||A07DA03|01.10.1991||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|123534|156918|lyfsjukr|||1|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||123534|156918| 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|31703|41670|lyfsjukr|||1|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||31703|41670| 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|INN|0|0|0|100|XEU|27176|35988|lyfsjukr|||1|1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||27176||27176|35988| 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|INN|0|0|0|100|XEU|9058|13073|lyfsjukr|||1|1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||9058||9058|13073| 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|51916|67037|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||51916||51916|67037| 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|103860|132227|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||103860||103860|132227| 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|207646|262478|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||207646||207646|262478| 126926|B01AX0601 |Xarelto|filmhtfl|15|mg|100|stk|1|ţpakki||B01AX06|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|42153|55447|lyfalmen|V0031|55447|1|100|0|150,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||42153|55447| 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.10.1991||R|1|0|0|0|E|0|MCS|0|0|0|100|SEK|1141|2540|lyfalmen|||1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||1141||1141|2540| 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|ţpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Icepharma hf|Orifarm Generics A/S|Nikótín|||||| 128058|N05AH0301|Zyprexa|húđuđtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|*|0|ELD|0|0|0|100|XEU|9341|6577|lyfalmen|V0279|2434|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||4092||4092|6577| 128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|ţpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|13150|25423|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíđar í blöndu međ öđrum lyfjum||13150||13150|25423| 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|E|0|LEP|0|0|0|100|DKK|1318|2782|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1318||1318|2782| 128777|N02BA5102|Treo|freyđit|||60|stk|1|glas||N02BA51|01.07.1988||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4393|6340|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Mesna||4393||4393|6340| 129098|N05AH0301|Zyprexa|húđuđtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|33678|32036|lyfalmen|V0280|7888|1|56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||23499||23499|32036| 129106|N05AH0301|Zyprexa|húđuđtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|*|0|ELD|0|0|0|100|XEU|36603|24659|lyfalmen|V0282|6215|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||17621||17621|24659| 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|ţpakki||H02AB06|01.02.2011||R|1|0|0|0|B|0|AUK|0|0|1|100|GBP|249|1320|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||249||249|1320| 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|1|0|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||0|100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3443| 129817|R03BB0101|Atrovent|innúđal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|0|0|0|0|B|0|BOI|0|0|0|100|DKK|4685|7388|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||4685||4685|7388| 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|20450|24939|lyfalmen|V0285|9840|1|100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||17844||17844|24939| 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|32371|37995|lyfalmen|V0286|20555|1|100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||28247||28247|37995| 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|2571|4496|lyfalmen|||2|10|0|20,0000|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||2571||2571|4496| 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|DKK|14954|28886|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||14954||14954|28886| 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|4276|6828|lyfalmen|||2|125|0|31,2500|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||4276||4276|6828| 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|2009|3727|lyfalmen|||2|10|0|3,3400|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||2009||2009|3727| 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|ţpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|12167|17815|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||12167|17815| 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|72038|117530|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||72038|117530| 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|3684|6018|lyfalmen|||2|10|0|10,0000|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríđ||||3684|6018| 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|519|1689|lyfalmen|||2|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||519||519|1689| 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|818|2098|lyfalmen|||2|100|0|15,0000|Vistor hf|Recip AB|Fenemal||818||818|2098| 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|1091|2471|lyfalmen|||2|100|0|50,0000|Vistor hf|Recip AB|Fenemal||1091||1091|2471| 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|1207|2630|lyfalmen|||2|100|0|100,0000|Vistor hf|Recip AB|Fenemal||1207||1207|2630| 131450|B01AC0405|Clopidogrel Qualigen (Lyfjaver)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2011||R|1|0|0|0|E|0|LVR|0|0|0|100|XEU|2797|3061|lyfalmen|V0009|1860|3|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Klópídógrel||1522||1522|3061| 131565|G03CA0306|Evorel|forđapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|6221|9489|lyfalmen|V0132|9489|1|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||6221||6221|9489| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AX06|01.05.2009||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|4204|6730|lyfalmen|V0032|6124|1|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||4204||4204|6730| 131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AX06|01.05.2009||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|12611|18372|lyfalmen|V0032|18372|1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||12611||12611|18372| 131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AX06|01.05.2009||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|41873|55096|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||41873||41873|55096| 132260|N06DA0404|Galantamine Portfarma|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.12.2011||R|1|0|0|0|E|0|POF|0|0|0|100|SEK|8794|13009|lyfalmen|||2|28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||8794||8794|13009| 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|9929|3285|lyfalmen|V0581|3222|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||1686||1686|3285| 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|7957|3285|lyfalmen|V0580|3222|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||1686||1686|3285| 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|E|0|REP|0|0|1|100|SEK|1633|3213|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Kódein||1633||1633|3213| 132663|N06BA0402|Concerta|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|8545|12668|lyfalmen|||1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||8545||8545|12668| 132761|D08AG0201|Betadine|húđlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|SAL|0|0|0|100|USD|1177|2589|lyfalmen|||1|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1177||1177|2589| 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||| 132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|ţpakki||G03AB04|01.01.1993||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1521|3060|lyfalmen|||1|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1521||1521|3060| 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|31083|40892|lyfsjukr|||1|0|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||31083||31083|40892| 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|41346|53772|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||41346||41346|53772| 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|54024|69683|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||54024|69683| 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|SEK|||lyfalmen|||0|50|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||7271| 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|ţpakki||J02AC03|01.05.2008|31.12.2012|R|1|0|0|0|0|1|DAC|0|0|0|100|DKK|89738|114504|lyfsjukr|||3|14|0|7,0000|D.A.C. ehf|D.A.C. ehf|Voricónazól||89738||89738|114504| 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|0|0|0|0|0|0|ABS|0|0|1|100|DKK|1618|3192|lyfalmen|||1|50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||1618||1618|3192| 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|4281|6835|lyfalmen|V0378|6216|1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||4281||4281|6835| 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|12832|18649|lyfalmen|V0378|18649|1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||12832||12832|18649| 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|5056|7297|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||5056||5056|7297| 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|75056|96078|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||75056||75056|96078| 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|0|1|0|1|GSI|0|0|0|100|DKK|139067|176412|lyfsjukr|||1|30|0|30,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||139067||139067|176412| 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|56531|72829|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||56531||56531|72829| 135289|C07AG0203|Carvedilol Actavis|filmhtfl|12,5|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|1|0|0|0|B|0|ADG|0|0|0|100|XEU|2822|4839|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||2822||2822|4839| 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1111|2499|lyfalmen|||2|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Verapamíl||1111||1111|2499| 135434|R03BA0502|Flixotide Diskus|innúđadu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2445|4324|lyfalmen|||1|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2445||2445|4324| 136168|G03AB0401|Trinovum|töflur|||63|stk|1|ţpakki||G03AB04|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1831|3484|lyfalmen|||1|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1831||1831|3484| 136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|0|1|*|0|IPI|0|0|0|100|DKK|36270|48064|lyfalmen|V0582|48064|1|60|0|20,0000|Icepharma hf|Pfizer Limited|Sirolimus||36270||36270|48064| 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|7625|11410|lyfalmen|||1|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíđ||7625||7625|11410| 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|78954|100970|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||78954||78954|100970| 136658|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|491|1511|lyfalmen|V0307|1511|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||389||389|1511| 136964|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|21457|3620|lyfsjukr|||2|5|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||2508||2508|3620| 136975|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|67209|11332|lyfsjukr|||2|17|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||7852||7852|11332| 136987|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|49535|8352|lyfsjukr|||2|25|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||5787||5787|8352| 136998|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|77216|13020|lyfsjukr|||2|50|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||9021||9021|13020| 137110|L01XA0302|Oxaliplatin Hospira|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|6342|9153|lyfsjukr|||2|20|0||Icepharma hf|Hospira UK Ltd|Oxalíplatín||6342||6342|9153| 137218|G03AC0902|Gestrina|filmhtfl|75|mcg|168|stk|1|ţpakki|6x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|3583|5880|lyfalmen|||2|168|0|168,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||3583||3583|5880| 137513|S01XA2011|Oculac|augndr|||10|ml|1|glas|međ rotvörn|S01XA20|01.10.1999||L|0|0|0|0|E|0|ACK|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||1723| 137521|S01XA2011|Oculac|augndr|||0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|0|0|0|0|E|0|ACK|0|0|0|100|DKK|||lyfalmen|||0|8|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||2128| 137809|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|XEU|197539|30844|lyfsjukr|||2|25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||23077||23077|30844| 137820|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|XEU|6709|9683|lyfsjukr|||2|10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6709||6709|9683| 137831|M05BA0302|Pamidronatdinatrium Hospira|irţ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|XEU|11263|16018|lyfsjukr|||2|10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||11263||11263|16018| 137842|M05BA0302|Pamidronatdinatrium Hospira|irţ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|XEU|56694|9560|lyfsjukr|||2|10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6624||6624|9560| 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|0|0|0|0|0|1|HOS|0|0|0|100|XEU|795|1147|lyfsjukr|||2|500|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||795||795|1147| 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|0|0|0|0|0|1|HOS|0|0|0|100|XEU|12025|2328|lyfsjukr|||2|1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1613||1613|2328| 138318|L01BA0109|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|3573|5867|lyfalmen|||1|0|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3573||3573|5867| 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|1810|3455|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1810||1810|3455| 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|0|0|0|0|*|0|APC|0|0|0|100|XEU|5040|7778|lyfalmen|V0373|7778|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||4970||4970|7778| 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|ţpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||| 140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|146008|185123|lyfsjukr|||1|20|0||Vistor hf|N.V. Organon|Sugammadex||146008||146008|185123| 140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|364903|459836|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Sugammadex||364903||364903|459836| 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|1546|3094|lyfalmen|V0266|1324|1|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1546||1546|3094| 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|12509|17581|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12509||12509|17581| 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|0|0|0|0|0|1|DES|0|0|0|100|DKK|678|979|lyfsjukr|||1|5|0|3,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||678||678|979| 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|bađlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|1|0|0|100|NOK|104356|200552|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||104356||104356|200552| 140954|N07BA0103|Nicorette|nefúđi|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|1321|2786|lyfalmen|V0413|2486|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1321||1321|2786| 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|0|0|0|0|0|1|DAC|0|0|0|100|DKK|4709|6613|lyfsjukr|||3|1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||4582||4582|6613| 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4101|5919|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||4101||4101|5919| 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|2923|4977|lyfalmen|||1|30|0|2,1600|Vistor hf|Boehringer Ingelheim International |Pramipexól||2923||2923|4977| 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|22311|30545|lyfalmen|||1|0|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||22311||22311|30545| 141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|međ breyttan losunarhrađa|H02AB09|01.01.2013||R|1|0|0|0|B|0|VIO|0|0|1|100|DKK|55869|72661|lyfalmen|||1|50|0|8,3300|Williams & Halls efh|ViroPharma SPRL|Hýdrókortisón||55869||55869|72661| 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|5313|8247|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||5313|8247| 141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.02.2013||R|1|0|0|0|B|0|TEV|0|0|0|100|XEU|14304|16687|lyfalmen|V0492|16687|2|98|0|39,2000|Medical ehf|Teva Pharma B.V.|Montelúkast||11483||11483|16687| 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|9161|13511|lyfalmen|V0267|2674|1|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||9161||9161|13511| 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|2951|3832|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2086||2086|3832| 142203|QS02QA0301|Otimectin vet.|eyrnahl|1|mg/g|10|g|1|túpa|fyrir ketti|QS02QA03|01.10.2012||L|0|0|0|0|0|0|LEV|1|0|0|100|XEU|1770|3088|vetorma|||0|10|0||Le Vet B.V.|Le Vet B.V.|Ivermectinum||||1770|3088| 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|3656|5277|lyfsjukr|||1|30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||3656||3656|5277| 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|ţpakki||C01BD01|01.04.1987||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|1198|2618|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1198||1198|2618| 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|3166|5310|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||3166||3166|5310| 143139|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|1537|3081|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1537||1537|3081| 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2414|3484|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2414||2414|3484| 143511|J07BC2002|Twinrix Paediatric|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|4151|6657|lyfalmen|||1|0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4151||4151|6657| 143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.10.2012||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|625|1713|lyfalmen|V0542|1694|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Atenólól||537||537|1713| 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|SAL|0|0|0|100|USD|972|2309|lyfalmen|||1|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Trópíkamíđ||972||972|2309| 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|ţpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1568|3124|lyfalmen|||1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1568||1568|3124| 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|ţpakki||N02CX02|01.04.1974||R|1|0|0|0|E|0|BOI|0|0|0|100|DKK|1413|2912|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1413||1413|2912| 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|ţpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|8968|13247|lyfalmen|V0386|10085|1|56|0|28,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||8968||8968|13247| 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|646|1863|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||646||646|1863| 143800|N05AN0101|Litarex|forđatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|*|0|AGT|0|0|0|100|DKK|1281|2731|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1281||1281|2731| 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2156|3928|lyfalmen|V0174|3296|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||2156||2156|3928| 144030|N04BA0207|Sinemet depot mite|forđatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|E|0|MSD|0|0|0|100|DKK|2223|4020|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2223||2223|4020| 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|24440|33217|lyfalmen|||1|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||24440||24440|33217| 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|0|0|100|DKK|85830|109599|lyfsjukr|||1|2|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||85830||85830|109599| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|0|0|100|DKK|64149|82389|lyfsjukr|||1|2|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||64149||64149|82389| 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|0|0|100|DKK|39859|51906|lyfsjukr|||1|2|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||39859||39859|51906| 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|697|1932|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||697||697|1932| 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|1|0|1|CEO|0|0|0|100|DKK|90763|115790|lyfsjukr|||1|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||90763||90763|115790| 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|2361|4209|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Betametasón||2361||2361|4209| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|ţpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|8|0|1,1400|Vistor hf|Recip AB|Pýrvín|||||| 145698|N05AH0301|Zyprexa|húđuđtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|21911|21179|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||14848||14848|21179| 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|33437|43846|lyfsjukr|||1|1|0|4,8000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||33437||33437|43846| 146207|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|3239|4675|lyfsjukr|||2|2|0||Icepharma hf|Hospira UK Ltd|Írinótekan||3239||3239|4675| 146218|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|6581|9498|lyfsjukr|||2|5|0||Icepharma hf|Hospira UK Ltd|Írinótekan||6581||6581|9498| 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|ţpakki|hart|N06BA09|01.01.2010||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|19179|26615|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||19179||19179|26615| 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|ţpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|975|2313|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||975||975|2313| 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2686|3877|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||2686||2686|3877| 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1664|2402|lyfsjukr|||2|10|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||1664||1664|2402| 147343|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.02.2012|31.12.2012|L|0|0|0|0|0|0|LVR|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól|||||| 148213|R05CB1301|Pulmozyme|innúđal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|0|0|0|ROA|0|0|1|100|DKK|120316|153542|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||120316||120316|153542| 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|ţpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1287|2393|lyfalmen|V0577|2393|2|20|0|6,6667|Portfarma ehf|Orion Corporation|Pívmecillínam||1034||1034|2393| 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|ţpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1914|3597|lyfalmen|||2|30|0|10,0000|Portfarma ehf|Orion Corporation|Pívmecillínam||1914||1914|3597| 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|6861|9549|lyfalmen|||2|100|0|33,3300|Portfarma ehf|Orion Corporation|Pívmecillínam||6265||6265|9549| 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|88796|113984|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||88796||88796|113984| 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|88796|113984|lyfalmen|||1|30|0|45,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||88796||88796|113984| 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|ţpakki||N04AA02|01.11.2005||R|1|0|0|0|*|0|LFS|0|0|0|100|DKK|909|2222|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||909||909|2222| 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|79814|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíđ og súrefni||62097||62097|79814| 148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|59826|10087|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Vínkristín||6989||6989|10087| 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|125417|20271|lyfsjukr|||2|10|0||Icepharma hf|Hospira Nordic AB|Vínkristín||14652||14652|20271| 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|1|0|1|HOS|0|0|0|100|XEU|268297|41219|lyfsjukr|||1|1|0||Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||31344||31344|41219| 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|3875|7613|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||3875||3875|7613| 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|ţpakki||N05AG02|01.03.2004||R|0|0|0|0|0|0|PCO|0|0|0|100|SEK|2321|4154|lyfalmen|||0|75|1|18,7500|Distica|Distica - óskráđ lyf|Pímózíđ||2321||2321|4154| 149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|0|0|0|0|*|0|POF|0|0|0|100|DKK|2319|2696|lyfalmen|V0376|2298|2|2|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1255||1255|2696| 150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||R|0|0|0|0|E|0|LTH|0|0|0|100|SEK|5801|8914|lyfalmen|V0583|8914|1|24|0||Vistor hf|Laboratoires THEA|Ketotifen||5801||5801|8914| 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|55927|72071|lyfsjukr|||1|2|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||55927|72071| 150539|C10AD5201|Tredaptive|töflur|1020|mg|28|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|0|0|0|0|0|0|MSD|0|0|0|100|DKK|4040|6505|lyfalmen|||1|28|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||4040|6505| 150550|C10AD5201|Tredaptive|töflur|1020|mg|56|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|0|0|0|0|0|0|MSD|0|0|0|100|DKK|6702|10147|lyfalmen|V0120|7967|1|56|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||6702|10147| 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3965|6403|lyfalmen|||1|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hreinsađir fjórgildir meningókokka polysakkaríđ mótefnavakar||||3965|6403| 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|*|0|LBK|0|0|0|100|DKK|7005|10561|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||7005||7005|10561| 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|E|0|SNO|0|0|0|100|NOK|1315|2778|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1315||1315|2778| 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.11.2008||R|1|0|0|0|E|0|LBK|0|0|0|100|DKK|17010|23893|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||17010|23893| 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.11.2008||R|1|0|0|0|E|0|LBK|0|0|0|100|DKK|52521|65320|lyfalmen|||1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||50020||50020|65320| 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|5613|8657|lyfalmen|||1|0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5613||5613|8657| 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.05.2006||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|5909|4281|lyfalmen|V0148|2983|2|90|0|90,0000|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||2414||2414|4281| 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|1680|3277|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1680||1680|3277| 151975|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|E|0|RAT|0|0|0|100|IKR|4359|3838|lyfalmen|V0006|3838|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||2090||2090|3838| 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|2142|3091|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||2142||2142|3091| 152318|D01BA0204|Terbinafine (D.A.C.)|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.12.2010||R|1|0|0|0|0|0|DAC|0|0|0|100|XEU|2765|3403|lyfalmen|V0123|3306|3|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||1772||1772|3403| 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúđadu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|4309|6166|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3792||3792|6166| 152413|R03BA0202|Pulmicort Turbuhaler|innúđadu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|6298|9594|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||6298||6298|9594| 152421|R03BA0202|Pulmicort Turbuhaler|innúđadu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|B|0|ASZ|0|0|0|100|SEK|11555|16786|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníđ||11555||11555|16786| 152635|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||| 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|E|0|LYF|0|0|0|100|XEU|20133|21080|lyfalmen|V0269|21080|3|100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||14769||14769|21080| 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|ţpakki|hart|J02AC02|01.01.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|1376|2861|lyfalmen|||1|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1376||1376|2861| 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1972|3676|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1972||1972|3676| 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|42474|55187|lyfsjukr|||1|1|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||42474|55187| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2490|4385|lyfalmen|V0561|3946|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2490||2490|4385| 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1741|3361|lyfalmen|V0560|3054|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1741||1741|3361| 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|ţpakki||R06AE07|01.01.1998||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|2449|3354|lyfalmen|V0575|3354|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||1736||1736|3354| 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GIS|0|0|0|100|DKK|244407|308613|lyfsjukr|||1|10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||244407||244407|308613| 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|B|0|AGT|0|0|0|100|XEU|583|1776|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||583|1776| 153507|L02BG0602|Exemestan Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||L02BG06|01.08.2011||R|0|0|0|0|*|0|APC|0|0|0|100|XEU|37581|49709|lyfalmen|V0452|49709|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||37581||37581|49709| 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|4753|7481|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4753||4753|7481| 153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|343|1448|lyfalmen|||2|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||343||343|1448| 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|569|1757|lyfalmen|||2|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||569||569|1757| 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|E|0|APS|0|0|1|100|DKK|10063|14745|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||10063||10063|14745| 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|1129|2523|lyfalmen|||1|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1129||1129|2523| 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|31148|40973|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||31148||31148|40973| 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|40808|53097|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||40808||40808|53097| 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|44836|58152|lyfsjukr|||1|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||44836||44836|58152| 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|33185|43530|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||33185||33185|43530| 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|40821|53113|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||40821||40821|53113| 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29244|38584|lyfsjukr|||1|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||29244||29244|38584| 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|4049|6518|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4049||4049|6518| 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|38131|49737|lyfsjukr|||1|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||38131||38131|49737| 154728|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1631|3210|lyfalmen|||2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1631||1631|3210| 154732|G04CA0102|Xatral Uno|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.01.2003|31.12.2012|R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|7706|11520|lyfalmen|||1|90|0|120,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7706||7706|11520| 154739|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|4636|6101|lyfalmen|V0334|5904|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3744||3744|6101| 154761|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|7441|6101|lyfalmen|V0335|5904|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3744||3744|6101| 154952|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|INT|0|0|0|100|DKK|480699|605822|lyfalmen|||1|252|0|28,0300|Vistor hf|InterMune Europe Ltd.|Pírfenidon||480699||480699|605822| 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|0|0|0|0|*|0|ATL|0|0|0|100|XEU|1684|3283|lyfalmen|||1|25|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Chlorambucíl||1684||1684|3283| 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|2370|4210|lyfalmen|V0247|4210|2|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||2362||2362|4210| 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|3994|6438|lyfalmen|V0248|6438|2|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||3991||3991|6438| 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|7182|10798|lyfalmen|V0249|10798|2|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||7178||7178|10798| 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|1626|3203|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1626||1626|3203| 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|696|1931|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||696||696|1931| 155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|1792|3430|lyfalmen|V0590|3430|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||1792||1792|3430| 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|7421|11130|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||7421||7421|11130| 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|6276|9564|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||6276||6276|9564| 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|6329|9637|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||6329||6329|9637| 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|ţpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|478|1633|lyfalmen|||2|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||478||478|1633| 156563|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2518|3634|lyfsjukr|||2|15|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||2518||2518|3634| 156574|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1476|2130|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||1476||1476|2130| 156585|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|6896|9953|lyfsjukr|||2|45|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||6896||6896|9953| 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|ţpakki||A08AB01|01.07.1999||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|10113|14813|lyfalmen|||1|84|0|28,0000|Icepharma hf|Roche|Orlístat||10113||10113|14813| 156597|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|9237|13331|lyfsjukr|||2|60|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||9237||9237|13331| 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|ţpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|959|2291|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||959||959|2291| 156861|QJ01MA9002|Enrotron Flavour|töflur|50|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|1898|3775|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||1898||1898|3775| 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|10|spr||QP52AF02|01.04.1992|31.12.2012|R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|7338|12801|vetorma|||0|260|0||Icepharma hf|Pfizer Oy Animal Health|||7338||7338|12801| 157741|N05AH0311|Olanzapine Ranbaxy|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|*|0|RAN|0|0|0|100|XEU|2908|2526|lyfalmen|V0279|2434|2|28|0|14,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||1131||1131|2526| 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|ţpakki||N03AF01|01.01.2010||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|1629|3207|lyfalmen|V0239|3207|1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1629||1629|3207| 157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|7539|11292|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||7539||7539|11292| 158163|N05AH0405|Seroquel Prolong|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|1738|3356|lyfalmen|||1|10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1738|3356| 158185|N05AH0405|Seroquel Prolong|forđatfl|150|mg|100|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|32024|42735|lyfalmen|||1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||32024|42735| 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|ţpakki||N03AF01|01.12.1972||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|1016|2369|lyfalmen|V0239|1604|1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1016||1016|2369| 158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|110536|140605|lyfsjukr|||1|1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||110536|140605| 158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|221074|279330|lyfsjukr|||1|1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||221074|279330| 158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|626849|788578|lyfsjukr|||1|1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||626849|788578| 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|56600|72916|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||56600|72916| 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|80743|103215|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||80743||80743|103215| 158683|H01BB0201|Syntocinon|nefúđi|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|0|0|0|0|E|0|DES|0|0|0|100|DKK|876|2177|lyfalmen|||1|5|0|13,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||876||876|2177| 158725|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.12.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|1135|2532|lyfalmen|V0469|2532|2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1135|2532| 159107|N02AB0303|Fentanyl Actavis|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|E|0|AGP|0|0|0|100|XEU|3612|4308|lyfalmen|V0219|4096|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||2434||2434|4308| 159118|N02AB0303|Fentanyl Actavis|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|E|0|AGP|0|0|0|100|XEU|6218|6931|lyfalmen|V0220|6719|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4351||4351|6931| 159130|N02AB0303|Fentanyl Actavis|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|E|0|AGP|0|0|0|100|XEU|8067|8773|lyfalmen|V0221|8561|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||5698||5698|8773| 159141|N02AB0303|Fentanyl Actavis|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|E|0|AGP|0|0|0|100|XEU|9399|10191|lyfalmen|V0223|9767|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||6734||6734|10191| 159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|ţpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|IKR|3218|3222|lyfalmen|V0581|3222|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||1640||1640|3222| 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5542|4925|lyfalmen|V0318|1467|1|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2885||2885|4925| 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|ţpakki||L02BG06|01.06.2001|30.11.2012|R|0|0|0|0|*|0|PER|0|0|0|100|DKK|20434|28190|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Exemestan||20434||20434|28190| 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|14212|13133|lyfalmen|V0320|2846|1|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8885||8885|13133| 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|2010|2760|lyfalmen|V0062|1386|1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1302||1302|2760| 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|3479|3889|lyfalmen|V0067|1386|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2127||2127|3889| 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|7169|5185|lyfalmen|V0071|2164|1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3075||3075|5185| 159672|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|E|0|MYL|0|0|1|100|SEK|582|1775|lyfalmen|||2|25|0|10,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||582||582|1775| 159683|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|E|0|MYL|0|0|1|100|SEK|1765|3393|lyfalmen|||2|100|0|40,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||1765||1765|3393| 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|APC|0|0|0|100|DKK|107749|137107|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||107749||107749|137107| 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|4504|8821|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||4504||4504|8821| 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2011||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|2078|2939|lyfalmen|V0010|2937|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1433||1433|2939| 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2430|3507|lyfsjukr|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2430||2430|3507| 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|40569|52797|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||40569||40569|52797| 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|59070|76015|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||59070||59070|76015| 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|ţpakki||N05AB04|01.06.1981||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|1113|2501|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||1113||1113|2501| 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|0|0|0|0|0|0|BRS|0|0|0|100|DKK|2531|4441|lyfalmen|||1|50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2531||2531|4441| 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|78803|100780|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||78803||78803|100780| 160852|R01AX0301|Atrovent|nefúđi|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|0|0|0|0|E|0|BOI|0|0|1|100|DKK|1286|2738|lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíđ||1286||1286|2738| 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009|31.01.2013|R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|79833|102073|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||79833||79833|102073| 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|635|1848|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||635||635|1848| 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|986|1423|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||986||986|1423| 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|895|1292|lyfsjukr|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||895||895|1292| 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|649|1867|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||649||649|1867| 161133|G03CA0306|Evorel|forđapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|5527|8540|lyfalmen|V0131|8540|1|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||5527||5527|8540| 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|ţpakki||L02BG06|01.06.2001||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|64526|83525|lyfalmen|V0452|49709|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||64526||64526|83525| 161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|ţpakki|8+2 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|15206|20848|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||15112||15112|20848| 162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|0|0|100|DKK|170044|215288|lyfsjukr|||1|8|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||170044||170044|215288| 162115|N06AA0906|Saroten|töflur|25|mg|100|stk|1|glas||N06AA09|01.12.2011||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|834|2120|lyfalmen|V0512|2095|1|100|0|33,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||834||834|2120| 162149|N06AA0906|Saroten|töflur|10|mg|100|stk|1|glas||N06AA09|01.12.2011||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|464|1614|lyfalmen|V0510|1609|1|100|0|13,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||464||464|1614| 162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|584097|735587|lyfalmen|||1|60|0||Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||584097||584097|735587| 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|2054|3789|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||2054||2054|3789| 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|5832|11371|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||||5832|11371| 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|XEU|473|1566|lyfalmen|V0500|1566|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||429||429|1566| 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|XEU|767|2028|lyfalmen|||2|100|0|42,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||767||767|2028| 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|XEU|946|2273|lyfalmen|||2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||946||946|2273| 162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|IKR|743|1512|lyfalmen|V0108|1512|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||390||390|1512| 162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|IKR|836|1649|lyfalmen|V0109|1649|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||490||490|1649| 162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|IKR|1347|2005|lyfalmen|V0110|2005|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||750||750|2005| 162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|0|0|0|0|*|0|APC|0|0|0|100|XEU|1758|3310|lyfalmen|V0373|2593|2|5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1704||1704|3310| 162929|G04CA0205|Ranomax|forđahlk|0,4|mg|100|stk|1|ţpakki||G04CA02|01.04.2009||R|1|0|0|0|E|0|RAN|0|0|0|100|XEU|5096|3838|lyfalmen|V0148|3314|2|100|0|100,0000|Artasan ehf|Ranbaxy (UK) Ltd|Tamsúlósín||2090||2090|3838| 162933|R03BA0501|Flixotide|innúđal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|2445|4324|lyfalmen|||1|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2445||2445|4324| 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.12.1972||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|1226|2656|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1226||1226|2656| 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|ţpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|1876|3545|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1876||1876|3545| 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|1|0|0|0|E|0|AEA|0|0|0|100|XEU|217|1276|lyfalmen|||2|20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíđ||||217|1276| 163493|R03BA0501|Flixotide|innúđal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|3614|5230|lyfalmen|||1|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3108||3108|5230| 163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|8140|12114|lyfalmen|||0|454|1|10,0800|Distica|Distica - óskráđ lyf|Pólýstýren súlfónat||8140||8140|12114| 164119|J05AE1101|Incivo|filmhtfl|375|mg|42|stk|1|glas||J05AE11|01.02.2012||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|383863|483631|lyfsjukr|||1|42|0|7,0000|Vistor hf|Janssen-Cilag International N.V.|Telaprevír||383863||383863|483631| 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|0|0|0|0|*|0|ATL|0|0|0|100|XEU|3709|6053|lyfalmen|||1|25|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Merkaptópúrín||3709||3709|6053| 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4158|6001|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4158||4158|6001| 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|3313|5511|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||||3313|5511| 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|10923|15921|lyfalmen|||2|100|0|200,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||10923||10923|15921| 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1347|2822|lyfalmen|||2|100|0|10,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||1347||1347|2822| 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1593|3158|lyfalmen|V0314|3158|2|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||1593||1593|3158| 164871|A07EC0204|Asacol|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|B|0|TIL|0|0|0|100|SEK|8093|12050|lyfalmen|V0014|12050|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||8093|12050| 165001|C05AA0102|Proctosedyl|eţ-stíll|||12|stk|1|pakki||C05AA01|01.12.1972||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|12|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165019|C05AA0102|Proctosedyl|eţ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|898|2207|lyfalmen|||2|100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||898||898|2207| 165306|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|7420|14420|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|||7420||7420|14420| 165449|C08CA0202|Plendil|forđatfl|10|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|5606|8648|lyfalmen|V0059|6197|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5606||5606|8648| 165548|C08CA0202|Plendil|forđatfl|5|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|3618|5928|lyfalmen|V0058|5121|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3618||3618|5928| 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|294620|371631|lyfsjukr|||1|8|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||294620||294620|371631| 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|40569|52797|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||40569||40569|52797| 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|59070|76015|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||59070||59070|76015| 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|ţpakki||R06AE05|01.12.1972||R|1|0|0|0|E|0|UCN|0|0|1|100|SEK|776|2040|lyfalmen|||1|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||776||776|2040| 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|ţpakki||R06AE05|01.12.1972||R|1|0|0|0|E|0|UCN|0|0|1|100|SEK|225|1287|lyfalmen|||1|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||225||225|1287| 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|ţpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||| 165791|N06DA0206|Donepezil Medical|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|1|0|0|0|E|0|MED|0|0|0|100|XEU|26126|13281|lyfalmen|V0341|12583|2|98|0|65,3300|Medical ehf|Medical ehf|Dónepezíl||8993||8993|13281| 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4394|6342|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4394||4394|6342| 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|78803|100780|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||78803||78803|100780| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|267132|337133|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||267132||267132|337133| 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|5015|9802|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||5015|9802| 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|ţpakki||P01BA02|01.12.1972||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|2118|3876|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||2118||2118|3876| 166165|H01CA0201|Synarela|nefúđi|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|E|0|PER|0|0|0|100|DKK|16284|22982|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||16284||16284|22982| 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|2455|4337|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2455||2455|4337| 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|4648|7337|lyfalmen|V0428|7337|2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||4648||4648|7337| 166709|G04CA0103|Alfuzosin Ranbaxy|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.07.2009||R|1|0|0|0|E|0|RAN|0|0|0|100|XEU|5241|6857|lyfalmen|V0550|6857|2|90|0|120,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alfúzósín||4297||4297|6857| 166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|0|1|0|1|E|0|IPI|0|0|0|100|DKK|140116|178391|lyfalmen|||1|1|0|1,0000|Icepharma hf|Pfizer Limited|Clostridíum||140116||140116|178391| 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||| 167319|N06AX1608|Venlafaxin Actavis|forđahlk|37,5|mg|7|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|482|1638|lyfalmen|V0333|1638|2|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||482||482|1638| 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.06.2009||R|1|0|0|0|E|0|AUK|0|0|0|100|GBP|680|1909|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||680|1909| 168309|A02BC0306|Lanser|sţ-hylki|30|mg|98|stk|1|ţpakki||A02BC03|01.08.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|IKR|4452|5144|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||3045||3045|5144| 168618|L01BA0109|Metoject|stl|50|mg/ml|0,15|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|2735|4720|lyfalmen|||1|0|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2735||2735|4720| 168629|L01BA0109|Metoject|stl|50|mg/ml|0,2|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|2930|4987|lyfalmen|||1|0|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2930||2930|4987| 168640|L01BA0109|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|3218|5381|lyfalmen|||1|0|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3218||3218|5381| 168651|L01BA0109|Metoject|stl|50|mg/ml|0,4|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|3638|5956|lyfalmen|||1|0|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3638||3638|5956| 168662|L01BA0109|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|3832|6221|lyfalmen|||1|0|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3832||3832|6221| 168740|N03AF0105|Tegretol Retard|forđatfl|200|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|3271|5453|lyfalmen|V0240|5452|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3271||3271|5453| 168971|N03AF0105|Tegretol Retard|forđatfl|400|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|6037|9237|lyfalmen|V0433|9236|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||6037||6037|9237| 168997|L01CA0401|Navelbine|irţ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|59688|76791|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||59688||59688|76791| 169433|L01CA0401|Navelbine|irţ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|259514|327573|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||259514||259514|327573| 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|23255|31068|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||23255||23255|31068| 169664|J07BK0101|Varilrix|bóluefni|||0,5|ml|1|hgl|ţurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|5826|8949|lyfalmen|||1|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluđ veira||5826||5826|8949| 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|0|1|0|1|C|0|POF|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827|2|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2827| 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|0|1|0|1|C|0|POF|0|0|0|30|IKR|2450|4196|lyfalmen|V0125|4196|2|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4196| 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577|2|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2577| 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864|2|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1864| 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852|2|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1852| 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517|2|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1517| 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3265|5445|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3265||3265|5445| 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3515|5787|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3515||3515|5787| 170062|L04AC0701|RoActemra|irţ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|26034|34555|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||26034|34555| 170085|L04AC0701|RoActemra|irţ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|64613|82972|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||64613|82972| 170092|J07BC2001|Twinrix Adult|bóluefni|||1|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|6263|9546|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||6263||6263|9546| 170107|L04AC0701|RoActemra|irţ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|122133|155159|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||122133||122133|155159| 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|ţpakki||J04AB02|01.07.2012||R|1|0|0|0|E|0|SAD|0|0|0|100|DKK|17196|24126|lyfalmen|V0571|24126|1|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||17196||17196|24126| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|1|0|0|1|B|0|ABS|0|0|0|100|DKK|4180|6697|lyfalmen|||1|100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||4180||4180|6697| 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|1|0|0|1|B|0|ABS|0|0|0|100|DKK|7317|10988|lyfalmen|||1|100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||7317||7317|10988| 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2672|4634|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||2672||2672|4634| 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|12270|17281|lyfsjukr|||2|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||12270||12270|17281| 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|29517|38926|lyfsjukr|||2|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||29517||29517|38926| 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|44275|57448|lyfsjukr|||2|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||44275||44275|57448| 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.06.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|XEU|3603|3886|lyfalmen|V0203|3843|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||2125||2125|3886| 170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|12363|2340|lyfalmen|V0207|2340|2|12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||995||995|2340| 170997|L01BC0701|Vidaza|irţ|25|mg/ml|4|ml|1|hgl||L01BC07|01.09.2009||R|0|0|0|1|0|1|CEE|0|0|0|100|XEU|61798|79439|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||61798||61798|79439| 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|1|0|0|100|DKK|2935|5808|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2935||2935|5808| 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|4048|6516|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||4048||4048|6516| 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|4361|6945|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||4361||4361|6945| 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|0|0|0|0|0|0|LDR|0|0|0|100|NOK|1741|3361|lyfalmen|||0|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Karbímazól||1741||1741|3361| 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|4942|7739|lyfalmen|V0247|4210|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4942||4942|7739| 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|8134|12106|lyfalmen|V0248|6438|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||8134||8134|12106| 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|48006|62130|lyfsjukr|||1|75|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||48006||48006|62130| 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|32005|42049|lyfsjukr|||1|50|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||32005||32005|42049| 172249|QJ01MA9002|Enrotron Flavour|töflur|150|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|3289|6488|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||3289||3289|6488| 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|14690|20981|lyfalmen|V0249|10798|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||14690||14690|20981| 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|27569|37144|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||27569||27569|37144| 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|73611|94264|lyfsjukr|||1|100|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||73611||73611|94264| 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|32212|31868|lyfalmen|V0346|31868|3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||23365||23365|31868| 172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|0|0|0|1|*|0|ATL|0|0|0|100|XEU|3747|6105|lyfalmen|||1|100|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Búsúlfan||3747||3747|6105| 172627|C07FB0202|Logimax forte|forđatfl|105|mg|98|stk|1|pakki|ţp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|12861|18686|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||12861||12861|18686| 172684|N02AA0303|Palladon|forđahlk|4|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|6819|10307|lyfalmen|||1|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6819||6819|10307| 172692|N02AA0303|Palladon|forđahlk|8|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|12668|18443|lyfalmen|||1|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||12668||12668|18443| 172759|N02AA0303|Palladon|forđahlk|16|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|21978|30128|lyfalmen|||1|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||21978||21978|30128| 172794|M05BA0707|Risedronato Semanal Qualigen (Lyfjaver)|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.05.2011||R|1|0|0|0|0|0|LVR|0|0|0|100|IKR|830|2114|lyfalmen|V0207|780|3|4|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rísedrónsýru||830||830|2114| 172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|656101|825952|lyfalmen|||1|60|0||Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||656101||656101|825952| 172916|N02AA0303|Palladon|forđahlk|24|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|28662|38516|lyfalmen|||1|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||28662||28662|38516| 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|ţpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MAB|0|0|1|100|DKK|460|1608|lyfalmen|||1|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||460||460|1608| 173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11423|16605|lyfalmen|V0118|16605|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||11423||11423|16605| 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|3846|6240|lyfalmen|||2|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||3846||3846|6240| 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||3760| 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|6804|10286|lyfalmen|||2|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||6804||6804|10286| 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar spr.međ nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|17808|24095|lyfsjukr|||1|2|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||17699||17699|24095| 173856|N05CF0105|Zopiklon Mylan|töflur|5|mg|30|stk|1|ţpakki||N05CF01|01.10.2001||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|390|1512|lyfalmen|||2|30|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||390||390|1512| 173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|0|0|100|DKK|17005|23224|lyfsjukr|||1|2|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||17005||17005|23224| 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1623|2342|lyfsjukr|||2|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1623||1623|2342| 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|ţpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|746|1999|lyfalmen|||1|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||746||746|1999| 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|ţpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|763|2023|lyfalmen|||1|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||763||763|2023| 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|1971|3675|lyfalmen|V0368|2962|1|5|0|25,0000|Vistor hf|Allergan|Brímónidín||1971||1971|3675| 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|5780|8886|lyfalmen|V0368|8886|1|15|0|75,0000|Vistor hf|Allergan|Brímónidín||5780||5780|8886| 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.10.1996||R|1|0|0|0|E|0|GSK|0|0|1|100|GBP|2770|2332|lyfalmen|V0033|2164|1|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||989||989|2332| 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kćlt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||| 176214|N05AH0301|Zyprexa|húđuđtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|7117|5252|lyfalmen|V0278|1846|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3124||3124|5252| 176616|N05CH0101|Circadin|forđatfl|2|mg|30|stk|1|ţpakki||N05CH01|01.10.2012||R|1|0|0|0|0|0|RAD|0|0|1|100|DKK|2957|5024|lyfalmen|V0574|5024|2|30|0|30,0000|Nycomed Danmark ApS|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2957||2957|5024| 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|723|1968|lyfalmen|||0|1|1|5,3330|Distica|Distica - óskráđ lyf|Tríamcínólón||723||723|1968| 178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|5438|5083|lyfalmen|V0320|5083|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||3000||3000|5083| 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|CEO|0|0|0|100|DKK|178903|226406|lyfsjukr|||1|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||178903||178903|226406| 179364|N03AX1406|Zelta|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|13786|7347|lyfalmen|V0253|7347|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Levetíracetam||4655||4655|7347| 179552|B01AX0601 |Xarelto|filmhtfl|15|mg|28|stk|1|ţpakki||B01AX06|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|11848|17186|lyfalmen|||1|28|0|42,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||11848|17186| 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|139700|177206|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||139700||139700|177206| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|B|0|UCB|0|0|0|100|DKK|6006|9195|lyfalmen|||1|100|0|25,0000|Vistor hf|U.C.B|Olsalazín||6006||6006|9195| 180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.12.2012||R|1|0|0|0|E|0|MED|0|0|0|100|XEU|2793|3314|lyfalmen|V0148|3314|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||1707||1707|3314| 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|E|0|PER|0|0|1|100|DKK|855|2148|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||855||855|2148| 181219|J04AB0201|Rimactan|hylki|300|mg|60|stk|1|ţpakki||J04AB02|01.02.2013||R|1|0|0|0|E|0|SAD|0|0|0|100|DKK|10318|15093|lyfalmen|V0571|14476|1|60|0|30,0000|Icepharma hf|Sandoz GmbH|Rífampicín||10318||10318|15093| 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DA32|01.10.1995||R|0|0|0|0|0|0|PFV|0|0|0|100|DKK|8626|16736|vetalmen|||0|100|0||Icepharma hf|Pfizer vet.|||8626||8626|16736| 181750|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|10486|15042|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||10486||10486|15042| 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|0|0|0|0|0|0|IBV|0|0|0|100|SEK|6495|12644|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||6495||6495|12644| 182307|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.11.2012||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|13883|19968|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13883||13883|19968| 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5783|11277|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||5783||5783|11277| 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|B|0|ALK|0|0|1|100|DKK|6209|9473|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||6209|9473| 183735|J05AE1101|Incivo|filmhtfl|375|mg|168|stk|1|pakki||J05AE11|01.03.2012||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|1535444|1928865|lyfsjukr|||1|168|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Telaprevír||1535444||1535444|1928865| 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|B|0|BRS|0|0|0|100|DKK|1275|2723|lyfalmen|||1|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1275||1275|2723| 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|525|1697|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||525||525|1697| 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1643|2121|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2121| 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|666|1890|lyfalmen|||2|15|0|3,7500|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||666||666|1890| 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|B|0|TIL|0|0|0|100|SEK|5447|8430|lyfalmen|V0017|7787|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5447|8430| 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.1998||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|23305|31793|lyfalmen|V0170|10669|1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||23305||23305|31793| 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.1998||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|59229|76878|lyfalmen|V0185|23354|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||59229||59229|76878| 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|1267|2712|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1267||1267|2712| 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|ţpakki||N02CC03|01.05.2001||R|0|0|0|0|E|0|AZA|0|0|0|100|SEK|5891|9037|lyfalmen|V0235|8583|1|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5891||5891|9037| 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|E|0|MAB|0|0|1|100|DKK|5511|8518|lyfalmen|||1|30|0||Vistor hf|Meda AB|Pímekrólímus||5511||5511|8518| 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|WTE|0|0|0|100|DKK|82775|105765|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||82775||82775|105765| 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|0|0|0|E|0|DEA|0|0|0|100|XEU|3147|5284|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3147||3147|5284| 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|1|0|0|0|*|0|MPH|0|0|0|100|USD|2116|3873|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíđ||2116||2116|3873| 189052|M05BA0604|Iasibon|irţ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|1|PSA|0|0|0|100|DKK|10353|14876|lyfsjukr|||2|2|0|0,3400|Portfarma ehf|Pharmathen S.A.|Íbandrónsýra||10353||10353|14876| 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|7679|11083|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S-|Deferoxamín||7679||7679|11083| 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|2675|4638|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2675||2675|4638| 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|1102|2486|lyfalmen|V0413|2486|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1102||1102|2486| 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|533|1708|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||533||533|1708| 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|494|713|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||494||494|713| 190702|M01AB0101|Confortid|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|0|0|0|0|E|0|AGT|0|0|1|100|DKK|1070|2443|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1070||1070|2443| 190728|M01AB0101|Confortid|eţ-stíll|50|mg|10|stk|1|ţpakki||M01AB01|01.08.2012||R|0|0|0|0|E|0|AGT|0|0|1|100|DKK|945|2272|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||945||945|2272| 191064|B05XC03|Vitalipid Infant|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4142|5978|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||4142||4142|5978| 191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|7519|11265|lyfalmen|V0117|11265|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||7519||7519|11265| 191247|B05XC02|Vitalipid Adult|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3946|5695|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3946||3946|5695| 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4072|5877|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||4072||4072|5877| 191403|R01AA0503|Nezeril|nefúđi|0,25|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|8|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 191742|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.08.2012||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|4964|7769|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4964||4964|7769| 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|E|0|PER|0|0|1|100|DKK|559|1744|lyfalmen|||1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||559||559|1744| 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|0|0|0|0|B|0|AGP|0|0|0|100|XEU|4114|6607|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||4114||4114|6607| 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|E|0|LEP|0|0|0|100|DKK|1723|3336|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1723||1723|3336| 192826|L01DB0103|Caelyx|irţ|2|mg/ml|25|ml|1|hgl||L01DB01|01.10.2012|31.12.2012|R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|163849|207513|lyfsjukr|||1|25|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||163849||163849|207513| 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|1|0|1|API|0|0|0|100|SEK|206416|261597|lyfalmen|||2|1|0||Vistor hf|Allergan Pharmaceuticals Ireland|Dexametasón||206416||206416|261597| 193583|L01XE1801|Jakavi|töflur|5|mg|60|stk|1|glas||L01XE18|01.11.2012||R|1|0|0|1|0|1|NOE|0|0|0|100|DKK|348970|439840|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||348970||348970|439840| 193821|A12AA0601|Calcium-Sandoz|freyđit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2233| 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|B|0|MYL|0|0|0|100|SEK|2029|3754|lyfalmen|||2|250|0|83,3300|Actavis Group PTC ehf|Mylan AB|Atenólól||2029||2029|3754| 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|0|0|0|0|E|0|AGT|0|0|1|100|DKK|2649|4603|lyfalmen|||2|5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2649||2649|4603| 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|0|0|0|0|E|0|AGT|0|0|1|100|DKK|842|2131|lyfalmen|||2|1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||842||842|2131| 195472|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|13844|7920|lyfalmen|V0012|5012|2|98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||5074||5074|7920| 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|98207|125132|lyfsjukr|||1|2|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||98207||98207|125132| 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|CEO|0|0|0|100|DKK|178903|226406|lyfsjukr|||1|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||178903||178903|226406| 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|835|2121|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||835||835|2121| 195768|R01BA0101|Rinexin|forđatfl|50|mg|30|stk|1|ţpakki||R01BA01|01.03.1981||R|1|0|0|0|E|0|REP|0|0|1|100|SEK|428|1564|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||428||428|1564| 195776|R01BA0101|Rinexin|forđatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|1|0|0|0|E|0|REP|0|0|1|100|SEK|907|2220|lyfalmen|||1|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||907||907|2220| 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|B|0|MYL|0|0|0|100|SEK|2592|4525|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Mylan AB|Atenólól||2592||2592|4525| 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|ţp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1649|3235|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||1649||1649|3235| 196327|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||| 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|B|0|ATL|0|0|0|100|GBP|6420|9761|lyfalmen|||1|100|0|0,8333|Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Labetalól||6420||6420|9761| 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|28496|37645|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||28496|37645| 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|2741|5436|vetalmen|||0|10|0||Vistor hf|Intervet International BV|||2741||2741|5436| 197554|N07BA0147|Nicorette QuickMist|munnhúđi|1|mg/sk|150|skammtar|1|fl|1 x 150 úđaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|ţpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|913|2228|lyfalmen|||1|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||913||913|2228| 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|ţpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2988|5066|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2988||2988|5066| 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2399|4261|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2399||2399|4261| 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|0|0|0|1|*|0|ATL|0|0|0|100|XEU|2264|4070|lyfalmen|||1|25|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Melphalan||2260||2260|4070| 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|7648|11038|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||7648||7648|11038| 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|0|0|0|0|0|1|LFS|0|0|0|100|DKK|434|626|lyfsjukr|||1|5|0|2,5000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||434||434|626| 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|38433|50779|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||38433||38433|50779| 199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|9097|4730|lyfalmen|V0515|4659|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2742||2742|4730| 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|ţpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|674|1901|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||674||674|1901| 199584|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|7641|5012|lyfalmen|V0011|5012|2|98|0|65,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2948||2948|5012| 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|100369|127846|lyfsjukr|||1|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||100369|127846| 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|4976|7786|lyfalmen|V0126|7786|1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4976||4976|7786| 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|0|0|0|0|0|1|JAB|0|0|0|100|XEU|60084|77288|lyfsjukr|||1|5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||60084||60084|77288| 199940|L01XC1101|Yervoy|stţ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|0|0|100|DKK|2915770|3661170|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2915767||2915767|3661170| 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|ţpakki||A05AA02|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|5845|8787|lyfalmen|||0|60|1|12,0000|Distica|Distica - óskráđ lyf|Úrsódeoxýkól sýra||5708||5708|8787| 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|719|1038|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||719||719|1038| 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|DKK|33028|63591|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||33028||33028|63591| 370434|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|11531|5012|lyfalmen|V0012|5012|2|98|0|130,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2948||2948|5012| 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|0|0|0|0|0|1|NOM|0|0|0|100|DKK|625|902|lyfsjukr|||1|1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||625||625|902| 371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|E|0|MAB|0|0|1|100|DKK|10964|15977|lyfalmen|||1|60|0||Vistor hf|Meda AB|Pímekrólímus||10964||10964|15977| 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||| 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||| 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||10884| 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|ţpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|7093|10682|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||7093||7093|10682| 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|E|0|ROC|0|0|0|100|DKK|3899|6313|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3899||3899|6313| 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 372283|N06AB1006|Escitalopram Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.11.2012||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|4922|4170|lyfalmen|V0325|4125|2|100|0|100,0000|Portfarma ehf|Portfarma|Escítalópram||2333||2333|4170| 373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.07.1998||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2674|4637|lyfalmen|||1|66|0|66,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||2674||2674|4637| 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|21337|29323|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||21337||21337|29323| 373324|R03AK0602|Seretide Diskus|innúđadu|150|mcg/sk|60|skammtar|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|4477|7103|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4477||4477|7103| 373340|R03AK0602|Seretide Diskus|innúđadu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|7396|11096|lyfalmen|V0436|11095|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7396||7396|11096| 373365|R03AK0602|Seretide Diskus|innúđadu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|10209|14944|lyfalmen|V0437|14944|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10209||10209|14944| 373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|0|0|0|0|*|0|MED|0|0|0|100|XEU|7944|7102|lyfalmen|V0420|7102|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíđ||4476||4476|7102| 373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|ţpakki||C07AB03|01.10.2012||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|498|1660|lyfalmen|V0541|1645|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||498||498|1660| 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|1684|3283|lyfalmen|V0126|1947|1|2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1684||1684|3283| 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|429696|541151|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||429696||429696|541151| 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|ţpakki||A10BA02|01.01.1987||R|1|0|0|0|*|0|MCK|0|0|0|100|SEK|755|2012|lyfalmen|V0500|1566|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||755||755|2012| 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6111|8820|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||6111||6111|8820| 374348|G04CA0201|Omnic|forđahlk|0,4|mg|30|stk|1|ţpakki||G04CA02|01.08.1998||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|4912|7698|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4912||4912|7698| 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|ţpakki||J05AB11|01.01.2003||R|1|0|0|0|E|0|GSK|0|0|1|100|GBP|12489|18219|lyfalmen|||1|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||12489||12489|18219| 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forđaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|10062|14743|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||10062||10062|14743| 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|11942|17315|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||11942||11942|17315| 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|13952|20055|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||13952||13952|20055| 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|E|0|AZA|0|0|0|100|SEK|34266|45549|lyfalmen|V0459|45549|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||34266||34266|45549| 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|21709|29790|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||21709||21709|29790| 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|99476|127388|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||99476||99476|127388| 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|1|0|0|0|0|0|ABS|0|0|1|100|DKK|4571|7232|lyfalmen|||1|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4571||4571|7232| 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|ţpakki||J05AB11|01.10.1996||R|1|0|0|0|E|0|GSK|0|0|1|100|GBP|12096|9626|lyfalmen|V0182|9470|1|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||6321||6321|9626| 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|17485|24489|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húđlyf-Diclofenacum||17485||17485|24489| 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|157886|200029|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||157886||157886|200029| 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|122589|155732|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||122589||122589|155732| 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|172720|218646|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||172720||172720|218646| 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|218684|276331|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||218684||218684|276331| 379796|N04BC0406|Ropinirole Portfarma|forđatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|9805|11954|lyfalmen|V0532|11314|2|84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||8023||8023|11954| 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1609|3180|lyfalmen|||2|12|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1609||1609|3180| 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1989|3700|lyfalmen|||2|12|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1989||1989|3700| 380276|N03AX1406|Zelta|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|8948|4659|lyfalmen|V0515|4659|2|100|0|16,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||2690||2690|4659| 381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|5980|9159|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5980||5980|9159| 381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|8136|7902|lyfalmen|V0143|7902|3|12|0|12,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||5061||5061|7902| 382162|N04BC0406|Ropinirole Portfarma|forđatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|17328|20140|lyfalmen|V0533|19100|2|84|0|56,0000|Portfarma ehf|Portfarma|Rópíníról||14020||14020|20140| 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kćlt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||| 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|7714|11531|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||7714||7714|11531| 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||L|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1371|2392|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||||1371|2392| 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|8261|14411|vetorma|||0|20|0||Icepharma hf|Bayer Animal Health GmbH|||8261||8261|14411| 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||| 383933|L01XE1801|Jakavi|töflur|15|mg|60|stk|1|glas||L01XE18|01.11.2012||R|1|0|0|1|0|1|NOE|0|0|0|100|DKK|697926|877780|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||697926||697926|877780| 386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|6580|6385|lyfalmen|V0144|6385|3|8|0|16,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||3952||3952|6385| 386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.1998||R|0|0|0|0|*|0|AZA|0|0|0|100|SEK|63700|82489|lyfalmen|V0184|14564|1|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||63700||63700|82489| 387579|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|992|2057|lyfalmen|V0308|2057|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||788||788|2057| 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|0|0|0|0|0|0|ICE|0|0|0|100|XEU|782|1556|vetalmen|||0|100|0||Icepharma hf|Icepharma hf|||782||782|1556| 387746|J02AA0101|Abelcet|irţ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|0|0|0|0|0|1|CEP|0|0|0|100|DKK|214357|270901|lyfsjukr|||1|200|0|28,5714|Icepharma hf|Cephalon France (I)|Amfóterícín||214357||214357|270901| 387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2013||R|1|0|0|0|B|0|TEV|0|0|0|100|XEU|14304|15296|lyfalmen|V0491|15296|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||10466||10466|15296| 388198|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|174101|220379|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||174101||174101|220379| 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúđ.|N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3667|5995|lyfalmen|||1|25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3667||3667|5995| 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|4623|7303|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||4623||4623|7303| 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||| 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|8970|13249|lyfalmen|||1|20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||8970||8970|13249| 388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|857|1612|lyfalmen|V0466|1612|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||463||463|1612| 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|ţp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|E|0|BIP|0|0|0|100|SEK|3108|5230|lyfalmen|V0410|5230|1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||3108||3108|5230| 389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|ţp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|E|0|BIP|0|0|0|100|DKK|2319|4151|lyfalmen|||1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2319||2319|4151| 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|0|0|0|0|E|0|BIP|0|0|0|100|SEK|917|2233|lyfalmen|V0128|2233|1|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||917||917|2233| 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|0|0|0|0|E|0|BIP|0|0|0|100|DKK|681|1910|lyfalmen|||1|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||681||681|1910| 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|E|0|NOH|0|0|1|100|DKK|1037|2397|lyfalmen|V0367|1841|1|3|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||1037||1037|2397| 389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|2878|3785|lyfalmen|V0143|2634|3|4|0|4,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2051||2051|3785| 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|E|0|LYF|0|0|0|100|XEU|5583|2674|lyfalmen|V0267|2674|3|100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||1239||1239|2674| 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|64296|83237|lyfalmen|||1|2|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||64296||64296|83237| 389944|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|20011|27659|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||20011||20011|27659| 390699|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|87803|112075|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||87803||87803|112075| 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|0|0|0|0|E|0|BRS|0|0|1|100|DKK|3127|5256|lyfalmen|||1|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||3127||3127|5256| 390784|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.11.2012||R|1|1|0|0|*|0|TEV|0|0|0|100|XEU|3255|5432|lyfalmen|V0578|5432|2|28|0|14,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||3255||3255|5432| 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|7492|11228|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||7492||7492|11228| 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|2959|5027|lyfalmen|V0037|5027|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2959||2959|5027| 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|33434|44505|lyfalmen|||1|1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||33434||33434|44505| 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|14438|20665|lyfalmen|V0196|20664|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||14438||14438|20665| 391730|N01BB0203|Xylocain|úđalyf|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.1990||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2953|5018|lyfalmen|||1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2953||2953|5018| 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|267132|337133|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||267132||267132|337133| 392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|4888|6902|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||4330||4330|6902| 392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|fl||A04AA01|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|12000|17605|lyfalmen|||0|50|1|2,5000|Distica|Distica - óskráđ lyf|Ondansetrón||||12000|17605| 393192|N05AH0409|Quetiapin Orion|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|*|0|OPF|0|0|0|100|IKR|20927|21998|lyfalmen|V0286|20555|2|100|0|50,0000|Portfarma ehf|Orion Corporation|Quetíapín||15500||15500|21998| 393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|međ breyttan losunarhrađa|H02AB09|01.01.2013||R|1|0|0|0|B|0|VIO|0|0|1|100|DKK|91896|117875|lyfalmen|||1|50|0|33,3300|Williams & Halls efh|ViroPharma SPRL|Hýdrókortisón||91896||91896|117875| 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.09.1983||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|6017|11726|vetalmen|||0|24|0||Icepharma hf|Pfizer Oy Animal Health|||6017||6017|11726| 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 394010|N06AB1005|Escitalopram LYFIS|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|IKR|4775|3988|lyfalmen|V0327|3988|2|100|0|200,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2200||2200|3988| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt spr.međ nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|159179|200407|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||158187||158187|200407| 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|192028|242878|lyfsjukr|||1|300|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||192028||192028|242878| 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|E|0|APS|0|0|1|100|DKK|4336|6910|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||4336||4336|6910| 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|1|0|1|MKA|0|0|0|100|SEK|40116|52228|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||40116||40116|52228| 397567|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.01.2013|31.01.2013|R|0|0|1|0|0|1|RBP|0|0|0|100|DKK|1317|1901|lyfsjukr|||1|7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1317||1317|1901| 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|ţpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|10598|15183|lyfsjukr|||1|60|0||Icepharma hf|Roche|Capecitabín||10598||10598|15183| 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|ţpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|60766|78144|lyfsjukr|||1|120|0||Icepharma hf|Roche|Capecitabín||60766||60766|78144| 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|Ferring Lćgemidler A/S|Natríumpicosúlfat|||||| 398821|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|7175|3287|lyfalmen|V0012|2864|3|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1687||1687|3287| 399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|3775|1924|lyfalmen|V0009|1860|3|28|0|28,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||691||691|1924| 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|ţpakki||N02AX02|01.05.2012||R|1|0|1|0|E|0|GLP|0|0|1|100|SEK|436|1575|lyfalmen|V0225|1542|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||436||436|1575| 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.03.1999||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|2049|2620|lyfalmen|V0244|2575|1|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1200||1200|2620| 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|E|0|PER|0|0|1|100|DKK|9660|14193|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9660||9660|14193| 399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|44989|58344|lyfsjukr|||1|2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||44989||44989|58344| 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||| 399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|122109|155129|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||122109||122109|155129| 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|1670|3263|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1670||1670|3263| 400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur|||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|ţpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5517|8526|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5517||5517|8526| 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|239|1306|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||239||239|1306| 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|434|1573|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||434||434|1573| 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|207|1262|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||207||207|1262| 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|E|0|AZA|0|0|0|100|SEK|11839|17174|lyfalmen|V0459|15183|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||11839||11839|17174| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|812|2090|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||812||812|2090| 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|1299|2756|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1299||1299|2756| 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1279|2729|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1279||1279|2729| 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|2053|3787|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||2053||2053|3787| 402651|J07BB0205|Influvac|bóluefni|||0,5|ml|1|áfspr||J07BB02|01.12.1998||R|0|0|0|0|0|0|AHP|0|0|0|100|XEU|700|1936|lyfalmen|||1|0|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir mótefnavakar||700||700|1936| 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1789|3559|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1789||1789|3559| 402873|N06DA0302|Exelon (Lyfjaver)|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|E|0|LVR|0|0|0|100|DKK|16162|22828|lyfalmen|V0349|22828|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||16162||16162|22828| 403226|L04AA0605|Myfenax (Lyfis)|hylki|250|mg|100|stk|1|ţpakki||L04AA06|01.03.2011||R|1|0|0|1|*|0|LYF|0|0|0|100|XEU|22098|26908|lyfalmen|V0470|26908|3|100|0|12,5000|LYFIS ehf|LYFIS ehf|Mýcófenólsýra||19413||19413|26908| 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5501|10735|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||5501||5501|10735| 403550|C08CA0302|Lomir Retard|forđahlk|2,5|mg|100|stk|1|ţpakki||C08CA03|01.10.1992||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|6283|9574|lyfalmen|||1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||6283||6283|9574| 403856|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|39584|51560|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||39584|51560| 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|0|0|0|0|E|0|SNO|0|0|0|100|NOK|1594|3159|lyfalmen|||1|14|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1594||1594|3159| 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||1920| 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|69720|89381|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||69720||69720|89381| 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|732|1056|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||732||732|1056| 405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|8714|16905|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||8714||8714|16905| 405589|J07BD5203|Priorix|bóluefni|||0,5|ml|1|hgl|+ einnota dćla|J07BD52|01.03.1999||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1945|3640|lyfalmen|||1|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||1945||1945|3640| 405597|J07BD5203|Priorix|bóluefni|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|20726|28556|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||20726||20726|28556| 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|19404|26897|lyfalmen|||1|28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||19404||19404|26897| 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813| 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|22138|30328|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22138||22138|30328| 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|24264|32996|lyfalmen|||1|28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||24264||24264|32996| 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|21887|30013|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||21887||21887|30013| 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901| 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|65993|85366|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||65993||65993|85366| 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|77469|99769|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||77469||77469|99769| 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|87833|112776|lyfalmen|||1|100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||87833||87833|112776| 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|ţpakki||N05AE03|01.01.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6698|10141|lyfalmen|||1|30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||6698||6698|10141| 406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|0|0|100|DKK|85025|108589|lyfsjukr|||1|8|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||85025||85025|108589| 407142|C09CA0304|Valsartan LYFIS|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|3578|2236|lyfalmen|V0072|2109|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Valsartan||919||919|2236| 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|2417|4285|lyfalmen|||1|100|0|12,5000|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||2417||2417|4285| 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|179|1224|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||179||179|1224| 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|390|1512|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||390||390|1512| 408266|N05BA1206|Alprazolam Krka|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|2096|3073|lyfalmen|V0310|3073|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1531||1531|3073| 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|3074|5184|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Betametasón||3074||3074|5184| 408773|D07AC0104|Diproderm|áburđur|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|2410|4276|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Betametasón||2410||2410|4276| 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|4573|7235|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4573||4573|7235| 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|3978|6421|lyfalmen|||1|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3978||3978|6421| 409425|R01AD0502|Rhinocort Turbuhaler|nefúđad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|0|0|0|0|E|0|AZD|0|0|1|100|SEK|4683|7385|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4683||4683|7385| 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|13319|19260|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||13319||13319|19260| 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|3176|5324|lyfalmen|||1|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3176||3176|5324| 409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|86037|110522|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||86037||86037|110522| 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|10792|15742|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||10792||10792|15742| 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|ţpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|1256|2697|lyfalmen|||1|20|0|6,2000|Vistor hf|Recip AB|Klórókín||1256||1256|2697| 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|858|2153|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Tretínóín||858||858|2153| 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|ţpakki||M03BX01|01.01.1990||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|751|2006|lyfalmen|||2|50|0|10,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||751||751|2006| 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|5217|7529|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||5217||5217|7529| 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|27549|36456|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||27549||27549|36456| 411918|N02CC0101|Imigran|nefúđi|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|8059|12003|lyfalmen|||1|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||8059||8059|12003| 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|*|0|AZA|0|0|0|100|SEK|25096|34041|lyfalmen|||1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||25096||25096|34041| 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|međ rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|4189|6046|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4189||4189|6046| 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|DKK|9123|17690|vetalmen|||0|100|0||Vistor hf|Merial|||9123||9123|17690| 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|137138|173991|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||137138||137138|173991| 412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|66915|86523|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||66915||66915|86523| 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|*|0|MYL|0|0|0|100|SEK|3772|6139|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||3772||3772|6139| 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|*|0|MYL|0|0|0|100|SEK|4633|7317|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||4633||4633|7317| 414006|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|890|1485|lyfalmen|V0062|1485|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||370||370|1485| 414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|1|0|0|0|E|0|WIH|0|0|0|100|XEU|30505|13998|lyfalmen|V0342|13998|2|98|0|130,6700|Portfarma ehf|Williams & Halls|Dónepezíl||9517||9517|13998| 414680|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|90|stk|1|ţpakki||C03BA11|01.03.1999||R|1|0|0|0|E|0|SEV|0|0|0|100|DKK|4605|7278|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíđ||4605||4605|7278| 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1414|2913|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1414||1414|2913| 415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AA02|01.11.2012||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|2303|4129|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2303||2303|4129| 415556|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.03.2011||R|0|0|0|0|E|0|DAC|0|0|1|100|CHF|15955|20062|lyfalmen|V0034|20007|3|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíđ (sykurflétta)||13958||13958|20062| 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|2032|3759|lyfalmen|||1|15|0|15,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2032||2032|3759| 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|13786|7393|lyfalmen|V0253|7347|2|100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||4689||4689|7393| 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|10162|10146|lyfalmen|V0088|1936|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||6701||6701|10146| 416494|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|4213|2466|lyfalmen|V0005|2114|2|28|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||1087||1087|2466| 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|5520|8530|lyfalmen|||0|300|1|15,0000|Distica|Distica - óskráđ lyf|Ranitidín||5520||5520|8530| 416829|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.03.2011|31.01.2013|R|0|0|1|0|0|1|RBP|0|0|0|100|DKK|5073|7322|lyfsjukr|||1|7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||5073||5073|7322| 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|E|0|GOG|0|0|1|100|XEU|3100|5220|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||3100||3100|5220| 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|0|0|0|0|E|0|GOG|0|0|1|100|DKK|27819|37458|lyfalmen|||1|150|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||27819||27819|37458| 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|1389|2879|lyfalmen|||1|30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1389||1389|2879| 417266|N05AH0409|Quetiapin Orion|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|*|0|OPF|0|0|0|100|IKR|10510|10555|lyfalmen|V0285|9840|2|100|0|25,0000|Portfarma ehf|Orion Corporation|Quetíapín||7000||7000|10555| 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|ţpakki||J05AF06|01.07.2005||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|45092|58473|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||45092||45092|58473| 417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|106377|135386|lyfsjukr|||1|1|0|2,2200|Icepharma hf|Pfizer Limited|Storkuţáttur IX||106377||106377|135386| 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|36663|48557|lyfalmen|V0460|48557|1|180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||36663|48557| 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|ţpakki||A07EC02|01.10.1991||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|5419|8392|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||5419||5419|8392| 418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|144154|182796|lyfsjukr|||1|19|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||144154||144154|182796| 418665|D07XC0101|Diprosalic|smyrsli|||50|g|1|túpa||D07XC01|01.11.1979||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|1713|3322|lyfalmen|||1|50|0||Vistor hf|Schering-Plough Europe|Betametasón||1713||1713|3322| 418731|A07EC0201|Mesasal|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|B|0|SNO|0|0|0|100|NOK|8254|12270|lyfalmen|V0014|12050|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||8254||8254|12270| 418950|N05AH0310|Zalasta (LYFIS)|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|23815|19417|lyfalmen|||3|28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||13044||13444|19417| 418981|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2012||R|1|0|0|0|E|0|APC|0|0|1|100|XEU|4191|5619|lyfalmen|V0458|5619|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||3392||3392|5619| 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|2190|4356|vetalmen|||0|200|0||Vistor hf|Boehringer Ingelheim Danmark|||2190||2190|4356| 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dćla|QA07AA01|01.03.1981||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|2842|5630|vetalmen|||0|200|0||Vistor hf|Boehringer Ingelheim Danmark|||2842||2842|5630| 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|1|0|0|0|B|0|LEP|0|0|0|100|DKK|3561|5850|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||3561||3561|5850| 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|1|0|0|0|B|0|LEP|0|0|0|100|DKK|7615|11396|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7615||7615|11396| 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|55908|72047|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||55908||55908|72047| 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|1|ORP|0|0|0|100|DKK|42424|55125|lyfsjukr|||1|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||42424||42424|55125| 419945|D07AD0101|Dermovat|húđlausn|0,5|mg/ml|25|ml|1|glas|í hársvörđ|D07AD01|01.09.1982||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|911|2225|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||911||911|2225| 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|E|0|PER|0|0|1|100|DKK|12908|18745|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||12908||12908|18745| 420678|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.01.2013||R|0|0|1|0|0|1|RBP|0|0|0|100|DKK|5247|7573|lyfsjukr|||1|7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||5247||5247|7573| 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.07.1989||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|1704|3310|lyfalmen|V0036|3309|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1704||1704|3310| 422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.05.2009||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|1673|3267|lyfalmen|V0051|3099|1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1673||1673|3267| 422246|C07AB0206|Seloken ZOC|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|3823|6209|lyfalmen|V0049|4409|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3823||3823|6209| 422337|C07AB0206|Seloken ZOC|forđatfl|190|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|6588|9991|lyfalmen|V0054|8080|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||6588||6588|9991| 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|1|0|1|CSB|0|0|0|100|SEK|81067|103622|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||81067||81067|103622| 423527|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|6383|3530|lyfalmen|V0011|2864|3|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1865||1865|3530| 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|23454|31317|lyfsjukr|||2|1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||23454||23454|31317| 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dćl||QP52AC13|01.05.1999||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1736|3028|vetorma|||0|24|0||Vistor hf|Intervet International BV|||1736||1736|3028| 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|1190|2607|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||1190||1190|2607| 425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|ţpakki|2+0,5 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|5109|7324|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||5075||5075|7324| 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2248|3884|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis hf|Lósartan||2124||2124|3884| 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|746|1999|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||746||746|1999| 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|974|2311|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||974||974|2311| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2738| 428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|920|2237|lyfalmen|||1|30|0||Vistor hf|Schering-Plough Europe|Mómetasón||920||920|2237| 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|1080|2456|lyfalmen|||1|30|0||Vistor hf|Schering-Plough Europe|Mómetasón||1080||1080|2456| 428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|54929|70818|lyfsjukr|||1|2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||54929||54929|70818| 428822|C10AA0504|Atorvastatin Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|6185|2381|lyfalmen|V0113|1991|2|100|0|100,0000|Portfarma ehf|Portfarma|Atorvastatín||1025||1025|2381| 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|29624|29663|lyfalmen|V0344|29663|3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||21608||21608|29663| 429167|J07CA0602|Pentavac|bóluefni|||0,5|ml|1|hgl|+ dreifa í dćlu|J07CA06|01.10.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4529|7174|lyfalmen|||1|0|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4529||4529|7174| 429225|J07CA0602|Pentavac|bóluefni|||0,5|ml|10|hgl||J07CA06|01.12.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|44558|58465|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||44558||44558|58465| 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.07.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|108052|137488|lyfsjukr|||1|105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||108052||108052|137488| 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|ţpakki||C03DA01|01.11.1981||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|4373|6961|lyfalmen|||1|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||4373||4373|6961| 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|1881|2715|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||1881||1881|2715| 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1544|2228|lyfsjukr|||1|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1544||1544|2228| 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4789|9368|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||4789||4789|9368| 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.08.2011||R|0|0|0|0|*|0|WIH|0|0|0|100|XEU|31401|14564|lyfalmen|V0184|14564|2|98|0|98,0000|Portfarma ehf|Williams & Halls|Anastrózól||9931||9931|14564| 430417|N03AX2101|Trobalt|filmhtfl|400|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|36622|48506|lyfalmen|||1|84|0|37,3300|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||36622||36622|48506| 430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|3178|3887|lyfalmen|V0144|3193|3|4|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2126||2126|3887| 430710|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áfspr||J07AP03|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2628|4574|lyfalmen|||1|0|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2628||2628|4574| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|815|2094|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||815||815|2094| 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|ţpakki||C01DA08|01.07.1989||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|1287|2739|lyfalmen|||1|100|0|16,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1287||1287|2739| 431495|L01CD0201|Taxotere|irţ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|261771|330405|lyfsjukr|||1|8|0||Vistor hf|Aventis Pharma SA|Docetaxel||261771||261771|330405| 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|1513|3049|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1513|3049| 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|5130|7996|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||5130||5130|7996| 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.10.2011||R|0|0|0|0|E|0|NDR|0|0|0|100|SEK|41570|54715|lyfalmen|||1|12|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||41570|54715| 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1232|2664|lyfalmen|V0231|2664|2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1232||1232|2664| 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3975|7805|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||3975||3975|7805| 433194|N05AD0301|Buronil|húđuđtfl|25|mg|100|stk|1|glas||N05AD03|01.01.2013||R|1|0|0|0|*|0|MEV|0|0|0|100|DKK|1895|3571|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1895||1895|3571| 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|11837|17171|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||11837||11837|17171| 433292|N02AA0106|Contalgin Uno|forđahlk|30|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|2768|4765|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2768||2768|4765| 433318|N02AA0106|Contalgin Uno|forđahlk|90|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|6061|9270|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||6061||6061|9270| 433342|N02AA0106|Contalgin Uno|forđahlk|150|mg|28|stk|1|ţpakki||N02AA01|01.05.1998|31.12.2012|R|1|0|1|0|E|0|PER|0|0|0|100|DKK|8712|12896|lyfalmen|||1|28|0|42,0000|Icepharma hf|Pfizer ApS|Morfín||8712||8712|12896| 433512|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|581|1774|lyfalmen|||2|7|0|4,6700|Portfarma ehf|Portfarma|Esómeprazól||581||581|1774|31.12.2012 434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.01.2013||R|1|0|0|0|B|0|TEV|0|0|0|100|XEU|7482|7981|lyfalmen|V0490|7981|2|98|0|98,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||5119||5119|7981| 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|ţpakki||QP52AC13|01.04.1992||L|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1216|2121|vetorma|||0|10|0||Vistor hf|Intervet International BV|||||1216|2121| 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|991|2335|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||991||991|2335| 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|B|0|MEB|0|0|1|100|DKK|6209|9473|lyfalmen|||1|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||6209||6209|9473| 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|B|0|MEB|0|0|1|100|DKK|6209|9473|lyfalmen|||1|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||6209||6209|9473| 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|ţp (10x10 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|XEU|11017|16050|lyfalmen|||1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||11017||11017|16050| 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|ţpakki||N02CC03|01.06.1999||R|1|0|0|0|E|0|ASZ|0|0|0|100|SEK|7422|11132|lyfalmen|||1|6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||7422||7422|11132| 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|ţpakki||N02CC03|01.11.1998||R|1|0|0|0|E|0|ASZ|0|0|0|100|SEK|5150|8024|lyfalmen|||1|6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||5150||5150|8024| 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|9159|11906|lyfalmen|V0284|2853|1|100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7988||7988|11906| 435817|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|25|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|1|0|0|0|*|0|LVR|0|0|0|100|IKR|929|2073|lyfalmen|V0284|1712|3|60|0|3,7500|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||800||800|2073| 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|3098|5217|lyfalmen|||1|250|0|41,6700|Vistor hf|Recip AB|Ísósorbíđ dínítrat||3098||3098|5217| 436010|L01AA0901|Levact|irţ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|0|0|100|DKK|252731|319060|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||252731||252731|319060| 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|3786|6158|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||3786||3786|6158| 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|ţpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 436394|H01BA0202|Octostim|nefúđi|0,15|mg/sk|2,5|ml|1|úđagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|46171|59827|lyfsjukr|||1|2|0|150,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||46171||46171|59827| 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|793|2064|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||793||793|2064| 436877|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|0|0|100|DKK|259183|327157|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||259183||259183|327157| 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|1058|2426|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||1058||1058|2426| 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|3871|6274|lyfalmen|||1|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3871||3871|6274| 437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|10799|8455|lyfalmen|V0029|8455|3|100|0|100,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||5465||5465|8455| 437935|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|0|0|100|DKK|72646|93053|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||72646||72646|93053| 438225|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|glas||N07XX07|01.12.2011||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|34996|46465|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||34996||34996|46465| 438333|N06AX1602|Efexor Depot|forđahlk|150|mg|28|stk|1|ţpakki||N06AX16|01.10.1998|31.12.2012|R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6214|9479|lyfalmen|||1|28|0|42,0000|Icepharma hf|Pfizer ApS|Venlafaxín||6214||6214|9479| 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|E|0|SAL|0|0|1|100|USD|1301|2759|lyfalmen|||1|10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Hýdrókortisón og sýkingalyf||1301||1301|2759| 438424|N06AX1602|Efexor Depot|forđahlk|75|mg|28|stk|1|ţpakki||N06AX16|01.10.1998|31.12.2012|R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3255|5432|lyfalmen|||1|28|0|21,0000|Icepharma hf|Pfizer ApS|Venlafaxín||3255||3255|5432| 438432|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.10.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11886|17238|lyfalmen|V0334|5904|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11886||11886|17238| 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|ţpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|371016|467508|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration Limited|Vemurafeníb||371016||371016|467508| 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín|||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.07.1989||R|1|0|0|0|0|0|SCP|0|0|1|100|DKK|2014|3734|lyfalmen|||1|30|0|30,0000|Vistor hf|Schering-Plough|Lóratadín||2014||2014|3734| 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.07.1989||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|6339|9650|lyfalmen|V0362|2328|1|100|0|100,0000|Vistor hf|Schering-Plough|Lóratadín||6339||6339|9650| 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|176141|222939|lyfsjukr|||1|3|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||176141||176141|222939| 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|ţpakki||J01DC02|01.10.1990||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|2991|5070|lyfalmen|||1|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2991||2991|5070| 439489|C07FB0201|Logimax|forđatfl|55|mg|98|stk|1|pakki|ţp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|9462|13922|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||9462||9462|13922| 439794|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1066|2437|lyfalmen|V0163|2168|1|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2437| 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1585|2288|lyfsjukr|||2|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1585||1585|2288| 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2502|3611|lyfsjukr|||2|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2502||2502|3611| 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|ţpakki||C03DA01|01.12.1972||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|990|2333|lyfalmen|V0046|2333|1|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||990||990|2333| 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|1390|2880|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1390||1390|2880| 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|134146|170236|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|Emtrícítabín, rilpívírin og tenófóvír||134146||134146|170236| 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|0|0|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||0|59|0||Aco Hud Nordic AB|ACO Hud AB|Permetrín|||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|ţpakki||G03DC02|01.12.1972||R|0|0|0|0|E|0|BAP|0|0|0|100|DKK|1126|2519|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1126||1126|2519| 442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|*|0|KNM|0|0|0|100|XEU|15486|7888|lyfalmen|V0283|7853|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5051||5051|7888| 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|12221|17882|lyfalmen|V0460|16186|1|60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||12221|17882| 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dćla|H04AA01|01.01.1989||R|0|0|0|0|*|0|NAS|0|0|1|100|DKK|3691|6028|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3691||3691|6028| 443358|N02AA0101|Contalgin|forđatfl|200|mg|90|stk|1|ţpakki||N02AA01|01.04.1993||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|28136|37856|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||28136||28136|37856| 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|8147|12124|lyfalmen|||1|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||8147||8147|12124| 444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|ţpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|ICE|0|0|0|100|GBP|1085|2463|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||1085||1085|2463| 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|ţp (2 x 15 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|DKK|3345|5555|lyfalmen|V0061|3492|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3345||3345|5555| 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|E|0|ROC|0|0|0|100|DKK|2435|4310|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2435||2435|4310| 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|B|0|LEO|0|0|1|100|DKK|1699|3303|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1699||1699|3303| 445479|N04BC0407|Ropinirol Actavis|forđatfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|9238|11954|lyfalmen|V0532|11314|2|84|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||8023||8023|11954| 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1547|3077|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||1547||1547|3077| 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|E|0|EIS|0|0|0|100|SEK|21536|29573|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíđ||21536||21536|29573| 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|11331|16479|lyfalmen|||1|4|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||11331||11331|16479| 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|6457|9812|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6457||6457|9812| 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|7992|11912|lyfalmen|||1|2|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7992||7992|11912| 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|9511|13989|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9511||9511|13989| 448217|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|713|1954|lyfalmen|||1|10|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||713||713|1954| 448233|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|1393|2884|lyfalmen|||1|30|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1393||1393|2884| 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|ţpakki||M03BX01|01.12.1972||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|2265|4077|lyfalmen|V0202|3841|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||2265||2265|4077| 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|1229|1774|lyfsjukr|||2|0|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1229||1229|1774| 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1542|3088|lyfalmen|||2|98|0|130,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||1542||1542|3088| 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|5934|8564|lyfsjukr|||2|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5934||5934|8564| 449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|0|0|0|0|*|0|ELI|0|0|0|100|XEU|5772|8875|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5772||5772|8875| 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|5005|9783|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||5005||5005|9783| 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|ţp 875+125 mg|J01CR02|01.01.1997||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1115|2382|lyfalmen|V0169|1894|1|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2382| 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|3409|4463|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||2547||2547|4463| 450979|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA03|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|7987|13933|vetorma|||0|2|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Doramectinum||7987||7987|13933| 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|61440|78990|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||61440||61440|78990| 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|92162|117546|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||92162||92162|117546| 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|122881|156098|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||122881||122881|156098| 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|ţpakki||N06AB04|01.11.1999||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6126|8522|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5514||5514|8522| 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|16179|22850|lyfalmen|||1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||16179||16179|22850| 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||| 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|0|0|0|0|E|0|ROA|0|0|1|100|DKK|1243|2679|lyfalmen|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1243||1243|2679| 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|11967|20876|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||11967||11967|20876| 452482|V07AB09|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|2000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|LAB|0|0|1|100|SEK|13162|19063|lyfalmen|||1|3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóđ||13162||13162|19063| 452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|0|0|0|0|0|0|LCC|0|0|0|100|DKK|2509|4411|lyfalmen|||1|90|0||Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2509||2509|4411| 452904|N02AA0501|Oxycontin|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|2543|4458|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2543||2543|4458| 452920|N02AA0501|Oxycontin|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|7475|11204|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||7475||7475|11204| 452995|N02AA0501|Oxycontin|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|4910|7696|lyfalmen|V0584|6356|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||4910||4910|7696| 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dćl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1581|2758|vetorma|||0|6|0||Vistor hf|Merial (MSD)|Ivermectinum||1581||1581|2758| 453175|N02AA0501|Oxycontin|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|14477|20714|lyfalmen|V0585|16820|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||14477||14477|20714| 453498|N02AA0501|Oxycontin|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|9397|13834|lyfalmen|V0586|11269|1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||9397||9397|13834| 453571|N02AA0501|Oxycontin|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|26386|35660|lyfalmen|V0587|27744|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||26386||26386|35660| 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2947|4253|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2947||2947|4253| 453795|J07AL0102|Pneumo 23|bóluefni|||0,5|ml|1|dćla||J07AL01|01.09.2003||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2465|4351|lyfalmen|||1|0|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||2465||2465|4351| 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|16421|23153|lyfalmen|||1|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||16421||16421|23153| 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|46586|41546|lyfalmen|V0341|12583|1|98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||31076||31076|41546| 454491|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|2138|2105|lyfalmen|V0004|2066|2|28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||823||823|2105| 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|18433|25679|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||18433||18433|25679| 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|51327|46320|lyfalmen|V0342|13998|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||34880||34880|46320| 454819|N02BE0115|Paracet|eţ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||| 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|58101|74799|lyfsjukr|||1|1|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||58101||58101|74799| 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1229|2445|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1229||1229|2445| 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.12.1997||R|1|0|0|0|*|0|BAP|0|0|0|100|DKK|1149|2551|lyfalmen|||1|30|0|5,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||1149||1149|2551| 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|ţpakki||A10BF01|01.12.1997||R|1|0|0|0|*|0|BAP|0|0|0|100|DKK|4129|6627|lyfalmen|||1|120|0|20,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||4129||4129|6627| 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|ţpakki||J05AB09|01.10.1995||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|23477|32009|lyfalmen|||1|21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||23477||23477|32009| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|ţpakki|0|J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|988|2330|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||988||988|2330| 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|ţpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|1118|2508|lyfalmen|||2|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1118||1118|2508| 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|ţpakki|0|J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|2317|4148|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2317||2317|4148| 457615|N06AB1006|Escitalopram Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.11.2012||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|4787|4046|lyfalmen|V0327|3988|2|100|0|200,0000|Portfarma ehf|Portfarma|Escítalópram||2242||2242|4046| 457692|L01BA0109|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|3892|6303|lyfalmen|||1|0|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3892||3892|6303| 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|857|1612|lyfalmen|V0003|1612|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||463||463|1612| 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|SEK|1298|2754|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1298||1298|2754| 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|ţpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1544|3091|lyfalmen|V0577|2393|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1544||1544|3091| 458865|A07AA0906|Vancomycin Xellia|hylki|250|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|E|0|XEL|0|0|1|100|DKK|25928|35085|lyfalmen|||2|28|0|3,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||25928||25928|35085| 459104|N05AH0310|Zalasta (LYFIS)|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|2508|1846|lyfalmen|||3|28|0|7,0000|LYFIS ehf|LYFIS ehf|Olanzapín||634||634|1846| 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|917|1323|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||917||917|1323| 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|1679|2423|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1679||1679|2423| 459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|8147|12124|lyfalmen|||1|20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||8147||8147|12124| 459828|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|ţpakki||B02AA02|01.04.1989||R|1|0|0|0|E|0|MAS|0|0|1|100|SEK|2425|4296|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2425||2425|4296| 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|ţpakki||B02AA02|01.04.1989||R|1|0|0|0|E|0|MAS|0|0|1|100|SEK|4922|7712|lyfalmen|||1|60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||4922||4922|7712| 460170|J07BC0202|Avaxim|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC02|01.04.1998||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4311|6876|lyfalmen|||1|0|0||Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4311||4311|6876| 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|ţpakki||J04AB02|01.09.2012||R|1|0|0|0|E|0|SAD|0|0|0|100|DKK|8814|13036|lyfalmen|||1|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8814||8814|13036| 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|töflur||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|7640|14843|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||7640||7640|14843| 460972|J07BB0205|Influvac|bóluefni|||0,5|ml|10|áf.spr||J07BB02|01.12.1998||R|0|0|0|0|0|0|AHP|0|0|0|100|XEU|6004|9192|lyfalmen|||1|5|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir mótefnavakar||6004||6004|9192| 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1989||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|201|1254|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||201||201|1254| 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|728|1975|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||728||728|1975| 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|728|1975|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||728||728|1975| 462358|A07EA0601|Entocort|endaţ.dr|20|mcg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.04.1993||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|8421|12498|lyfalmen|||1|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||8421||8421|12498| 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|E|0|XEL|0|0|1|100|DKK|12946|18792|lyfalmen|||2|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||12946||12946|18792| 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|7179|13957|vetalmen|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|||||7179|13957| 463490|N03AX2101|Trobalt|filmhtfl|100|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|9783|14362|lyfalmen|||1|84|0|9,3300|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||9783||9783|14362| 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|5726|11167|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||5726||5726|11167| 463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||| 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972|31.01.2013|R|1|0|0|0|*|0|MEV|0|0|0|100|DKK|1832|3485|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1832||1832|3485| 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|0|0|0|0|*|0|APC|0|0|0|100|DKK|4367|6894|lyfalmen|V0376|6894|2|8|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||4324||4324|6894| 465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1272|2530|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1272||1272|2530| 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|||100|ml|1|hgl||QJ01CR50|01.05.1983||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|1201|2389|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1201||1201|2389| 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1288|2562|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1288||1288|2562| 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|||3|g|4|spr||QJ51RC23|01.04.1985||R|0|0|0|0|0|0|IBV|0|0|0|100|XEU|679|1351|vetalmen|||0|12|0||Vistor hf|Intervet International BV|||679||679|1351| 465333|L01BA0109|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|4270|6820|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||4270||4270|6820| 466003|N06AB0310|Seromex|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.02.2013||R|1|0|0|0|B|0|RGM|0|0|0|100|IKR|1601|2101|lyfalmen|V0038|2101|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||820||820|2101| 466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.02.2013||R|1|0|0|0|B|0|RGM|0|0|0|100|IKR|4767|3701|lyfalmen|V0039|3701|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||1990||1990|3701| 466086|N02AA0101|Contalgin|forđatfl|10|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|714|1956|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||714||714|1956| 466094|N02AA0101|Contalgin|forđatfl|10|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|2211|4003|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2211||2211|4003| 466169|N02AA0101|Contalgin|forđatfl|30|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|1583|3144|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1583||1583|3144| 466219|N02AA0101|Contalgin|forđatfl|30|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|6186|9441|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||6186||6186|9441| 466466|N02AA0101|Contalgin|forđatfl|60|mg|25|stk|1|ţpakki||N02AA01|01.10.1995||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|2943|5005|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2943||2943|5005| 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|8476|12574|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||8476||8476|12574| 466680|N02AA0101|Contalgin|forđatfl|100|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|4841|7601|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4841||4841|7601| 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|ţpakki||N06AG02|01.10.1990||R|1|0|0|0|B|0|MAS|0|0|0|100|SEK|5025|7853|lyfalmen|V0063|6711|1|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíđ||5025||5025|7853| 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|16351|22403|lyfsjukr|||1|0|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||16351||16351|22403| 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|25057|33329|lyfsjukr|||1|0|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||25057||25057|33329| 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|19791|25898|lyfsjukr|||1|1|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||19136||19136|25898| 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|0|0|0|1|*|0|WTE|0|0|0|100|DKK|36270|48064|lyfalmen|V0582|48064|1|60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||36270||36270|48064| 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|16536|23298|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||16536||16536|23298| 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|59367|73920|lyfsjukr|||1|1|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||57400||57400|73920| 467699|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|8028|11961|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||8028||8028|11961| 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|31485|42059|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||31485||31485|42059| 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|559|807|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||559||559|807| 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|6862|7059|lyfalmen|V0317|2484|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4445||4445|7059| 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|425|613|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||425||425|613| 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|9991|6723|lyfalmen|V0318|2620|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4199||4199|6723| 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|25245|13611|lyfalmen|V0320|5083|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||9234||9234|13611| 468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|4530|2340|lyfalmen|V0207|2340|2|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||995||995|2340| 468996|A02BC0402|Rabeprazol Actavis|sţ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|4172|5077|lyfalmen|V0467|5077|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2996||2996|5077| 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|ţpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6033|9232|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||6033||6033|9232| 469375|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.11.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|12970|7393|lyfalmen|V0253|7347|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4689||4689|7393| 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8124|11725|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8124||8124|11725| 469817|N02AX0206|Nobligan Retard|forđatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|E|0|GRU|0|0|1|100|DKK|6756|10221|lyfalmen|V0228|10221|1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||6756||6756|10221| 469874|N02AX0206|Nobligan Retard|forđatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|E|0|GRU|0|0|1|100|DKK|5493|8493|lyfalmen|V0227|7927|1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||5493||5493|8493| 469932|N02AX0206|Nobligan Retard|forđatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|E|0|GRU|0|0|1|100|DKK|3586|5884|lyfalmen|V0226|5170|1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3586||3586|5884| 470385|R03BA0501|Flixotide|innúđal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|6408|9745|lyfalmen|||1|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||6408||6408|9745| 470397|N05CM1801|Dexdor|irţ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|33096|43418|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||33096||33096|43418| 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|8007|11556|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Jóhexól||8007||8007|11556| 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|10688|15296|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||10688||10688|15296| 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|4414|6371|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4414||4414|6371| 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|10677|15282|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||10677||10677|15282| 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|15334|21127|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||15334||15334|21127| 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|ţpakki||A10BB07|01.07.1990||R|1|0|0|0|*|0|PER|0|0|0|100|DKK|1304|2763|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíđ||1304||1304|2763| 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|ţpakki||QP52AC13|01.04.1992||L|0|0|0|0|0|0|IBV|0|0|0|100|DKK|2275|3969|vetorma|||0|20|0||Vistor hf|Intervet International BV|||||2275|3969| 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.01.1988||R|0|0|0|0|*|0|BAM|0|0|0|100|SEK|3683|6017|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3683||3683|6017| 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|5098|9961|vetalmen|||0|10|0||Vistor hf|Orion Corporation|||5098||5098|9961| 472092|C07AB0206|Seloken ZOC|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.07.1989||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|2349|4192|lyfalmen|V0048|2891|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2349||2349|4192| 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|ţpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dćla|einnota dćla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3418|5655|lyfalmen|||1|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3418||3418|5655| 472599|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|IKR|13009|5012|lyfalmen|V0012|5012|3|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2948||2948|5012| 472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|E|0|MLD|0|0|1|100|DKK|4918|7706|lyfalmen|V0458|5619|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||4918||4918|7706| 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|17140|23393|lyfsjukr|||1|400|0||Vistor hf|Meda AB|Dextran||17140||17140|23393| 474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|5657|8164|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5657||5657|8164| 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|1130|2525|lyfalmen|||1|30|0|3,7500|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||1130||1130|2525| 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|ţpakki||J05AG01|01.03.2007||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|39116|50973|lyfsjukr|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||39116||39116|50973| 474431|N05AH0310|Zalasta (LYFIS)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.02.2012|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|14560|9608|lyfalmen|||3|28|0|28,0000|LYFIS ehf|LYFIS ehf|Olanzapín||6008||6308|9608| 474551|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.05.1998||R|0|0|0|0|E|0|SPL|0|0|1|100|DKK|1982|3690|lyfalmen|||1|140|0|35,0000|Vistor hf|Schering-Plough Europe|Mómetasón||1982||1982|3690| 474608|QB03AC9001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC90|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|29593|56996|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíđ||||29593|56996| 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|E|0|LYF|0|0|0|100|XEU|857|1324|lyfalmen|V0266|1324|3|30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||252||252|1324| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|1100|2484|lyfalmen|||2|100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||1100||1100|2484| 475467|G03CA0306|Evorel|forđapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|3526|5802|lyfalmen|V0130|5802|1|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||3526||3526|5802| 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|320|1417|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||320||320|1417| 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|390|1512|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||390||390|1512| 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|1|0|0|0|ACA|0|0|1|100|NOK|1091|2471|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||1091||1091|2471| 475798|R03AC1302|Oxis Turbuhaler|innúđadu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|4061|6534|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||4061||4061|6534| 475822|R03AC1302|Oxis Turbuhaler|innúđadu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|5350|8297|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||5350||5350|8297| 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|5981|9161|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5981||5981|9161| 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|0|0|0|0|*|0|ELI|0|0|0|100|XEU|6463|9820|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||6463||6463|9820| 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|82950|105985|lyfsjukr|||1|1|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||82950|105985| 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|B|0|GSK|0|0|1|100|IKR|1200|2538|lyfalmen|||1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1140||1140|2538| 476736|N05AH0311|Olanzapine Ranbaxy|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|*|0|RAN|0|0|0|100|XEU|12724|6916|lyfalmen|V0282|6215|2|56|0|56,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||4340||4340|6916| 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|5630|8680|lyfalmen|||1|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5630||5630|8680| 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|1000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|*|0|APC|0|0|0|100|XEU|531|1571|lyfalmen|V0500|1566|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||433||433|1571| 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|*|0|WIL|0|0|0|100|XEU|31480|42053|lyfalmen|V0454|42053|2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||31480||31480|42053| 480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|1|0|0|0|E|0|WIH|0|0|0|100|XEU|28082|12583|lyfalmen|V0341|12583|2|98|0|65,3333|Portfarma ehf|Williams & Halls|Dónepezíl||8483||8483|12583| 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|ţpakki||G03XC01|01.02.1999||R|0|0|0|0|E|0|DSG|0|0|0|100|SEK|14013|20131|lyfalmen|||1|84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||14013||14013|20131| 481176|N06AX1201|Zyban|forđatfl|150|mg|100|stk|1|ţpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|15177|21592|lyfalmen|||1|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||15177||15177|21592| 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|ţpakki||N02AX02|01.05.2012||R|1|0|1|0|E|0|GLP|0|0|1|100|SEK|368|1482|lyfalmen|V0055|1289|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||368||368|1482| 482457|N02BA5102|Treo|freyđit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||| 483217|B01AX0601 |Xarelto|filmhtfl|20|mg|98|stk|1|ţpakki||B01AX06|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|41311|54390|lyfalmen|V0030|54338|1|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||41311|54390| 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2968|4284|lyfsjukr|||1|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2968||2968|4284| 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|E|0|SHS|0|0|1|100|DKK|3783|6154|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||3783||3783|6154| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|5123|7394|lyfsjukr|||1|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||5123||5123|7394| 483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|*|0|POF|0|0|0|100|DKK|2595|4529|lyfalmen|V0374|4529|2|2|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2595||2595|4529| 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|ţpakki||N02AX02|01.09.2011||R|1|0|1|0|E|0|AGP|0|0|1|100|XEU|312|1289|lyfalmen|V0055|1289|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||227||227|1289| 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|61225|78720|lyfsjukr|||1|3|0|112,5000|Vistor hf|Ferring|Triptórelín||61225||61225|78720| 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|ţpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|6362|9682|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríđ||6362||6362|9682| 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|163864|207532|lyfsjukr|||1|1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||163864||163864|207532| 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|0|0|0|0|E|0|MEB|0|0|1|100|SEK|1523|3062|lyfalmen|||1|300|0||Vistor hf|Meda AB (V)|Benzýdamín||1523||1523|3062| 484721|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|60031|77884|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||60031||60031|77884| 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|E|0|ANS|0|0|1|100|XEU|1332|2801|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1332||1332|2801| 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|E|0|SAL|0|0|1|100|USD|497|1659|lyfalmen|||1|5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||497||497|1659| 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|E|0|SAL|0|0|1|100|USD|709|1949|lyfalmen|||1|5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||709||709|1949| 487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|1|1|0|0|*|0|APC|0|0|0|100|XEU|21091|29014|lyfalmen|V0573|26501|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||21091||21091|29014| 487682|N06AB1005|Escitalopram LYFIS|filmhtfl|15|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|IKR|4775|4287|lyfalmen|V0326|4287|2|100|0|150,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2418||2418|4287| 487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|38033|49614|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Limited|Etanercept||38033||38033|49614| 487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|59367|76388|lyfsjukr|||1|1|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||59367||59367|76388| 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|*|0|WIL|0|0|0|100|XEU|35157|46667|lyfalmen|V0453|46667|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||35157||35157|46667| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|ţpakki||M01AX01|01.04.1995||R|1|0|0|0|E|0|MAB|0|0|1|100|SEK|1053|2419|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||1053||1053|2419| 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|1|0|0|0|E|0|MAB|0|0|1|100|SEK|2927|4983|lyfalmen|V0198|4127|1|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2927||2927|4983| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|1|0|0|1|B|0|APC|0|0|0|100|DKK|6726|10180|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6726||6726|10180| 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|1|0|0|1|B|0|APC|0|0|0|100|DKK|12096|17726|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||12096||12096|17726| 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|110571|140649|lyfsjukr|||1|2|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||110571|140649| 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|0|0|NOH|0|0|1|100|IKR|338|1242|lyfalmen|V0188|497|1|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1242| 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|E|0|NOH|0|0|1|100|IKR|882|1618|lyfalmen|V0188|1491|1|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1618| 490417|G03FB0504|Evorel Sequi|forđapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|2634|4582|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2634||2634|4582| 490425|G03FA0104|Evorel Conti|forđapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|2776|4776|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2776||2776|4776| 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4235|6772|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||4235||4235|6772| 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11591|11260|lyfalmen|V0112|2449|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7516||7516|11260| 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5631|8682|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5631||5631|8682| 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16449|15289|lyfalmen|V0113|1991|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||10461||10461|15289| 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|20921|19110|lyfalmen|V0114|3715|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||13199||13199|19110| 491313|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2012||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|44989|58344|lyfsjukr|||1|2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||44989||44989|58344| 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|52857|68218|lyfsjukr|||1|3|0|20,8300|Vistor hf|N.V. Organon|BCG bóluefni||52857||52857|68218| 492405|N04BA0202|Madopar Depot|forđahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|3514|5786|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3514||3514|5786| 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|ţpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13919|20013|lyfalmen|V0002|5247|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||13919||13919|20013| 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 493113|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 493313|G04BD0704|Tolterodin Actavis|forđahlk|2|mg|100|stk|1|ţpakki||G04BD07|01.01.2013||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|19509|27029|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||19509||19509|27029| 493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|25710|14702|lyfalmen|V0516|14564|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||10032||10032|14702| 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|1572|3129|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1572||1572|3129| 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|ţpakki||N02CX01|01.04.1974||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|2642|4593|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||2642||2642|4593| 494237|L01XC0201|MabThera|irţ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|86531|110479|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||86531||86531|110479| 494286|L01XC0201|MabThera|irţ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|216328|273374|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||216328||216328|273374| 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburđur, fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|2156|3928|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2156||2156|3928| 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|2418|4287|lyfalmen|V0128|2233|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2418||2418|4287| 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|3514|5786|lyfalmen|V0410|5230|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3514||3514|5786| 494831|B01AC0702|Persantin retard|forđahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|E|0|BII|0|0|0|100|DKK|1998|3712|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1998||1998|3712| 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|ţpakki||A04AA01|01.01.1991||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|20233|7258|lyfalmen|V0384|6678|1|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||4590||4590|7258| 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|7869|6890|lyfalmen|V0382|6757|1|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||4321||4321|6890| 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991|31.12.2012|R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|10805|10373|lyfalmen|||1|20|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||7038||6867|10373| 495820|J05AH0101|Relenza|innúđadu|5|mg/úđask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3087|5202|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||3087||3087|5202| 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|32212|31868|lyfalmen|V0345|31868|3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||23365||23365|31868| 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4524|8859|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4524|8859| 496468|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|1|1|0|0|*|0|APC|0|0|0|100|XEU|13636|13451|lyfalmen|V0572|12266|2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||9117||9117|13451| 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|0|0|0|0|B|0|ATL|0|0|0|100|GBP|6420|9761|lyfalmen|||1|100|0|0,8333|Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Labetalól||6420||6420|9761| 496554|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|1|0|0|0|B|0|ATL|0|0|0|100|GBP|1126|2519|lyfalmen|||1|50|0|8,3333|Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Labetalól||1126||1126|2519| 496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|0|0|0|1|0|1|SOI|0|0|0|100|DKK|92018|117365|lyfsjukr|||1|3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||92018||92018|117365| 496752|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|1|0|0|0|B|0|ATL|0|0|0|100|GBP|3533|5812|lyfalmen|||1|100|0|33,3333|Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Labetalól||3533||3533|5812| 496935|N02AG0201|Ketogan|eţ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|0|0|1|0|E|0|PER|0|0|0|100|DKK|502|1666|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||502||502|1666| 496950|N02AG0201|Ketogan|töflur|||20|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|906|2218|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||906||906|2218| 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|ţpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|265488|335070|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||265488||265488|335070| 497099|N02AG0201|Ketogan|töflur|||100|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|3455|5705|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3455||3455|5705| 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|364|1477|lyfalmen|||2|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||364||364|1477| 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|540|1620|lyfalmen|V0448|1619|2|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||469||469|1620| 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1123|2307|lyfalmen|V0449|2306|2|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||971||971|2307| 497983|N04BC0407|Ropinirol Actavis|forđatfl|4|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|16143|20140|lyfalmen|V0533|19100|2|84|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||14020||14020|20140| 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|1613|3122|lyfalmen|V0369|3122|2|5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíđ||1567||1567|3122| 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|1456|2971|lyfalmen|||1|2|0|9,3300|Vistor hf|Schering-Plough Europe|Betametasón||1456||1456|2971| 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|18151|25325|lyfalmen|||1|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||18151||18151|25325| 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|19362|26844|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||19362||19362|26844| 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|24118|32813|lyfalmen|||1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||24118||24118|32813| 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|29137|39112|lyfalmen|||1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||29137||29137|39112| 499273|B01AX0601 |Xarelto|filmhtfl|20|mg|28|stk|1|ţpakki||B01AX06|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|11848|17186|lyfalmen|||1|28|0|56,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||11848|17186| 501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|ţpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|IKR|4880|3746|lyfalmen|||2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||2023||2023|3746| 501734|M01AB0508|Vostar-R|forđatfl|75|mg|100|stk|1|glas|0|M01AB05|01.03.2000|31.12.2012|R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|2810|4823|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis hf|Díklófenak||2810||2810|4823| 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|3276|5460|lyfalmen|V0434|4690|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3276||3276|5460| 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|ţpakki||N06AA21|01.06.1977||R|1|0|0|0|B|0|AML|0|0|0|100|DKK|3194|5348|lyfalmen|||1|100|0|25,0000|Vistor hf|Amdipharm Limited|Maprótilín||3194||3194|5348| 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|32217|42315|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||32217||32217|42315| 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|7103|7542|lyfalmen|||3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||4798||4798|7542| 503795|M01AB0512|Voltaren Dolo|húđuđtfl|25|mg|20|stk|1|ţpakki||M01AB05|01.10.2011||L|1|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|20|0|5,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 504014|N04BC0407|Ropinirol Actavis|forđatfl|8|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|31621|37023|lyfalmen|V0534|35180|2|84|0|112,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||27472||27472|37023| 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.11.2011||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|1773|3039|lyfalmen|V0494|3038|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríđ||1506||1506|3039| 504191|N02BA5102|Treo|freyđit|||20|stk|1|glas||N02BA51|01.07.1988||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||| 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|ţpakki||G03CA04|01.01.1988||R|0|0|0|0|E|0|ORG|0|0|0|100|DKK|2185|3968|lyfalmen|||1|90|0|45,0000|Vistor hf|N.V. Organon|Estríól||2185||2185|3968| 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|1242|2678|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1242||1242|2678| 505647|N07BA0147|Nicorette QuickMist|munnhúđi|1|mg/sk|300|skammtar|1|fl|2 x 150 úđaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|ţpakki||N06AA21|01.05.1978||R|1|0|0|0|B|0|AML|0|0|0|100|DKK|8788|13000|lyfalmen|||1|100|0|75,0000|Vistor hf|Amdipharm Limited|Maprótilín||8788||8788|13000| 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|1932|2788|lyfsjukr|||1|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1932||1932|2788| 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3858|5568|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3858||3858|5568| 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|8803|12705|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||8803||8803|12705| 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|2638|4588|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2638||2638|4588| 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|ţpakki||A06AB02|01.12.1975||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|ţpakki||A06AB02|01.12.1975||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|428|1564|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||428||428|1564| 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|705|1230|vetorma|||0|24|0||Icepharma hf|Pfizer Oy Animal Health|||||705|1230| 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995|31.12.2012|L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|2824|4926|vetorma|||0|120|0||Icepharma hf|Pfizer Oy Animal Health|||||2824|4926| 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|17212|30025|vetorma|||0|1000|0||Vistor hf|Intervet International BV|||17212||17212|30025| 508622|C08DA0103|Isoptin retard|forđatfl|240|mg|98|stk|1|ţpakki||C08DA01|01.10.1993||R|1|0|0|0|B|0|ABS|0|0|0|100|DKK|2737|4723|lyfalmen|||1|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2737||2737|4723| 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5469|10674|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||5469|10674| 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4386|8594|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4386||4386|8594| 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|13571|26231|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||13571||13571|26231| 508921|L01CD0401|Jevtana|irţ|60|mg|15|ml|1|hgl|+ leysir|L01CD04|01.08.2011||R|0|0|0|1|0|1|SOF|0|0|0|100|NOK|804577|1011627|lyfsjukr|||1|15|0||Vistor hf|SANOFI|Cabazitaxel||804577||804577|1011627| 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|*|0|LBK|0|0|0|100|DKK|9734|14295|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9734||9734|14295| 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|0|0|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2950| 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|ţpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|52331|67558|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||52331||52331|67558| 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|17810|24234|lyfsjukr|||1|2|0|12,0000|Icepharma hf|Roche|Epóetín||17810||17810|24234| 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|26659|35340|lyfsjukr|||1|2|0|18,0000|Icepharma hf|Roche|Epóetín||26659||26659|35340| 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|43729|56762|lyfsjukr|||1|2|0|30,0000|Icepharma hf|Roche|Epóetín||43729||43729|56762| 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|86477|110411|lyfsjukr|||1|4|0|60,0000|Icepharma hf|Roche|Epóetín||86477||86477|110411| 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|200789|253873|lyfsjukr|||1|1|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||200789|253873| 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|4468|4452|lyfalmen|V0445|4169|2|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríđ||2539||2539|4452| 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|ţpakki||C09CA07|01.03.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|2900|4946|lyfalmen|||1|28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2900||2900|4946| 511245|N05AH0310|Zalasta (LYFIS)|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.02.2012|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|36715|31239|lyfalmen|||3|28|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||22864||22864|31239| 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|2881|4920|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2881||2881|4920| 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|25784|34241|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||25784||25784|34241| 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|16129|22124|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||16129||16129|22124| 512192|N06AB1005|Escitalopram LYFIS|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|IKR|4775|4125|lyfalmen|V0325|4125|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2300||2300|4125| 512608|B05XA3101|Peditrace|irţ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5624|8117|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5624||5624|8117| 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||| 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|24440|33217|lyfalmen|||1|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||24440||24440|33217| 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|2272|4519|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2272||2272|4519| 514265|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|B|0|AZD|0|0|1|100|SEK|2259|4069|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2259||2259|4069| 514427|C07AG0203|Carvedilol Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|1|0|0|0|B|0|ADG|0|0|0|100|XEU|4161|6671|lyfalmen|||2|100|0|66,6667|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||4161||4161|6671| 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|ţpakki||N06AX18|01.06.2000||R|1|0|0|0|B|0|PER|0|0|0|100|IKR|4301|4222|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4222| 515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2681| 515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2694| 516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|5751|8300|lyfsjukr|||1|10|0|1,0000|Portfarma ehf|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||5751||5751|8300| 517073|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|120|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|5112|6293|lyfalmen|V0010|6293|2|120|0|120,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3885||3885|6293| 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|3162|5304|lyfalmen|V0462|2906|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3162||3162|5304| 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|3443|5689|lyfalmen|V0471|3049|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3443||3443|5689| 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|3702|6043|lyfalmen|V0472|3296|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3702||3702|6043| 517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 518241|M01AB0509|Modifenac|forđahlk|75|mg|20|stk|1|ţpakki||M01AB05|01.11.2000||R|1|0|0|0|E|0|AGT|0|0|1|100|DKK|982|2322|lyfalmen|||1|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||982||982|2322| 518258|M01AB0509|Modifenac|forđahlk|75|mg|100|stk|1|ţpakki|međ breyttan losunarhrađa|M01AB05|01.11.2000||R|1|0|0|0|E|0|AGT|0|0|1|100|DKK|3698|6038|lyfalmen|||1|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3698||3698|6038| 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2231|4031|lyfalmen|V0590|3430|1|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2231||2231|4031| 518337|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|200|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|1|0|0|0|*|0|LVR|0|0|0|100|IKR|12890|12743|lyfalmen|V0286|12333|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||8600||8600|12743| 518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|ţpakki||A10BH05|01.12.2012||R|1|0|0|0|*|0|BII|0|0|0|100|DKK|20611|28412|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||20611||20611|28412| 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1221|2649|lyfalmen|||1|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1221||1221|2649| 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|AUG|0|0|1|100|SEK|1830|3482|lyfalmen|||1|100|0|2,5000|Aspen Europe GmbH|Aspen Europe GmbH|Súlfametoxazól og trímetóprím||1830||1830|3482| 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|7771|11609|lyfalmen|V0431|10094|2|2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||7771||7771|11609| 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5151|8025|lyfalmen|V0142|7884|1|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5151||5151|8025| 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5818|8938|lyfalmen|V0143|2634|1|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5818||5818|8938| 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16392|23117|lyfalmen|V0143|7902|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||16392||16392|23117| 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6239|9514|lyfalmen|V0144|3193|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||6239||6239|9514| 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|17263|24210|lyfalmen|V0144|9578|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||17263||17263|24210| 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1355|1724|lyfalmen|V0056|1724|2|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||545||545|1724| 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2163|2114|lyfalmen|V0057|2114|2|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||830||830|2114| 520759|M03BC5101|Norgesic|töflur|||30|stk|1|ţpakki||M03BC51|01.03.1981||R|1|0|0|0|E|0|MEB|0|0|1|100|SEK|394|1518|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||394||394|1518| 520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1765| 520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1776| 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|34313|45608|lyfalmen|V0269|21080|1|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||34313||34313|45608| 521954|N03AX2101|Trobalt|filmhtfl|200|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|19106|26523|lyfalmen|||1|84|0|18,6700|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||19106||19106|26523| 521966|A10BX0202|Repaglinid Krka (LYFIS)|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|3046|3049|lyfalmen|V0471|3049|3|90|0|22,5000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1513||1513|3049| 522003|QJ01RA0102|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|8978|17412|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|||8978||8978|17412| 522599|J07CA0202|Tetravac|bóluefni|||0,5|ml|1|spr|einnota dćla|J07CA02|01.10.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2449|4329|lyfalmen|||1|0|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mćnusótt, stífkrampi||2449||2449|4329| 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|199033|251669|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||199033||199033|251669| 522730|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|1|0|E|0|GLP|0|0|1|100|SEK|368|1482|lyfalmen|V0055|1289|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||368||368|1482| 522771|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|1|0|E|0|GLP|0|0|1|100|SEK|436|1575|lyfalmen|V0225|1542|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||436||436|1575| 522797|N02AX0204|Tradolan|filmhtfl|50|mg|250|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|1|0|E|0|GLP|0|0|1|100|DKK|2963|5032|lyfalmen|||1|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2963||2963|5032| 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|0|0|1|0|E|0|GLP|0|0|1|100|DKK|422|1556|lyfalmen|||1|10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||422||422|1556| 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|ţp 30+500 mg|N02AA59|01.11.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|499|1662|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||499||499|1662| 523274|S01XA2008|Artelac|augndr|||10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|0|0|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1395| 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|ţpakki||R06AD02|01.10.1995||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|1411|2909|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1411||1411|2909| 524215|C01DA1401|Imdur|forđatfl|30|mg|28|stk|1|ţpakki||C01DA14|01.07.1993||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|492|1652|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||492||492|1652| 524223|C01DA1401|Imdur|forđatfl|30|mg|98|stk|1|ţpakki||C01DA14|01.07.1993||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|3100|5220|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||3100||3100|5220| 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|8619|5951|lyfalmen|V0010|5139|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|5951| 524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|0|0|0|0|0|0|INI|0|0|0|100|DKK|2033|4044|vetalmen|||0|1|0||Icepharma hf|Intervet International B.V.|Vedaprófen||2033||2033|4044| 525014|M03BC5101|Norgesic|töflur|||100|stk|1|ţpakki||M03BC51|01.06.1981||R|1|0|0|0|E|0|MEB|0|0|1|100|SEK|966|2300|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||966||966|2300| 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|0|0|0|0|0|0|NOH|0|0|0|100|DKK|827|2110|lyfalmen|||1|15|0|3,7500|Vistor hf|Novartis Healthcare A/S-|Díklófenak||827||827|2110| 525076|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|100|stk|1|glas||A02BC01|01.02.2012|31.12.2012|R|0|0|0|0|E|0|LVR|0|0|0|100|IKR|4621|4194|lyfalmen|||3|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól||2350||2350|4194| 525147|M01AB0504|Klofen-L|forđahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|1599|3166|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1599||1599|3166| 525170|M01AB0504|Klofen-L|forđahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|5329|8269|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||5329||5329|8269| 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.03.2002||R|1|0|0|0|0|0|CPA|0|0|0|100|DKK|11592|16836|lyfalmen|||1|30|0|10,0000|Vistor hf|Cephalon France (V)|Modafinil||11592||11592|16836| 525720|B01AX0601 |Xarelto|filmhtfl|20|mg|100|stk|1|ţpakki||B01AX06|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|42153|55447|lyfalmen|V0030|55447|1|100|0|200,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||42153|55447| 525857|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5811|8387|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Kalíumklóríđ||5811||5811|8387| 525865|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5291|7636|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Natríumklóríđ||5291||5291|7636| 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 526004|V07AB09|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|4768|7501|lyfalmen|V0435|7501|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4768||4768|7501| 526376|N03AG0103|Orfiril Retard|forđatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|E|0|DEA|0|0|0|100|XEU|4449|7065|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4449||4449|7065| 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|E|0|DEA|0|0|0|100|XEU|3806|6185|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3806||3806|6185| 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|ţpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||| 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|17055|23287|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||17055||17055|23287| 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|E|0|ALC|0|0|0|100|USD|1313|2775|lyfalmen|||0|5|0||K.Pétursson hf|Alcon|Emedastín||1313||1313|2775| 528374|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2012||R|0|0|0|0|E|0|BGB|0|0|0|100|DKK|19428|26927|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||19428||19428|26927| 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|0|0|LVR|0|0|0|100|SEK|10845|14873|lyfalmen|V0356|14872|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10157||10157|14873| 528584|A07EC0202|Pentasa|forđatfl|1|g|60|stk|1|ţpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|B|0|FEL|0|0|0|100|DKK|7352|11036|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Mesalazín (5-amínósalicýlsýra)||7352||7352|11036| 529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.06.1998||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|4805|9399|vetalmen|||0|72|0||Icepharma hf|Pfizer Oy Animal Health|||4805||4805|9399| 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|5109|9983|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||5109||5109|9983| 529735|N03AB0501|Pro-Epanutin|irţ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|73341|93925|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||73341||73341|93925| 529852|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|XEU|30480|15612|lyfalmen|V0184|14564|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||10697||10697|15612| 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|||0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||7266| 530379|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|XEU|12587|7902|lyfalmen|V0186|7902|2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||5061||5061|7902| 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|ţp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|3317|5516|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3317||3317|5516| 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6376|9202|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||6376||6376|9202| 531459|R03CC0303|Bricanyl Retard|forđatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|3283|5470|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||3283||3283|5470| 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|0|0|0|1|0|1|BII|0|0|0|100|DKK|8767|12653|lyfsjukr|||1|240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||8767||8767|12653| 532048|L04AA0605|Myfenax (Lyfis)|hylki|500|mg|50|stk|1|ţpakki||L04AA06|01.03.2011||R|1|0|0|1|*|0|LYF|0|0|0|100|XEU|21672|24616|lyfalmen|V0187|11055|3|50|0|12,5000|LYFIS ehf|LYFIS ehf|Mýcófenólsýra||17586||17586|24616| 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|726|1972|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||726||726|1972| 532504|R06AX2704|Desloratadine ratiopharm|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.09.2012||R|1|0|0|0|E|0|RGM|0|0|1|100|XEU|1303|2761|lyfalmen|V0366|2582|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||1303||1303|2761| 532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|384|1504|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||384||384|1504| 532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|1114|2503|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||1114||1114|2503| 532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|308|1400|lyfalmen|||1|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||308||308|1400| 532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|1963|3664|lyfalmen|||1|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1963||1963|3664| 533302|N05AH0310|Zalasta (LYFIS)|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|14577|7921|lyfalmen|||3|28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||5015||5075|7921| 533737|R03CC0303|Bricanyl Retard|forđatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|2225|4023|lyfalmen|||1|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||2225||2225|4023| 533779|A02BC0111|Omeprazol Pensa|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||| 534183|N05AH0308|Lazapix|filmhtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.02.2013||R|1|0|0|0|*|0|POF|0|0|0|100|XEU|16269|22963|lyfalmen|V0281|22963|2|28|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||16269||16269|22963| 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|ţpakki||L04AA10|01.06.2012||R|0|0|0|1|*|0|IPI|0|0|0|100|DKK|62776|81329|lyfalmen|V0567|81329|1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||62776||62776|81329| 535773|P03AA5401|Tenutex|áburđur|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||| 535844|N05AH0310|Zalasta (LYFIS)|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|3280|2434|lyfalmen|||3|28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||1064||1064|2434| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|ţpakki||G04BD04|01.06.1998||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|7301|10966|lyfalmen|||1|84|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||7301||7301|10966| 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|*|0|SAL|0|0|0|100|USD|463|1612|lyfalmen|||1|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||463||463|1612| 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|*|0|SAL|0|0|0|100|USD|590|1786|lyfalmen|||1|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||590||590|1786| 536115|C10AA0504|Atorvastatin Portfarma|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|12900|7613|lyfalmen|V0115|6451|2|100|0|400,0000|Portfarma ehf|Portfarma|Atorvastatín||4850||4850|7613| 536133|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|30|stk|1|ţpakki||A10BA02|01.11.2012||R|1|0|0|0|*|0|APC|0|0|0|100|XEU|434|1573|lyfalmen|V0502|1573|2|30|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||434||434|1573| 536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|31921|41943|lyfsjukr|||1|1|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||31921||31921|41943| 536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|119310|152279|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||119310||119310|152279| 536840|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|glas||N07XX07|01.12.2011||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|69993|90386|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||69993||69993|90386| 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995|31.12.2012|L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|593|1034|vetorma|||0|2|0||Icepharma hf|Pfizer Oy Animal Health|||||593|1034| 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6753|9746|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6753||6753|9746| 537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|0|0|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2510| 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|149066|188960|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||149066||149066|188960| 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|ţpakki||N03AG04|01.10.1992||R|1|0|0|1|E|0|SNO|0|0|0|100|NOK|11703|16988|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||11703||11703|16988| 539152|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|100|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|1|0|0|0|*|0|LVR|0|0|0|100|IKR|5863|6177|lyfalmen|V0285|5904|3|60|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||3800||3800|6177| 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|236|1302|lyfalmen|||2|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||236||236|1302| 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|685|1916|lyfalmen|||2|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||685||685|1916| 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|1920|3605|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1920||1920|3605| 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|2982|5058|lyfalmen|||1|250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2982||2982|5058| 540970|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2012||R|0|0|0|0|0|0|PAS|0|0|0|100|XEU|2764|4822|vetorma|||0|12|0||Vistor hf|Pfizer Oy Animal Health|||2764||2764|4822| 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.07.2000||R|0|0|0|0|*|0|MSD|0|0|0|100|DKK|6291|9585|lyfalmen|V0373|7778|1|15|0|75,0000|Vistor hf|M.S.D.|Tímólól í blöndum||6291||6291|9585| 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|1|0|0|0|B|0|SGM|0|0|0|100|DKK|10172|14894|lyfalmen|V0199|14894|1|200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||10172||10172|14894| 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|1|0|0|0|B|0|SGM|0|0|0|100|DKK|16477|23224|lyfalmen|V0200|23224|1|200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||16477||16477|23224| 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|6294|9084|lyfsjukr|||2|800|0|3,3300|Actavis Group hf|Braun|Gentamícín||6294||6294|9084| 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|4756|7485|lyfalmen|||0|100|1|100,0000|Parlogis hf|Parlogis - óskráđ lyf|Dapsón||4756||4756|7485| 543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|ţpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|786|2054|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||786||786|2054| 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|ţpakki||C07AA03|01.12.1983||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|3109|5232|lyfalmen|||1|98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||3109||3109|5232| 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|2373|3310|lyfalmen|V0373|2593|2|5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1704||1704|3310| 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||| 543743|N05AH0310|Zalasta (LYFIS)|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.02.2012|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|7435|4875|lyfalmen|||3|28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||2728||2848|4875| 543744|R01AA0503|Nezeril|nefúđi|0,5|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|8|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|ţpakki|hörđ|J05AE12|01.01.2012||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|549446|691437|lyfsjukr|||1|336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||549446||549446|691437| 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|13932|20030|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||13932||13932|20030| 544919|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|951|2280|lyfalmen|||2|7|0|9,3300|Portfarma ehf|Portfarma|Esómeprazól||951||951|2280|31.12.2012 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|ţpakki||G03HB01|01.10.2012||R|0|0|0|0|0|0|RGM|0|0|0|100|XEU|2068|3808|lyfalmen|V0134|3808|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Cýpróterón og östrógen||2068||2068|3808| 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1066|2437|lyfalmen|||1|15|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||1066||1066|2437| 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|968|2303|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||968||968|2303| 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|2389|4247|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2389||2389|4247| 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|32332|43122|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||32332||32332|43122| 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|26068|35260|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||26068||26068|35260| 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|32522|43360|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||32522||32522|43360| 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|27630|37221|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||27630||27630|37221| 546143|N02BE0108|Paratabs Retard|forđatfl|500|mg|30|stk|1|ţpakki||N02BE01|01.10.1993||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 546168|N02BE0108|Paratabs Retard|forđatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1222|2651|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1222||1222|2651| 546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|ţpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|IKR|3218|3222|lyfalmen|V0580|3222|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||1640||1640|3222| 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|3141|5247|lyfalmen|V0010|5244|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3120||3120|5247| 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|ţpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4791| 547659|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|3215|2066|lyfalmen|V0004|2066|3|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||795||795|2066| 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|11175|15907|lyfsjukr|||1|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||11175||11175|15907| 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|3682|5314|lyfsjukr|||1|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||3682||3682|5314| 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|0|0|0|1|E|0|ORG|0|0|0|100|DKK|8342|12390|lyfalmen|||1|0|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||8342||8342|12390| 548120|C07AB0312|Atenolol LYFIS|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|613|1694|lyfalmen|V0542|1694|2|100|0|66,6600|LYFIS ehf|LYFIS ehf|Atenólól||523||523|1694| 548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|ţpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||| 548894|B02BC0001|Tisseel|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|195447|247168|lyfsjukr|||1|20|0||Icepharma hf|Baxter AG|Lyf til ađ minnka stađbundna blćđingu||195447||195447|247168| 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|101139|128812|lyfsjukr|||1|1|0||Vistor hf|AbbVie Ltd.|Palivisumab||101139||101139|128812| 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|10487|15325|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||10487||10487|15325| 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|149766|189839|lyfsjukr|||1|1|0||Vistor hf|AbbVie Ltd.|Palivisumab||149766||149766|189839| 549674|B01AX0601 |Xarelto|filmhtfl|15|mg|98|stk|1|ţpakki||B01AX06|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|41311|54390|lyfalmen|V0031|54338|1|98|0|147,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||41311|54390| 550061|N02BE0102|Panodil Brus|freyđit|500|mg|24|stk|1|ţpakki||N02BE01|01.04.1992||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen|||0|24|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1592| 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 550731|N02BE0103|Panodil Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 551183|N05AH0310|Zalasta (LYFIS)|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.10.2011|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|11382|7921|lyfalmen|||3|56|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||5035||5075|7921| 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|10009|14444|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||10009||10009|14444| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|ţpakki||N02CC03|01.05.2001||R|0|0|0|0|E|0|AZA|0|0|0|100|SEK|11833|17166|lyfalmen|V0235|17166|1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||11833||11833|17166| 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|B|0|MAB|0|0|1|100|SEK|2021|3744|lyfalmen|||1|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||2021||2021|3744| 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|ţpakki||M01AX01|01.04.1995||R|1|0|0|0|E|0|MAB|0|0|1|100|SEK|4313|6879|lyfalmen|V0198|6879|1|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||4313||4313|6879| 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|738|1988|lyfalmen|||0|20|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||738||738|1988| 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|2157|1752|lyfalmen|V0466|1612|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752| 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|3931|3432|lyfalmen|V0467|2843|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432| 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC04|01.11.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|1510|1008|lyfalmen|V0003|806|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1008| 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|3631|1752|lyfalmen|V0003|1612|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752| 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|7648|3432|lyfalmen|V0010|2937|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432| 551989|N03AX1406|Zelta|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|25710|14564|lyfalmen|V0516|14564|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||9931||9931|14564| 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.04.1985||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|4025|6485|lyfalmen|||1|100|0|66,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||4025|6485| 552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||| 552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|5562|8587|lyfalmen|||2|500|0|500,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||5562||5562|8587| 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|ţpakki||N03AF02|01.10.2000||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|3520|5794|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3520||3520|5794| 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|ţpakki||N02CC06|01.08.2009||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|12839|18658|lyfalmen|V0237|18658|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||12839|18658| 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|ţpakki||N02CC06|01.10.2001||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|4391|6986|lyfalmen|V0237|6219|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||4391||4391|6986| 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|8139|15801|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|||8139||8139|15801| 555235|N05AB0303|Peratsin|húđuđtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|*|0|ORC|0|0|0|100|DKK|2430|4303|lyfalmen|V0026|2812|2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||2430||2430|4303| 555268|N05AB0303|Peratsin|húđuđtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|*|0|ORC|0|0|0|100|DKK|2770|4768|lyfalmen|V0027|3592|2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2770||2770|4768| 555292|N05AB0303|Peratsin|húđuđtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|*|0|ORC|0|0|0|100|DKK|2091|3839|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||2091||2091|3839| 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|29486|38887|lyfsjukr|||1|1|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||29486||29486|38887| 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|5215|8113|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||5215||5215|8113| 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|7093|10682|lyfalmen|V0242|7444|1|50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7093||7093|10682| 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|10167|14887|lyfalmen|V0242|14887|1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||10167||10167|14887| 557546|D10AF0202|Zineryt|áburđur|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|0|0|0|0|0|0|ASP|0|0|0|100|XEU|1711|3319|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1711||1711|3319| 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|ţpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NOE|0|0|0|100|DKK|300208|378644|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||300208|378644| 559013|C08DA0103|Isoptin retard|forđatfl|120|mg|28|stk|1|ţpakki||C08DA01|01.01.1995||R|1|0|0|0|B|0|ABS|0|0|0|100|DKK|906|2218|lyfalmen|||1|28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||906||906|2218| 559021|C08DA0103|Isoptin retard|forđatfl|120|mg|98|stk|1|ţpakki||C08DA01|01.01.1995||R|1|0|0|0|B|0|ABS|0|0|0|100|DKK|2079|3823|lyfalmen|||1|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2079||2079|3823| 559104|N02AX0201|Nobligan|eţ-stíll|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|0|0|1|0|E|0|GRU|0|0|1|100|DKK|706|1945|lyfalmen|||1|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||706||706|1945| 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|1674|3269|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1674||1674|3269| 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|6123|9355|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||6123||6123|9355| 559971|C01DA0201|Discotrine|forđapl|10|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|0|0|0|0|B|0|MEB|0|0|0|100|SEK|3861|6261|lyfalmen|||1|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3861||3861|6261| 559989|N01AB0701|Suprane|innönd.l|||240|ml|1|fl||N01AB07|01.01.1995||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|15093|20824|lyfsjukr|||1|240|0||Icepharma hf|Baxter|Desflúran||15093||15093|20824| 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1454| 560244|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|791|1485|lyfalmen|V0067|1485|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||370||370|1485| 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.07.1989||R|1|0|0|0|E|0|GSK|0|0|1|100|GBP|3329|5533|lyfalmen|||1|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3329||3329|5533| 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|2|0||GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|E|0|GSK|0|0|1|100|GBP|1657|3246|lyfalmen|||1|4|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1657||1657|3246| 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|E|0|GSK|0|0|1|100|GBP|6345|9659|lyfalmen|||1|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6345||6345|9659| 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|E|0|GSK|0|0|1|100|GBP|6880|10390|lyfalmen|||1|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6880||6880|10390| 560490|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|107212|136434|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||107212||107212|136434| 560557|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|495821|624138|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||495821||495821|624138| 560761|C10AA0505|Atorvastatin Bluefish|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|9323|6451|lyfalmen|V0115|6451|2|100|0|400,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||4000||4000|6451| 561145|N03AX2101|Trobalt|filmhtfl|||63|stk|1|ţpakki|21x50mg+42x100mg|N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|6149|9390|lyfalmen|||1|63|0|5,8400|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||6149||6149|9390| 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|1838|3493|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1838||1838|3493| 562014|C09BA0201|Daraziđ|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|2675|4638|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og ţvagrćsilyf||2675||2675|4638| 562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|53266|68731|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Pfizer Limited|Storkuţáttur IX||53266||53266|68731| 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|111458|141762|lyfsjukr|||1|1|0|16,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||111458||111458|141762| 563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|INT|0|0|0|100|DKK|122768|156619|lyfalmen|||1|63|0|7,0000|Vistor hf|InterMune Europe Ltd.|Pírfenidon||122768||122768|156619| 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|22635|30952|lyfalmen|V0431|30283|2|6|0|17,1667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||22635||22635|30952| 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|38189|50472|lyfalmen|V0431|50472|2|10|0|28,6111|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||38189||38189|50472| 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|820|2101|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||820||820|2101| 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|740|1991|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||740||740|1991| 563502|N02AA0101|Contalgin|forđatfl|5|mg|100|stk|1|ţpakki||N02AA01|01.10.1993||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|1477|2999|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1477||1477|2999| 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|220176|278866|lyfalmen|||2|60|0|171,6667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||220176||220176|278866| 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|3836|6226|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3836||3836|6226| 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|3977|6419|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3977||3977|6419| 563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|496482|625630|lyfalmen|||1|60|0||Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||496482||496482|625630| 563779|M05BA0708|Risedronate Bluefish|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.07.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|IKR|2323|3783|lyfalmen|V0207|2340|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Rísedrónsýru||2050||2050|3783| 563899|QP54AA0105|Noromectin|áhella|0,5|w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|12176|21240|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||12176||12176|21240| 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|ţpakki|hart|J05AB04|01.02.2002||R|1|0|0|1|0|1|SCP|0|0|0|100|DKK|87577|111792|lyfsjukr|||1|168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||87577||87577|111792| 564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|E|0|MLD|0|0|1|100|DKK|1181|2594|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1181||1181|2594| 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|B|0|UCB|0|0|0|100|DKK|12354|18049|lyfalmen|||1|100|0|50,0000|Vistor hf|U.C.B|Olsalazín||12354||12354|18049| 565982|H01BA0401|Glypressin|stl|1|mg|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|38823|50605|lyfsjukr|||1|42|0|3,5500|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||38823||38823|50605| 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|1467|2986|lyfalmen|V0444|2299|0|5|0|25,0000|K.Pétursson hf|Alcon|Brinzólamíđ||1467||1467|2986| 566373|N05AA0201|Nozinan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AA02|01.11.2012||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|5847|8977|lyfalmen|||1|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5847||5847|8977| 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|224940|284182|lyfsjukr|||1|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||224940||224940|284182| 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|B|0|ALK|0|0|1|100|DKK|6209|9473|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||6209|9473| 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|3709|6053|lyfalmen|V0291|3373|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3709||3709|6053| 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|7506|11247|lyfalmen|V0292|5566|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||7506||7506|11247| 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|10971|15987|lyfalmen|V0293|8178|1|60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||10971||10971|15987| 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|14408|20627|lyfalmen|V0294|10467|1|60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||14408||14408|20627| 567545|R01AC0201|Livostin|nefúđi|0,5|mg/úđask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||| 567946|A02BX1302|Galieve Cool Mint|mixtúra|||10|ml|24|skammt|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|240|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1190|2607|lyfalmen|||1|3|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1190||1190|2607| 568840|C08CA0201|Feldil|forđatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|3110|5225|lyfalmen|V0058|5225|2|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||3104||3104|5225| 568865|C08CA0201|Feldil|forđatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|3913|6323|lyfalmen|V0059|6323|2|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||3907||3907|6323| 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|18386|24957|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||18386||18386|24957| 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|21141|28414|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||21141||21141|28414| 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 572422|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|90040|115545|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||90040||90040|115545| 572612|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|13786|7393|lyfalmen|V0253|7347|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4689||4689|7393| 572768|B02BC1001|Tisseel Duo Quick|vefjalím|||0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001|31.01.2013|R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|169752|214921|lyfsjukr|||1|5|0||Icepharma hf|Baxter|Fíbrínógen manna||169752||169752|214921| 572776|B02BC1001|Tisseel Duo Quick|vefjalím|||1|ml|10|stk|samsett pk|B02BC10|01.03.2001|31.01.2013|R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|201422|254667|lyfsjukr|||1|10|0||Icepharma hf|Baxter|Fíbrínógen manna||201422||201422|254667| 572784|B02BC1001|Tisseel Duo Quick|vefjalím|||2|ml|10|stk|samsett pk|B02BC10|01.03.2001|31.01.2013|R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|424160|534203|lyfsjukr|||1|20|0||Icepharma hf|Baxter|Fíbrínógen manna||424160||424160|534203| 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 573065|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|IKR|9783|5012|lyfalmen|V0011|5012|3|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2948||2948|5012| 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.12.2010||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|5300|4403|lyfalmen|V0245|4403|2|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||2503||2503|4403| 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|3763|6126|lyfalmen|V0464|5376|0|2|0|25,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||3763||3763|6126| 573287|G03CA0306|Evorel|forđapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|3577|5872|lyfalmen|V0129|5872|1|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3577||3577|5872| 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|103357|131596|lyfsjukr|||1|1|0||Icepharma hf|Roche|Trastuzumab||103357||103357|131596| 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|26442|35067|lyfsjukr|||1|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||26442||26442|35067| 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|44771|58070|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||44771||44771|58070| 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|E|0|NOH|0|0|1|100|IKR|2756|2659|lyfalmen|V0189|2322|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2659| 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.10.1995||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2646|2184|lyfalmen|V0151|1785|1|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||881||881|2184| 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.10.1995||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|8243|7351|lyfalmen|V0322|3609|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4658||4658|7351| 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.03.2001||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4880|2184|lyfalmen|V0152|1972|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||881||881|2184| 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.03.2001||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14610|7351|lyfalmen|V0323|5397|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4658||4658|7351| 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|0|0|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||0|40|0||Icepharma hf|Norpharma |Malatíón|||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007|31.12.2012|R|0|0|0|0|0|1|SAA|0|0|0|100|NOK|7206|10400|lyfsjukr|||1|12|0|2,4000|Vistor hf|Sanofi - Aventis|Adenósín||7206||7206|10400| 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.12.2010||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|1150|1789|lyfalmen|V0243|1683|2|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||592||592|1789| 576122|L01XE1801|Jakavi|töflur|20|mg|60|stk|1|glas||L01XE18|01.11.2012||R|1|0|0|1|0|1|NOE|0|0|0|100|DKK|697926|877780|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||697926||697926|877780| 576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|*|0|ATL|0|0|0|100|XEU|3709|6053|lyfalmen|||1|25|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Merkaptópúrín||3709||3709|6053| 578259|A04AA0106|Ondansetron Mylan|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.05.2012||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|4085|4614|lyfalmen|V0384|4452|2|10|0|5,0000|Actavis Group PTC ehf|Mylan AB|Ondansetrón||2657||2657|4614| 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|6030|10519|vetorma|||0|20|0||Icepharma hf|Icepharma hf|||6030||6030|10519| 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|1425|2928|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1425||1425|2928| 579421|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4499|2114|lyfalmen|V0005|2114|3|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||830||830|2114| 579854|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|755|2012|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||755||755|2012| 580190|N06AB1005|Escitalopram LYFIS|filmhtfl|5|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|IKR|2800|3441|lyfalmen|V0324|3272|2|100|0|50,0000|LYFIS ehf|LYFIS ehf|Escítalópram||1800||1800|3441| 580227|A10BX0202|Repaglinid Krka (LYFIS)|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|2938|2906|lyfalmen|V0462|2906|3|90|0|11,2500|LYFIS ehf|LYFIS ehf|Repaglíníđ||1409||1409|2906| 581328|C10AA0505|Atorvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|IKR|2837|1991|lyfalmen|V0113|1991|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||740||740|1991| 581806|A10BX0202|Repaglinid Krka (LYFIS)|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|3390|3296|lyfalmen|V0472|3296|3|90|0|45,0000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1694||1694|3296| 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|15419|29779|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||15419||15419|29779| 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|2448|4328|lyfalmen|||0|2|0|25,0000|K.Pétursson hf|Alcon|Cýklópentólat||2448||2448|4328| 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|30125|39689|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||30125||30125|39689| 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|58138|74846|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||58138||58138|74846| 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|116274|147806|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||116274||116274|147806| 582213|R01AA0503|Nezeril|nefúđi|0,1|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|8|0|1,8750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|73705|94382|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||73705||73705|94382| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|5312|9267|vetorma|||0|50|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||5312||5312|9267| 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|20018|34920|vetorma|||0|200|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||20018||20018|34920| 582451|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|4597|3741|lyfalmen|V0011|2864|2|56|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||2019||2019|3741| 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|49561|64082|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||49561||49561|64082| 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|112754|143389|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||112754||112754|143389| 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|54635|70449|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||54635||54635|70449| 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|58924|75832|lyfsjukr|||1|2|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||58924||58924|75832| 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|108647|138234|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||108647||108647|138234| 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|ţpakki||C07AA07|01.01.1994||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1214|2640|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1214||1214|2640| 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|129679|164630|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||129679||129679|164630| 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|59214|76196|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||59214||59214|76196| 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|121979|154966|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||121979||121979|154966| 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|133338|169222|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||133338||133338|169222| 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúđir|B05BB01|01.11.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4067|5870|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||4067||4067|5870| 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúđir|B05BA03|01.11.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2463|3555|lyfsjukr|||2|9000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2463||2463|3555| 584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|19791|26720|lyfsjukr|||1|1|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||19791||19791|26720| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|ţpakki||N06AG02|01.07.1995||R|1|0|0|0|B|0|MAS|0|0|0|100|SEK|2043|3774|lyfalmen|V0064|3244|1|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíđ||2043||2043|3774| 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|4889|7056|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||4889||4889|7056| 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dćla|einnota dćla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|4824|7578|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4824||4824|7578| 585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|501|1645|lyfalmen|V0541|1645|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||487||487|1645| 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|34751|46158|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||34751||34751|46158| 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|1856|3518|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1856||1856|3518| 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|15142|20886|lyfsjukr|||2|800|0|10,0000|Actavis Group hf|Braun|Gentamícín||15142||15142|20886| 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|ţpakki|hart hylki+innönd.tćki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|404070|508990|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||404070||404070|508990| 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|10808|15018|lyfalmen|V0095|15018|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og ţvagrćsilyf||10263||10263|15018| 588395|N03AX2101|Trobalt|filmhtfl|50|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|5021|7847|lyfalmen|||1|84|0|4,6700|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||5021||5021|7847| 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2334|4172|lyfalmen|V0461|4169|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2334||2334|4172| 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|ţpakki||B01AC05|01.04.1995||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|10693|15606|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||10693||10693|15606| 588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|10016|12167|lyfalmen|V0282|11098|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||8179||8179|12167| 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|6502|11342|vetorma|||0|3|0||Icepharma hf|Pfizer Animal Health|Selamectinum||6502||6502|11342| 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|2520|4396|vetorma|||0|1|0||Icepharma hf|Pfizer Animal Health|Selamectinum||2520||2520|4396| 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|6273|10943|vetorma|||0|6|0||Icepharma hf|Pfizer Animal Health|Selamectinum||6273||6273|10943| 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|3388|5910|vetorma|||0|1|0||Icepharma hf|Pfizer Animal Health|Selamectinum||3388||3388|5910| 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|3519|6139|vetorma|||0|2|0||Icepharma hf|Pfizer Animal Health|Selamectinum||3519||3519|6139| 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|DKK|3387|5908|vetorma|||0|2|0||Icepharma hf|Pfizer Animal Health|Selamectinum||3387||3387|5908| 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||| 590562|C01DA1403|Ismo|forđatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|2169|3946|lyfalmen|V0041|3946|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíđ mónónítrat||2169||2169|3946| 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|0|0|0|0|*|0|LBK|0|0|0|100|DKK|24451|33231|lyfalmen|||1|10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||24451||24451|33231| 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|192012|242858|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||192012||192012|242858| 591260|N06DA0302|Exelon (Lyfjaver)|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|E|0|LVR|0|0|0|100|DKK|16162|22828|lyfalmen|V0347|22828|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||16162||16162|22828| 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|0|0|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||0|500|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|876769|1102228|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||876769||876769|1102228| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|552|1734|lyfalmen|V0238|772|1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||552||552|1734| 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|977|2315|lyfalmen|V0238|2315|1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||977||977|2315| 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|1441|2950|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1441||1441|2950| 593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|B|0|MAB|0|0|1|100|SEK|22943|31339|lyfalmen|||1|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||22943||22943|31339| 594408|C10AA0504|Atorvastatin Portfarma|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|7867|4330|lyfalmen|V0114|3715|2|100|0|200,0000|Portfarma ehf|Portfarma|Atorvastatín||2450||2450|4330| 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|361|630|vetorma|||0|10|0||Icepharma hf|Pfizer Oy Animal Health|||||361|630| 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995|31.12.2012|L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|2824|4926|vetorma|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||||2824|4926| 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|6364|9185|lyfsjukr|||1|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||6364||6364|9185| 595991|J07BB0201|Fluarix|bóluefni|||0,5|ml|1|áfspr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|673|1900|lyfalmen|||1|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||673||673|1900| 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|0|0|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||0|250|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|69221|88755|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||69221|88755| 596881|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|20685|27842|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||20685||20685|27842| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|ţpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2493|4389|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2493||2493|4389| 597433|L01XC1101|Yervoy|stţ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|0|0|100|DKK|728948|916712|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||728948||728948|916712| 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNO|0|0|1|100|NOK|506|1671|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||506||506|1671| 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||| 692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|0|0|1|0|0|0|PCO|0|0|0|100|DKK|4391|6986|lyfalmen|||0|100|1|33,3300|Distica|Distica - óskráđ lyf|Amfetamín||||4391|6986| 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|ţpakki||A03FA03|01.05.1998||R|0|0|0|0|0|0|PCO|0|0|1|100|SEK|3051|5153|lyfalmen|||0|100|1|33,3333|Distica|Distica - óskráđ lyf|Dómíperídón||3051||3051|5153| 923351|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|480|1636|lyfalmen|||0|4|1||Distica|Distica - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||480||480|1636| 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|6713|10162|lyfalmen|||0|100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Kolkisín||6713||6713|10162| 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|19285|26748|lyfalmen|||0|100|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Kaptópríl||19285||19285|26748| 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|3147|5284|lyfalmen|||0|1|1|33,3300|Distica|Distica - óskráđ lyf|Testósterón||3147||3147|5284| 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5769|8871|lyfalmen|||0|100|1|13,3300|Distica|Distica - óskráđ lyf|Kortisón||5769||5769|8871| 944852|A06AX0102|Glycerol infant|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|342|1447|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||342||342|1447| 944985|A06AX0103|Glycerol adult|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|664|1887|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||664||664|1887| 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|2293|4116|lyfalmen|||0|10|1|10,0000|Distica|Distica - óskráđ lyf|Prómetazín||2293||2293|4116| 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|5033|7864|lyfalmen|||0|100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|Kortisón||5033||5033|7864| 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1990|3701|lyfalmen|||0|100|1|33,3300|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||1990||1990|3701| 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5769|8871|lyfalmen|||0|100|1|3,3300|Distica|Distica - óskráđ lyf|Hýdrókortisón||5769||5769|8871| 954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1870|3537|lyfalmen|||0|60|1||Parlogis hf|Parlogis - óskráđ lyf|Fúrósemíđ||||1870|3537| 954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|5690|8763|lyfalmen|||0|150|1||Parlogis hf|Parlogis - óskráđ lyf|Própranólól||||5690|8763| 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|ţpakki||A04AD05|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1960|3660|lyfalmen|||0|20|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Metópímazín||1960||1960|3660| 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|ţpakki||H02AB09|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1850|3510|lyfalmen|||0|20|1|6,6700|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||1850||1850|3510| 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|6231|9503|lyfalmen|||0|25|1|16,7000|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||6231||6231|9503| 962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|3451|5700|lyfalmen|||0|100|1|266,6600|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||||3451|5700| 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|ţpakki||R06AB02|01.11.2009||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2360|4207|lyfalmen|||0|30|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexklórfeníramín||2360||2360|4207| 965767|A03AA0703|Dicykloverin Syrup|mixtúra|2|mg/ml|120|ml|1|glas||A03AA07|01.08.2011||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|8480|12579|lyfalmen|||0|120|1|3,0000|Parlogis hf|Parlogis - óskráđ lyf|Dícýklóverín||8480||8480|12579| 967333|N05AH0408|Quetiapin Bluefish|filmhtfl|25|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|IKR|1200|2073|lyfalmen|V0284|1712|2|60|0|3,7500|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||800||800|2073| 967341|N05AH0408|Quetiapin Bluefish|filmhtfl|100|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|IKR|6800|5904|lyfalmen|V0285|5904|2|60|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||3600||3600|5904| 967359|N05AH0408|Quetiapin Bluefish|filmhtfl|200|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|IKR|12500|12333|lyfalmen|V0286|12333|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||8300||8300|12333| 967367|N05AH0408|Quetiapin Bluefish|filmhtfl|300|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|IKR|25000|26767|lyfalmen|V0287|26767|2|60|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||19300||19300|26767|